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Abstract 
 
 Novel symmetric and asymmetric water-soluble tetrabenzoporphyrins are 
synthesized in relatively good yields. These compounds are synthesized by the 
condensation of butanopyrrole with several aldehydes that contain masked water 
solubilizing groups followed by metal insertion, oxidation and demetallation and 
deprotection of the masked solubilizing groups. The biological evaluation (in vitro and in 
vivo) studies are described in addition to the photophyiscal evaluations of the 
corresponding compounds.  
 A novel versatile route to the syntheses of novel free-base and metallo-
benzoylbiliverdins is discussed. The treatment of metal free dodecasubstituted porphyrin 
with sodium nitrite and trifluoroacetic acid at room temperature in the presence of 
oxygen affords ring-opened benzoylbiliverdin in 77-80% yields. These compounds are 
metallated with several diamagnetic metal ions and their structures confirmed by NMR 
and X-Ray crystallography. Tetramerization of excess butanopyrrole and several 
aldehydes also afforded novel metallo-butanocorroles and metallo-benzocorrole. The 
structures of these compounds are also analysed using MS (MALDI), NMR and X-Ray 
crystallography. 
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Chapter 1: Introduction 
1-1: Porphyrins 
Porphyrins are biochemically important, medically useful, and synthetically 
interesting compounds. Porphyrins that occur naturally play a major role in the life 
sustaining biochemical reactions. They are a ubiquitous class of compounds with many 
important biological representatives including hemes, chlorophylls, myoglobins, 
cytochromes, catalases, peroxidases, and several others. Used by nature in the most 
important processes of photosynthesis and solving transport and other problems in living 
systems, these compounds have been described as “pigments of life”.1 Their aromatic 
character, inner chelating pocket and varying peripheral carbon chains have allowed 
scientists to discover new and unique chemical reactions. Porphyrins and their metal 
complexes have also stirred interdisciplinary interest due to a multitude of their intriguing 
physical, chemical and biological properties.2 
 
HN
N
N
NH
Figure 1-1: Porphyrin macrocycle 
 
The porphyrin macrocycle (Figure 1-1), consists of four pyrrole rings joined by 
four interpyrrolic methine bridges to give a highly conjugated macrocycle. The 
aromaticity of porphyrins has been well established both by its chemical and physical 
properties.3 These tetrapyrrolic systems have a closed loop of edgewise overlapping p 
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orbitals which interact favorably to stabilize the olefins; the 22 π electrons available in 
porphyrins make up six different 18e-delocalization pathways, (Scheme 1-1) which 
follow Huckel’s 4n + 2 rule for aromaticity. A lower number of delocalization pathways 
results in less aromatic character that produces differences in spectroscopic properties.4  
Kuster proposed the current model of the intricate porphyrin ring system in 1912.5 
X-ray crystallography supports this model and shows that the porphyrin macrocycle 
indeed consists of four pyrrole rings joined by interpyrrolic methine bridges. The entire 
ring system is considered to be planar but flexible, although meso-substituted sterically 
hindered porphyrins display less planarity.6a Lowered heats of combustion also 
demonstrate considerable resonance energy, and electrophilic aromatic substitutions 
readily occur at the periphery of the macrocycle. These substitution reactions can occur 
both on the porphyrin and metalloporphyrin derivatives; typical examples are nitration, 
halogenations, sulfonation, formylation, acylation and deuteration.6b  
Porphyrins and their derivatives are highly colored absorbing strongly in the 
visible region near 400 nm (molar extinction coefficients are about 105 Mol-1L) 
characteristic of the macrocyclic conjugation and several weaker absorption bands known 
as Q bands between 450-700 nm. The main intense absorption band is known as the Soret 
band,7 named after the biochemist who first observed it in hemoglobin. A variation in the 
peripheral substituents of the porphyrin ring normally results in a slight change in the 
intensity and wavelength of the absorption bands. A disrupted porphyrin macrocycle 
results in the disappearance of the Soret band.8 Each tetrapyrrolic system can be unique 
and therefore different in color. Porphyrins that occur naturally are dark red while 
chlorins, which are reduced tetrapyrrolic systems are dark green or blue green.  
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Scheme 1-1: 18 pi-electron pathways which make up the
aromatic character of the porphyrin ring system  
 
The absorbance energy intensities vary with chelation, pH, and differences in the 
structure of peripheral substituents. However, as long as a cyclic 18 π e- path exists, the 
intense Soret band is really a major characteristic of their optical spectra. 
The porphyrin macrocycle and its derivatives are amphoteric, behaving both as 
acids and bases. The nitrogen atoms at the centre of the porphyrin core are responsible for 
this interesting characteristic. The NHs can be deprotonated with strong bases, while the 
two-imine nitrogens can be protonated with acids. However, metallated porphyrins lack 
this amphoteric quality because the nitrogens are chelated to the metal with both covalent 
and dative bonds. The NMR spectrum of the aromatic tetrapyrrole shows anisotropic 
effects.9, 10, 11, 12 The ring current generated by the applied field induces a local magnetic 
field similar to that in benzene. The NH protons, inside the porphyrin ring system are 
therefore shifted upfield to as high as -5 ppm in porphyrins whereas the deshielded meso-
protons appear at very low field (δ ~ 10 ppm),13 the pyrrolic protons are also deshielded 
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and tend to resonate at δ 8 to 9, versus δ ~ 6 ppm in pyrrole. Although the aromaticity of 
these porphyrin systems makes their NMR spectra a challenge to assign, the tendency 
toward aggregation in some cases makes for even more complicated spectra. 14  
Awareness of porphyrins importance to life has stimulated large amounts of research into 
purification, structure determination, synthetic manipulation, and total synthesis of these 
macrocycles.15  
1-2: Porphyrin Syntheses 
The porphyrin field began with the synthesis of a large class of pyrroles. Most of 
this early work was accomplished by Fischer16 in Munich, and was followed by the 
synthesis of a variety of porphyrins. Known as the grandfather of porphyrin chemistry, 
Hans Fischer has inspired a large number of research groups throughout the world to 
improve upon his methodologies. In general, there are several routes that can be followed 
to afford porphyrins. The first route entails the functionalization of an intact ring system 
obtained from natural sources such as chlorophylls a or b, bacterio-chlorophylls and 
hemin (Figure 1-2), which are and modified to give the desired porphyrin. The second 
route is the formal total synthesis beginning with monopyrrolic subunits. The former 
method although useful, severely limits the type of functional groups that can be 
introduced. Regardless of the method of synthesis, porphyrins make up a selected class of 
compounds, which are an important part of chemistry and possess some very important 
applications that are yet to be completely explored. Most of the synthetic methodologies 
that will be discussed in detail henceforth are important because some will be utilized 
throughout this dissertation. 
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Figure 1-2: Examples of porphyrin derivatives that occur in nature
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1-2-1: Porphyrins from Tetramerization 
The simplest porphyrins are symmetric and have a C4d symmetry element. These 
porphyrins are easily prepared via the tetramerization of a suitable monopyrrolic 
subunits.17, 18 These symmetric porphyrins can fall in either category of octa-ß substituted 
or tetra-meso substituted porphyrins. The tetra-meso substituted porphyrins are prepared 
by condensation of a 2,5-unsubstituted pyrrole 1-1 in the presence of a meso-carbon 
providing reagent (e.g. benzaldehyde) 1-2 and in the presence of acid affording the 
corresponding porphyrin 1-3.19 On the other hand, octa- ß substituted porphyrins are 
synthesized via self-condensation of pyrroles 1-4  (R = electron-withdrawing groups) in 
the presence of a base followed by heating in acid to give the desired porphyrin 1-5, 
usually in yields as high as 40% or greater. Monopyrrole tetramerization works best for 
pyrroles with identical 3- and 4 substituents because if the substituents on the 
monopyrrole are not identical, acid catalyzed pyrrole ring scrambling reactions occur.20  
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Scheme 1-2: Symmetric Porphyrins from tetramerization  
 
1-2-2: Porphyrins from Dipyrromethenes 
This procedure was developed by Fischer (who won a Nobel prize in 1930) and 
used in the synthesis of Hemin 1-6, via a deutoroporphyrin IX (1-9) intermediate. This 
procedure was effected by condensation of 1,9-dimethyl-dipyrromethene (1-7) and 1,9 
dibromo-dipyrromethene (1-8) affording porphyrin (1-9). This dipyrromethene self-
condensation was accomplished in organic acid melts (e.g. tartaric, succinic) at 
temperatures of up to 200 ºC.21 However, as a result of synthetic restriction, this 
procedure is limited to only select symmetries. Very harsh thermal conditions are 
  
 7 
required thus hampering the introduction of sensitive substituents on the dipyrromethene 
ring. 
N
N
N
N
Me
Me
MeMe
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COOH
COOH
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Cl
 
 
HNNH
MeMe
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MeMe
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1-2-3: Porphyrins from Condensation of Dipyrromethanes 
MacDonald improved Fischer’s dipyrromethene condensation procedure in 
1960.22 The so-called “2 + 2” MacDonald’s condensation utilizes milder conditions thus 
allowing the use of dipyrromethanes, which are compounds that are generally much more 
available than dipyrromethenes. Fischer had previously reported that dipyrromethanes 
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were too unstable under the cyclization conditions.21 MacDonald’s route basically entails 
the condensation of 1,9-diformyl dipyrromethane 1-10 with 1,9-unsubstituted 
dipyrromethane 1-11 affording the desired porphyrin 1-12 in yields of up to 60%. 
However, the major drawback of this route is that dipyrromethanes are inherently 
unstable toward most acidic reagents resulting to scrambling or redistribution23 
occurrences. 
HNNH
R5
R6R6
R5
HN
CHOOHC
NH
R4
R3R2
R1
Scheme 1-4
1-10
HH
HN
N
N
NH
R2
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R3
R4
R5
R6
R5
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1-12
1-11
 
 
1-2-4:  Porphyrins from Cyclization of Open Chain Tetrapyrrolic Compounds 
 
This methodology favors the synthesis of totally unsymmetrical porphyrins where 
all four pyrrole rings are different. The previous methodologies discussed can only allow 
select symmetries. This synthetic route was developed to circumvent the scrambling of 
pyrrole subunits from occurring during the cyclization process and to facilitate the 
formation of only one porphyrin isomer. A variety of intermediates are available: bilanes 
1-13,24 a-oxobilanes 1-14,25 b-oxobilanes 1-15,26 a-bilenes 1-16, b-bilenes 1-17,27 and 
a,c-biladienes 1-18.28 Corwin and Coolidge24 utilized the bilane route to synthesize 
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etioporphyrin II, however this route was not very successful because it afforded a mixture 
of inseparable isomers due to the instability of bilanes that resulted to redistribution.  
HN
HN
NH
NH
1-13
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NH
NH
O
HN
HN
NH
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O
HN
HN
NH
N
HN
HN
NH
N
1-14 1-15
1-16 1-17 1-18
Figure 1-3: Examples of Open Chain Tetrapyrrolic Compounds  
 
An improved method that prevented pyrrole redistribution was then developed by 
Smith and Kenner.26 This method utilized the introduction of an electron withdrawing 
group (oxobilane). In this route, the most successful oxobilane was the b-oxobilane 
because the oxo-function at position a exerted such a stabilizing electron withdrawing 
effect that it reduced the nucleophilicity of the pyrrole A ring to a point that cyclization 
could not take place. One of the major drawbacks of the b-oxobilane route was that the 
method was lengthy and required a large number of steps. Cyclization from a-bilenes 
gives a mixture of porphyrins;29 all productive synthesis using bilenes have therefore 
made the use of b-bilenes.30 b-Bilenes bearing methyl substituents in positions 1 and 19 
have been readily cyclized to give copper porphyrins with copper salts in pyridine or 
dimethylformadide.31  
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This procedure can be used on many occasions for cyclization of b-bilenes bearing 
electron withdrawing groups. The porphyrins can then be easily demetallated with 
concentrated sulfuric acid. The most convenient and successful method via open chain 
tetrapyrrolic porphyin synthesis is the use of a,c-biladiene 1-18. 
 a,c-Biladienes that are symmetrical can be easily prepared by treating a 1,9-
diacid or unsubstituted dipyrromethane 1-19 with formylpyrrole 1-20 as shown in scheme 
1-5.32 Subsequent cyclization of the a,c-biladiene using Copper (II) salts in DMF affords 
the Cu(II) complex porphyrin, high yields of the metal-free porphyrin are usually 
obtained after removal of chelating copper atom 1-21.33 Synthesis of asymmetric 
porphyrins using the a,c-biladiene route is achieved via a tripyrrene, by differentially 
protecting the pyrromethane with terminally mixed esters. Selective removal of the esters 
  
 11 
affords an adequate intermediate for further elaboration.34 In the cyclization of a,c-
biladiene to porphyrin, the reaction is believed to proceed via a free radical pathway 
where one of the methyl groups is lost while the other is retained as the new methine 
carbon.35 
1-3: Biological Applications of Porphyrins 
1-3-1: Photodynamic Therapy (PDT) 
PDT is a therapeutic method that employs the combination of light and a drug to 
bring about a cytotoxic effect to cancerous or unwanted tissues. It is a developing 
technique, which can destroy unwanted tissue while sparing the normal tissue. In PDT, 
the drug (photosensitizer) of negligible dark toxicity is introduced to the body 
accumulating preferentially in the rapidly dividing cells. This drug is harmless and has no 
effect to both healthy and abnormal tissue and is only activated when exposed to a 
carefully regulated light dose, rapidly destroying the tissue precisely where the light is 
directed.36 
 Methods currently used to eliminate or control cancer are removing the cancer 
cells by surgery, killing the cancer cells with lethal doses of radiation, and chemotherapy 
or a combination of the above therapies. Although chemotherapy, radiotherapy and 
surgery effectively extend the lives of approximately 50 percent of patients who develop 
malignant tumors, the majority of the patients die from direct or indirect effect of tumor 
metastases or from adverse consequences of these therapies.37 In PDT, adverse side 
effects in normal tissues are minimal since the photosensitizer is taken up and retained in 
the tumor tissue.38 
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1-3-1-1: Mechanism of Action in PDT 
E
3O2
1
O2
S
1
S3
S2
1 3
4
5
6
7
2
1. Absorption of Light
2. Internal Conversion
3. Fluorescene
4. Inter-system crossing
5. Phosphorence
6. singlet Oxygen prodution
    (Type II Photoprocess)
7. Hydrogen or electron transfer
    (Type I Photoprocess)
Figure 1-4: Mechanism of PDT39
T1
S0
 
 
PDT combines the preferential accumulation of the photosensitizer in the target 
tissue with precise illumination to provide the selectivity of the treatment. The light 
penetrates the tissue and causes excitation of the photosensitizer which then reacts with 
molecular oxygen and other substrates generating highly cytotoxic species e.g. singlet 
oxygen, super oxide anion, hydroxyl radicals that cause irreversible damage to the tumor 
cells. Figure 1-4 shows a modified Jablonski diagram outlining the mechanism of PDT.39 
Photosensitizers have a stable electronic configuration that is in a singlet state in their 
lowest or ground state (S0). Irradiation of light of appropriate wavelength causes 
excitation of the photosensitizer to its singlet excited state (S1). The singlet excited 
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photosensitizer can decay back to the ground state with release of energy in form of 
fluorescence enabling identification of tumor tissue or by internal conversion with energy 
loss as heat as shown in Figure 1-4.40 The excited photosensitizer can also undergo a non-
radiative process of inter-system crossing (ISC) thereby converting the photosensitizer to 
a triplet excited state (T1).  
ISC is a spin-forbidden pathway as it involves a change in the electron spin, but a 
good photosensitizer goes through this path with very high efficiency. The 
photosensitizer can then relax from the triplet excited state via at least two pathways: 
radiatively by phosphorence, and non-radiatively by transferring its energy to another 
molecule with a triplet ground state. Phosphorence is typically measured in 
microseconds, and the tendency of a photosensitizer to reach the triplet state is measured 
by the triplet state quantum yield. Phosphorence involves a spin-inversion and thus is a 
spin-forbidden pathway therefore imposing a relatively long time on the triplet state and 
allowing interaction with molecules in the vicinity of the photosensitizer. Molecular 
oxygen, which is found in abundance in tissue, has a triplet ground and can interact with 
the triplet state photosensitizer, thereby generating highly cytotoxic species via either the 
type I or II mechanism as shown in Figure 1-3. Type I mechanism involves 
electron/hydrogen transfer from the sensitizer or from substrate molecule producing ions 
and free radical (e.g. super oxide and peroxide anions), which then attack the cellular 
targets. Type II mechanism involves the direct interaction of the excited triple state 
photosensitizer with molecular oxygen producing the electronically excited and highly 
reactive singlet oxygen. The photosensitizer then returns to its single ground state and is 
able to repeat the process of oxygen transfer to oxygen several times.41, 42 
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Numerous porphyrin type chromophores have been shown to be effective as 
photosensitizers for PDT of cancers.43 Porphyrins are the most explored sensitizer/tumor 
active compounds because of their known ability to accumulate in tumor tissues and 
persisting there for long periods of time.44 In comparison to other aromatic macrocycles 
that also exhibit reasonable tumor selectivity in tissues such as acridine, florescein, eosin 
and rhodamine, porphyrins have low-dark toxicities.45 Apart from exhibiting low dark 
toxicity, they also have high chemical stability, high affinity for serum proteins, favorable 
pharmacokinetic properties, formation of very stable complexes with a variety of metal 
ions while retaining their in vivo properties, are fluorescent and absorb strongly in the 
visible region of the optical spectrum.46  
The distribution of porphyrin drugs in the body is still under investigation. It is 
believed that the uptake and retention of porpyrin-type molecules in tumors is highly 
dependent upon structural features that is the nature of peripheral groups, coordinated 
metal ions and accompanying axial ligands. 46 Photosensitizers are administered 
systemically (via injection into the bloodstream) and it is generally believed that 
improved tumor-specificity is displayed by amphiphilic molecules that bear both 
hydrophobic sites (for transversing through the lipid membrane) and hydrophilic sites 
that favor water solubility at the macrocyclic periphery.47 The mechanisms responsible 
for porphyrin tumor- selectivity are still under debate, however it has been hypothesized 
that porphyrins have the tendency of association to plasma proteins,48 particularly low 
density lipoproteins (LDL) and the increased level of LDL receptors on cancer cells. 
Porphyrins effectiveness as therapeutic agents is also related to the developing 
vasculature of the neoplastic cells 49,50 These compounds can be internalized to the cells 
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via passive diffusion through the plasma membrane or fluid phase endocytosis and non-
receptor mediated processes.51 
The first porphyrin evaluated for PDT was hematoporphyrin, which is readily 
available from blood. In the early 1960’s, Lipson et al prepared a derivative of 
Hematoporphyrin (HPD) that was shown to display an enhanced selectivity for PDT 
efficiency. HPD is a complex mixture of compounds i.e., hematoporphyrin, 
protoporphyrin-IX, hydroxyethylvinylporphyrin, as well as a complex dimeric and 
oligomeric fraction containing esters, ether and carbon-carbon linkages of 
hematoporphyrin.52 
A more purified form of HPD known today as Photofrin® was prepared by 
Dougherty et al in 1981 by using gel exclusion chromatography. Photofrin® was 
approved in the US by the Food and Drug Administration (FDA) and in eleven European 
countries and has been used successfully over the last two decades in the treatment of 
patients with melanoma, early and advanced stages of cancer of the lung, digestive tract 
and genitourinary tract.53 Although Photofrin® has proven curative for a range of cancers, 
there some well documented drawbacks to treatment with this photosensitizer. Being a 
complex mixture of HPD’s, there questions concerning the reproducibility of the 
synthesis and pharmacological benchmarking. Photofrin® also absorbs weakly at 630 nm, 
this wavelength of light can penetrate tissue to a depth of few mm, making the compound 
unsuitable for treatment of deep-seated tumors. Prolonged skin sensitivity as a result of 
long retention time of this drug in normal skin is also an undesirable side effect.54 These 
considerations have led, since the early 1980’s to the search of new and improved 
compounds for PDT. The profile of an ideal PDT photosensititizer is that the drug should 
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have good pharmacokinetic properties, fluorescent with increased absorbance in the red 
region of the optical spectrum, high quantum yield of triplet fomation, good cytotoxic 
oxygen species generation, increased selectivity for malignant tissue over normal tissue 
and exhibiting low dark toxicity.55 
Research in the last decades has mainly centered on the synthesis of porphyrin 
type sensitizers and the investigation of their structure-activity relationships.56 Chlorins, 
benzoporphyrins, phthalocyanine, and texaphyrins (tripyrrole expanded macro cycles) are 
long wavelength absorbers and are the most studied porphyrin-type photosensitizing 
drugs. Compounds that absorb in the 650-750 nm spectral window are preferred, because 
light of this wavelength penetrates deeper through tissue with minimal light scattering. 
Mono-L-aspartyl chlorin e6 (MACE)57 1-22 obtained from chlorophyll and 
benzoporphyrin derivative mono-carboxylic acid (BPD-MA, VisudyneTM) 1-23, are 
examples of naturally derived second generation photosensitizers currently undergoing 
human clinical trials for treatment of various cancers using PDT. The FDA and the 
Canadian Therapeutic Products Health Program recently approved VisudyneTM 1-23, for 
the treatment of age-related macular degeneration.58 Synthetically derived second 
generation photosensitizers currently in early clinical trials for the treatment of various 
cancers are the symmetric meso-tetra (m-hydroxyphenyl)chlorin (m-THPC, Foscan®)59 
and Sn(IV)-etiopurpin (SnET2, PuryltinTM).60, 61 
Other synthetically derived compounds that display unique photo physical and 
biological characteristics making them highly suitable for applications in PDT are 
metallo-phthalocyanines and the related metallo-naphthalocyanine that have red shifted 
absorbance bands in the 750-800 nm region.62, 63  
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Figure 1-5: Examples of Porphyrin based Drugs  
 
Texaphyrins and porphycenes64 are other polypyrrolic compounds that have also 
shown excellent tumor localizing and photo physical properties. Texaphyrins, absorbing 
very strongly in the 720-780 nm region form very stable metal complexes with trivalent 
lanthanides.66  
1-3-2: Boron Neutron Capture Therapy 
Boron neutron capture therapy (BNCT) is a binary radiation modality that brings 
together two components that do not have adverse effects on the cells when kept separate. 
Like PDT, BNCT is a relatively new developing cancer therapy that has the potential of 
destroying diseased tissue whilst sparing normal tissue.68 The first component is a stable 
isotope of boron (10B) that can be concentrated in tumor cells by attaching it to a tumor-
seeking compound. The second component is a beam of low energy neutrons. After 
capturing a neutron, the 10B disintegrates and the high-energy charged particles produced 
destroy the cells in close proximity, primarily killing the cancer cells while leaving the 
adjacent normal cells largely unaffected.69 BNCT is based on a nuclear reaction that 
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occurs when a stable isotope of 10B that has a relatively high neutron capture cross-
section value (σ = 3838), is irradiated with low energy/ thermal neutrons to yield highly 
energetic helium-4 (4He2+) nuclei/ alpha particles and recoiling Lithium-7 (7Li3+) ions and 
releasing about 2.4 MeV of kinetic energy (eq. 1).70 
10B + 1n →7Li3+ + 4He2+ +γ + 2.4 MeV (eq. 1) 
Therefore the higher the dose of 10B existing in the tumor cells relative to the 
normal cells results to a concomitantly higher dose being delivered to the tumor cells 
during neutron irradiation.71 10B is the most common nuclide used in neutron capture 
therapy because it is non-radioactive and readily available comprising approximately 20 
% of naturally occurring boron, secondly, the particles emitted by the neutron capture 
reaction have combined travel paths of approximately 12 microns, about one cell 
diameter limiting the radiation effects to the tumor cells. Boron chemistry is also well 
studied and therefore several 10B derivatives can be incorporated into a multitude of 
different compounds.72 Other nuclides that occur abundantly in tissue like 12C, 1H, 14N 
and 16O, do not exhibit a high nuclear cross-section for neutron capture therapy (0.0035, 
0.333, 0.00019 and 1.83 barns) respectively.73 
The treatment of malignant and therapeutically persistent brain tumors, 
glioblastoma multiforme (GBM) with NCT, was first suggested by Sweet in 1951.74 
Sweet et al75 demonstrated that certain compounds would concentrate in human brain 
relative to normal brain tissue. However, a clinical trial of NCT76, 77 initiated in the early 
1950 and 1960 period using a thermal neutron beam and sodium tetraborate, borax 
(Na2B4O7*10H20) as the capture agent failed to show any evidence of therapeutic 
efficacy.  
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The two major reasons for their lack of success was that a rapid attenuation of the 
thermal neutrons in tissue due to absorption and scattering occurred resulting to a limited 
(3-4 cm) in depth penetration.  
 
Figure 1-6: Schematic of Boron-10 Neutron Interaction
http://web.mit.edu/nrl/www/bnct/info/description/description.html#RTFToC2  
 
The boron compounds used were also freely diffusible, low molecular weight substances 
that did not achieve selective localization in the brain tumors.78 In the ensuing years, 
second-generation boron based compounds based on polyhedralborane anions, 
carboranes and substituted phenylboronic acids were developed.  
SH
(HO)2B CO2
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BSH BPA
= BH
= B
1-24 1-25
Figure 1-7: Examples of Boron-10 Containing Drugs  
 
  
 20 
Because of  their low toxicity and tumor localizing properties, L-4-
dihyroxyborylphenylalanine (BPA) 1-2579 and disodium mercapto-closo-dodecarborate 
(BSH) 1-2480 were chosen for clinical studies and are currently undergoing Phase I/ II 
clinical trials in US, Europe and Japan, for the treatment of patients with melanomas and 
glioblastomas.81  
Figure 1-8: Schematic depicting the concept of BNCT
http://web.mit.edu/nrl/www/bnct/info/description/description.html#RTFToC2  
However, some of the major drawbacks of BPA (1-25) and BSH (1-24) are that 
they only display moderate selectivity for tumor cells and low retention times in tumors. 
BPA (1-25) also has a low boron content therefore a large dose is required to deliver 
therapeutic amount of 10B to the tumor cells.82 For BNCT to be effective, there must be 
~15-30 µg of 10B/g of tumor and a low concentration of (<5 µg of 10B/g of cell) in the 
surrounding normal cells and blood.83, 84 Less boron is needed for effective BNCT lethal 
damage, if the 10B is located intracellularly as opposed to extracellularly and also if the 
boron localizes inside or in close proximity to the cell nucleus.85 
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 The development of new 10 B-carriers with improved tumor selectivity and 
retention over BPA and BSH has been a major challenge. Various boron-containing 
analogues of biologically active compounds such as amino acids,86 peptides,87 and 
nucleosides/nucleotides,88 have been synthesized. Boron-containing analogues of 
porphyrins89 and DNA90 binders have also been considered as potential agents for PDT. 
Of the new boron-delivery agents, boron-containing porhyrins appear to be the most 
promising tumor-selective compounds because of their demonstrated tendency to 
effectively accumulate within neoplastic cells and to be retained there for long periods of 
time91 in addition to exhibiting most of the characteristics of an effective BNCT agent.92  
Several boron containing porphyrins derivatives have been synthesized and 
evaluated in vitro and in vivo.94 The source of boron in the new BNCT sensitizers is 
usually hydrophobic o-carborane (o-C2B10H11) 1-26 or the amphiphilic nido-carborane 
(o-C2B9H11-) 1-27. These cages are said to have relative high boron content and display 
extraordinary thermal, kinetic and photochemical stabilities relative to other boron 
clusters.93, 94 
H
C        BH
H H
HH
closo-carborane nido-carborane
(o-isomer)
1-26 1-27
Figure 1-9: Open and Closed Shell Carborane Cages 
Some of the results achieved for some of the compounds have shown that 
boronated porphyrins retain the ability to selectively accumulate in neoplastic tissues, 
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delivering seemingly high boron to tumor concentrations of >30 µg 10B/g of tumor. When 
compared to PDT, NCT has an advantage because the epithermal neutron beams can 
penetrate deeper than red light to reach deep-seated tumor sites. However several 
questions concerning the stability of carborane-porphyrin linkages, and their excessive 
hydrophobic nature still remain the topic of continuous research.95 In this dissertation, the 
synthesis of a novel-carboranylated porphyrin and preliminary in vitro and in vivo results 
will be discussed in the next Chapters.  
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Chapter 2: Syntheses and Characterization of Asymmetric Porphyrin Derivatives 
2-1: Introduction 
meso-Substituted asymmetric porphyrins (A3B) have recently found specific 
biomedical applications, particularly in the field of detection and treatment of neoplastic 
tissue (PDT) and also labeling and analysis of nucleic acids.1a Not only have they found 
use in the medicinal field, but they also display unique properties and find application in 
several, optoelectronics, catalysis, biomimetic and material chemistry.1b The availability 
of suitable building blocks through synthetic methodologies that have the flexibility for 
structural modification is closely tied to the level of architectural sophistication achieved 
in such systems. 5-Substituted dipyrromethanes are important synthetic intermediates and 
are well-established precursors for the synthesis of symmetric and asymmetric meso-
substituted porphyrins, expanded porphyrins, and other porphyrin analogues.2a Not only 
are they key precursors to meso-substituted asymmetric porphyrins, but also 
calix[4]pyrroles and calix[4]phyrin macro cycles, which are well established as redox-
active or optical sensors for anions.2b 
In the recent years, several convenient procedures for the synthesis of meso-
substituted porphyrins (A3B) bearing three identical molecular structure (A) and one 
different group (B) have been developed from meso-substituted dipyrromethanes.3a (B), 
bears a functional group which can be used to link the porphyrin with other biologically 
active molecules, while A are substituted with functional groups that allow the changing 
of the physical properties of the tetrapyrrolic macrocycle (i.e., water-solubilizing 
groups).3b In PDT, the effective photosensitization can be enhanced by having 
asymmetrically substituted porphyrins with a combination of hydrophobic and 
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hydrophilic groups. This substitution pattern normally results in an intramolecular 
polarity axis that facilitates membrane penetration of the porphyrin in subcellular 
compartments.4 Considerable effort for the development of new methodologies for the 
synthesis of these diverse building blocks towards the synthesis of asymmetric 
porphyrins has been invested. However, there still remains a scope for shorter and more 
efficacious approaches to contribute towards achieving the synthesis of these systems in a 
synthetically useful manner.5 In this Chapter, two routes to asymmetric porphyrins will 
be discussed. The first route entails the step wise synthesis of dipyrrolic intermediates 
followed by their condensation and the second route utilizes the tetramerization of 
pyrroles with several aryl aldehydes followed by para-functionalization of the meso-
phenyl substituents. 
2-2: “2+2” Condensation Route 
 The condensation of dipyrrolic intermediates to synthesize porphyrins is a useful 
approach for the formation of porphyrins that are centrosymmetrically substituted as well 
as porphyrins that have symmetry in one or both halves of the molecules.6 The first route 
to the formation of centrosymmertrically substituted porphyrins was first developed by 
Hans Fischer7 through the self condensation of 1-bromo-9-methyldipyrromethenes in an 
organic acid melt (e.g., succinic acid) at temperatures of up to 200 °C giving good yields 
of porphyrin. (See Chapter 1, Schemes 1-3).  
Fischer’s synthesis dominated the way porphyrins were constructed but this was 
subject to change when Ferguson MacDonald8 introduced the use of more reduced 
building blocks than those of Fischer’s in the form of dipyrromethanes. Although known 
in Fischer’s time, the dipyrromethane route was not widely used because of the problem 
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of pyrrole redistribution during porphyrin formation. However, in 1960, this route 
became common after MacDonald developed milder conditions for the reaction. The 
MacDonald condensation is a two-step sequence involving initial 2+2 condensation of 
dipyrromethane derivatives followed by oxidation. This procedure is useful for making a 
wide variety of symmetric and asymmetric porphyrins. The original “ Mac Donald’s 
2+2” approach involved the condensation of 1,9-diformyldipyrromethane with 
unsubstituted dipyrromethane or the self condensation of monoformyldipyrromethane 2-
1, affording a non-aromatic dication intermediate called a porphodimethene salt 2-2 as 
shown in Scheme 2-1.9 
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These intermediate chromophores exhibit a deep red color typical of 
dipyrromethene species with a characteristic visible spectrum (maximum absorbances at 
430 nm and 710 nm respectively). The condensations were generally catalyzed by a 
protic acid such as p-toluene sulfonic acid or trifluoroacetic acid.10 On occasion, protic 
acids have been substituted with Lewis acid catalysts such as boron triflouride dietherate 
and have been used successfully under Lindsey conditions.16 Various oxidizing agents 
including molecular oxygen, iodine and quinones and metallation with salts such as 
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zinc(II) acetate then readily convert the porphodimethene intermediates into the 
corresponding porphyrin.11  
2-3: Results and Discussion 
Dipyrromethane derivatives are useful building blocks and have been synthesized 
using a variety of procedures.12 Most of them are indefinitely stable in the purified form 
when stored at 273 K in the absence of light.13 5-Unsubstituted dipyrromethanes have 
been prepared in three steps from pyrrole. 5-Aryldipyrromethanes have also been 
synthesized indirectly, requiring either the elimination of a protecting group from a 
pyrrole, or through the formation of a Grignard reagent.14a In addition to these, other 
syntheses based on the direct condensation of carbonyl reagents with pyrroles also 
exist.14b An attractive small scale synthesis of dipyrromethanes, in which pyrrole is used 
as a reagent as well as solvent with a catalytic amount of acid affords good yields of 
dipyrromethane bearing many types of substituents at the meso position.15  
Asymmetric porphyrins (A3B) have previously been prepared by the mixed 
condensation of pyrrole and two aldehydes affording a statistical mixture of all six 
substituted products, which are then separated by lengthy chromatographic methods 
generally affording only small quantities of the desired porphyrin.16 Condensation of a 
dipyrromethane with a binary mixture of aldehydes has also been explored to obtain 
meso-substituted porphyrin with the A3B symmetry.17 This Chapter will focus on the 
development of synthetic routes to novel asymmetric dodeca-substituted water-soluble 
porphyrins with the A3B porphyrin symmetry pattern. The synthesis of porphyrins 2-4 
using a 2+2 MacDonald’s route will be discussed in this Chapter.  
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The retrosynthetic analysis to target asymmetric-meso-substituted TBP 2-4 is 
described in detail in Scheme 2-2. The condensation of dipyrromethane-dicarbinol 2-5 
with a 1,9-unsubstituted dipyrromethane 2-6 (route a), and the condensation of 1,9-
diformyldipyrromethane 2-7 with a Grignard reagent and 1,9-unsubstituted 
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dipyrromethane 2-6 (route b) to synthesize porphyrin 2-4 will be discussed. As an 
extension of MacDonald’s synthesis, the condensation of dicarbinol dipyrromethane 2-5 
with 1,9-unsubstituted dipyrromethane 2-6 afforded the asymmetric 
cyclohexenylporphyrin. In both routes, the precursor cyclohexenylporphyrins obtained 
are further aromatized to the corresponding tetrabenzoporphyrins (TBPs) with strong 
oxidizing agents like DDQ. The synthesis of dicarbinoldipyrromethane 2-5, an important 
intermediate in the 2 + 2 Macdonald’s route was achieved as outlined in Scheme 2-4 and 
the synthesis of 2-6 as shown in Scheme 2-3. 
Symmetric dipyrromethanes, that are the main building blocks in this synthetic 
methodology, are normally synthesized by self-condensation of a monopyrrole18 or by 
treatment of two moles of monopyrroles with a one carbon-reagent that provides the 5-
carbon.19 Reduction of dipyrromethene derivatives with NaBH4 also furnishes both 
symmetrical and asymmetric dipyrromethanes.20 In this dissertation, the dipyrromethane 
derivatives were synthesized by condensation of α-protected pyrroles with various 
aldehydes. Aldehydes and pyrroles are known to readily undergo acid-catalyzed 
condensations at room temperature.21 In solutions at equimolar concentrations, the 
condensation yields oligomers and the cyclic porphyrinogen.21a Therefore in order to 
achieve a direct synthesis of dipyrromethane, and to avoid continued oligomerization, a 
slight excess of pyrrole was condensed with aldehyde.21b Various substituted 
dipyrromethanes were synthesized via condensation of protected butanopyrrole 2-8 and 
several commercially available aldehydes as shown in Scheme 2-3. Pyrrole 2-8 was 
synthesized in 90% yield via treatment of commercially available 1-nitro-cyclohexene 
with ethyl isocyanoacetate using Barton-Zard reaction conditions.22  
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1-Nitro-cyclohexene was dissolved in freshly distilled THF under argon. This 
solution was stirred for ten minutes, and ethyl isocyanoacetate was added dropwise. The 
resultant mixture was cooled down to 0 °C and treated with DBU. The final mixture was 
stirred under argon for twelve hours and the reaction followed by TLC until completion. 
The reaction was then quenched by addition of 10% HCl, extracted into ethlyacetate 
affording a brownish oil. This oil was purified on a silica gel column eluting with 10% 
ethylacetate/ hexane to give pale yellow crystals of the desired pyrrole 2-8 in 90% yield. 
This compound was characterized by 1H NMR, which showed a broad singlet NH peak at 
8.5 ppm and the unsubstituted α-H pyrrolic signal at 6.5 ppm. Condensation of pyrrole 2-
8 with several p-substituted benzaldehydes (R=H, NHAc, Br, CO2Me) with TFA as a 
catalyst and montmorillonite K-10 clay afforded diyprromethane 2-9 in 60-70% yields as 
is shown in Scheme 2-3. Montmorillonite K-10 clay has been shown to be a very useful 
acid catalyst in dipyrromethane (and other pyrrolic) syntheses, the clay having the 
advantage that it can be filtered from the reaction mixture prior to work up.23  
Pyrrole 2-8 and montmorillonite K-10 clay were added to a flask of freshly 
distilled dichloromethane under argon. Benzaldehyde and TFA were then added and the 
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reaction mixture was stirred at room temperature and followed by TLC until completion. 
After 12 hours, the reaction mixture was filtered through a pad of silica to separate the 
clay, oxidized dipyrromethene derivatives, higher molecular weight oligomers and 
unreacted aldehyde starting material. The solvent was reduced in vacuo to affording an 
oil that was then redissolved in dichloromethane and neutralized by washing with basic 
water and then dried over sodium sulfate and concentrated in vacuo. Dipyrromethanes are 
very unstable compounds because they are easily oxidized to their dipyrromethene 
derivatives upon exposure to light and air, they also decompose easily and can therefore 
not be purified using silica gel columns which are slightly acidic, however purification 
with slightly basic eluant systems are more reliable. Therefore, the desired 
dipyrromethane compounds can be obtained via recrystallization processes that mainly 
removes the oxidized dipyrromethene by products.17a Synthetic dipyrromethane 
derivatives with R = H, Br, CO2Me, could be easily purified by a single recrystallization 
out of hot methanol to afford beige colored crystals in 70% yield. However, this was not 
the case for the synthesis of dipyrromethane when R = NHCOCH3. 1H NMR spectrum of 
the crude product had a strong aldehyde signal at ~ 10 ppm, moreover, the TLC analysis 
also showed the incomplete consumption of the acetamido-aldehyde starting material that 
was very difficult to purify because of its close rf with the desired dipyrromethane. The 
lower reactivity of this aldehyde results from the electron donating nature of the 
acetamide group, which lowers the electrophilicity of the aldehyde group during 
condensation with the pyrrole. This dipyrromethane was subjected to several silica gel 
columns in order to get rid of the starting material thus leading to a significant loss of the 
desired compound because of decomposition. 
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Figure 2-1: 1H NMR of 5-(4-Bromo-phenyl)-dipyrromethane (2-9) in CDCl3 
 
The 1H NMR spectra of dipyrromethanes have typical NH protons signals 
appearing at ~ 8 ppm, the meso proton appeared as a sharp singlet at ~ 5.5 ppm and ortho 
and meta protons appeared as doublets in the aromatic region. These compounds were 
also characterized by MS, giving molecular ion peaks at 553.1, 532.8 and 475.2 for 
dipyrromethanes 2-9 R= Br, NHAc and H, respectively. A typical 1HNMR spectrum of 
the 5-(4-bromophenyl)-dipyrromethane is shown in Figure 2-1.  
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Alkylation of dipyrromethane 2-9 to dicarbinol-dipyrromethane 2-5 (R=Br) was 
first attempted via treatment of 2-9 with 4-bromophenyl zinc iodide. 2-9 (R=Br) was 
dissolved in freshly distilled THF under argon and the solution stirred as the temperature 
was lowered to 0 °C. The organometallic reagent was then added dropwise over a period 
of 30 minutes while stirring and maintaining the reaction temperature at 0 °C. The 
reaction was monitored using TLC and after two hours, the reaction mixture still had a 
substantial amount of unreacted starting material. The reaction was warmed up to room 
temperature and allowed to go for 24 hours but TLC analysis barely indicated the 
formation of any other product apart from the starting material. A similar procedure was 
then attempted by using an organolithium reagent rather than a organozinc to alkylate the 
ethyl ester groups on the dipyrromethane to the dicarbinol dipyrromethane. The 
organolithium reagent was prepared by treating 1,4-dibromobenzene with 1.5 equivalents 
of n-BuLi in THF at -78 °C 23c under argon, and added dropwise to a solution of 2-9 
(R=Br) in freshly distilled THF, under argon. However after several hours, TLC analysis 
only showed mainly starting material, and it became clear that the ester groups were less 
reactive electrophiles.  
An alternative route to dicarbinol 2-5 is via 2-6 as shown in Scheme 2-3. 2-9 was 
suspended in ethylene glycol with an excess of NaOH.14b The solution was heated at 100 
°C for half an hour so as to saponify the ethyl ester groups followed by concomitant 
decarboxylation by reflux in ethylene glycol at 195 °C. The reaction was followed by 
TLC to completion and was complete after 25 minutes. On cooling the reaction mixture, 
an orange precipitate formed instantly, the precipitation was enhanced by addition of 10-
15 mL of water and cooling down the solution to 0 °C.  
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Figure 2-2: 1H NMR of 5-(4-Bromo-phenyl)-1,9-diunsubstituted dipyrromethane 2-6 in 
CDCl3 
 
The precipitate was then filtered and washed with water to get rid of the high 
boiling point ethylene glycol solvent and excess NaOH salt and finally dried under 
vacuum, yielding the desired 1,9-diunsubstituted dipyrromethane in a 60-65% yield. This 
compound was characterized by 1H NMR and MS giving the subsequent molecular ion 
peaks at 394.2, 375.5 and 316.8 for dipyrromethane 2-6 R= Br, NHAc and H, 
respectively. The 1H NMR spectrum had a sharp singlet peak at ~ 6.3 ppm corresponding 
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to the two protons at the 1 and 9 positions, 2-NH protons are buried under the ortho-
protons doublet peak at ~ 7.5 ppm and the proton at the meso position appeared at ~ 5 
ppm as a sharp singlet. The 1H NMR of 2-6 (R= Br) is shown in Figure 2-2. Due to the 
highly sensitive and reactive nature of 2-6, this compound was used without further 
purification in the next step. 
 Diacylation with identical acyl groups at the 1- and 9 positions of 
dipyrromethane 2-6 is a key reaction in the synthesis of A3B (asymmetric porphyrins).24 
The treatment of dipyrromethane 2-6 with an excess of ethyl magnesium bromide in THF 
and 4-bromo benzoyl chloride to form the dipyrromethane Grignard reagent produced 
both the diacylated dipyrromethane 2-10 (Scheme 2-4) and undesired monoacylated 
dipyrromethane, as was also obtained by Lindey et al.25 Both the monoacylated and 
diacylated dipyrromethanes were obtained in relatively low yields (20% total) and the 
desired diacylated compound was isolated using tedious silica gel chromatographic 
procedures followed by recrystallization from methanol. The ratio of the monoacylated 
and the diacylated product could be easily determined by integration of the peaks due to 
the pyrrolic NH protons in the 1H NMR spectra of the crude product. The monoacyl NH 
protons appeared at ~ 8.0 ppm and 9.1 ppm while the diacylated appeared at ~ 10.3 ppm. 
To obtain higher yields of the diacylated dipyrromethane 2-10, 4-bromo-N-
benzoylmorpholine,26 which is a modified Vilsmeier Haack reagent and being more 
electrophilic than 4-bromobenzoyl chloride was used. 4-Bromo-N-benzoyl morpholine 
was prepared by dropwise addition of 4-bromo-benzoylchloride dissolved in dry 
dichloromethane under argon to a solution of morpholine and triethylamine in dry 
dichloromethane. The initially colorless solution started forming a white precipitate as the 
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reaction progressed. The resultant mixture was stirred for 1 hour at room temperature and 
then refluxed for another 2 hours. The mixture was allowed to cool and neutralized by 
washing with a solution of 2 M HCl and basic water and dried over sodium sulfate. The 
solvent was evaporated to dryness to afford a colorless oil, which crystallized on standing 
giving pure white crystals of the N-4-bromobenzoyl morpholine quantitatively.  
This compound was characterized by 1HNMR with two doublet peaks appearing 
at 7.5 ppm and 7.0 ppm respectively as well as a broad peak at ~3.7 ppm that intergrated 
for 8H which corresponds to the protons on the α and β position on the morpholine unit. 
Subsequent reaction of 4-bromo-N-benzoylmorpholine with 1,9-unsubstituted 
dipyrromethane 2-6 (R = Br) afforded mostly the diacylated bisketone 2-10 in a 70% 
overall yield.27 4-Bromo-N-benzoyl morpholine was treated with POCl3 at room 
temperature in a flask under argon. This solution was warmed up to 35 °C for 1 hr before 
the addition of a solution of 2-6 (R = Br) in 1, 2-dichloroethane. Followed closely by 
TLC, the reaction was allowed to go for 14 hours before being quenched by the addition 
of aqueous sodium bicarbonate solution. The subsequent reaction mixture was then 
refluxed for 45 minutes, cooled down, washed with water, dried over sodium sulfate and 
evaporated to dryness under reduced pressure. The crude mixture was purified on a silica 
gel column eluting with 1% methanol and dichloromethane allowing the isolation of the 
desired diacylated dipyrromethane 2-10 in 70% yield. MS (Maldi) gave a peak of 2-10 at 
775.34. Higher yields of the desired 2-10 were isolated because treatment of the 4-
bromo-N-benzoyl morpholine with POCl3 facilitated the formation of the chloro-imine-
benzoyl derivative, which is more electrophilic than 4-bromo-benzoyl chloride and is 
prone to nucleophilic attack from the dipyrromethane 2-6.  
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Figure 2-3 illustrates the mechanistic approach of activation. The 1H NMR spectrum of 
diacylated dipyrromethane 2-10 (R= Br) is shown in Figure 2-4. 
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  Reduction to the dicarbinol-dipyrromethane 2-5 (Scheme 2-4) was achieved by 
treatment of the corresponding dipyrromethane 2-10 in 2:1 THF/MeOH solution with 50 
equivalents of NaBH4.28  
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Figure 2-4: 1H NMR of 1,9-bis(4-Bromophenyl)-5-(4-bromophenyl)-dipyrromethane 2-
10 in CDCl3 at 300 MHz 
 
The NaBH4 was added in small portions because this reaction is highly 
exothermic. The progress of the reaction was followed by TLC analysis; a spot 
corresponding to the mono-reduced species appeared after 5 minutes, and after 20 
minutes, a slightly more polar spot of the completely reduced species appeared. The 
reaction has to be stopped after two hours because NaBH4 starts to decompose and is 
therefore inactive. The reaction mixture was quenched with water and extracted into 
dichloromethane, dried over sodium sulfate and the solvent reduced to dryness. 
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A pink colored oil was obtained and due to the highly acid sensitive nature of the 
dicarbinol obtained, 2-5 was used without further purification in the next porphyrin 
synthesis step. 
An alternative route to the asymmetric TBP is via the route b as described in 
Scheme 2-5. 2-6 was easily formylated using adapted Vilsmeier-Haack29 conditions, by 
treatment with trimethylorthoformate ester in trifluoroacetic acid (TFA) at 0°C (Scheme 
2-5), followed by alkylation with phenylmagnesium bromide to dipyrromethane 2-5. This 
procedure though successful only yielded 35% of 2-7. Dipyrromethane 2-6 was dissolved 
in TFA under argon and stirred for ten minutes. The reaction mixture was then cooled 
down to 0 °C, followed by the drop wise addition of trimethylorthoformate. The resultant 
mixture was allowed to stir for 30 minutes at 0 °C and was then equilibrated to room 
temperature. The TLC plate had two spots that corresponded to the diformylated and 
monoformylated products. Prolonging the reaction time did not result to any significant 
increase in the diformylated species and therefore the reaction was stopped by quenching 
with water and extracting into dichloromethane, followed by repeated washing with 
aqueous sodium bicarbonate solution and water for neutralization.  
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Figure 2-5: 1H NMR of Diformylated Dipyrromethane 2-7 in CD2Cl2 at 300 MHz 
 
The solvent was evaporated and the resultant crude mixture purified on a silica gel 
column eluting with dichloromethane to get rid of the monoformylated product, gradually 
increasing the polarity of the eluant to 2% methanol in dichloromethane so as to elute the 
more polar diformylated dipyrromethane fraction 2-11. Further recrystallization from 
dichloromethane and methanol yielded a pure light brownish powder of the desired 
product 2-11. The 1H NMR of pure 2-11 (Figure 2-5) has a sharp singlet aldehyde peak at 
a 9.2 ppm and a broader singlet corresponding to the 2 NH protons shifted more 
downfield appearing at 10.2 ppm and a sharp singlet corresponding to the meso protons at 
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5.5 ppm. Gas chromatography mass spectrometry (GCMS) had a molecular ion peak at 
372.11 corresponding to the diformylated dipyrromethane. 
Dipyrromethane 2-7 in dry THF under argon was cooled to -23 °C, followed by 
the dropwise addition of 1 M phenyl magnesium bromide while maintaining the 
temperature at -23 C. The resultant mixture was stirred at this temperature for 4 hours and 
quenched by pouring into an aqueous ether/ice bath. The organic layer was collected and 
washed with water, dried over sodium sulfate and solvent reduced to dryness to afford a 
highly sensitive orange colored oil (dicarbinol dipyrromethane 2-5),29b that was used 
without further purification in the next porphyrin synthesis step. This oil was taken up in 
dichloromethane and degassed with argon for five minutes and then condensed with 
dipyrromethane 2-6 (R= NHAc) using a catalytic amount of BF3.OEt2.16 Formation of the 
porphyrinogen (an intermediate to the porphyrin) was monitored using UV-Vis, for a 
broad band at around 500 nm. After one hour, the reaction was treated with DDQ and 
monitored with UV-Vis for a Soret band30 for the dodeca substituted porphyrin that 
appears at ~ 440 nm for the free base species and ~ 460 nm for the dication species. 
However, the UV-Vis spectrum of this particular reaction mixture had a weak Soret band 
at around 410 nm. This could be probably due to the formation of a porphyrin lacking 
two meso-phenyl substituents.31 A plausible route to this porphyrin, Soret band at 410 nm 
could be as a result of the self condensation of dipyromethane 2-6 as well as acidolysis of 
the respective dicarbinol dipyrromethane.37 From this result, it was concluded that 
probably the acid catalyst used [BF3. OEt2] was not acidic enough and therefore the 
reaction was repeated using TFA which is a stronger acid. The reaction was monitored by 
UV-Vis and after an hour of stirring in DDQ, a spectrum with a Soret band at 449 nm 
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was obtained. The crude mixture isolated was passed through an alumina plug eluting 
with 1% methanol/ dichloromethane so as to get rid of higher oligomers and excess 
DDQ. Purification on an alumina column eluting with pure dichloromethane then ensued 
affording several compounds that were also characterized by UV-Vis giving Soret bands 
at 408, 418 and 439 nm respectively. Attempts to further characterize the several bands 
obtained using 1H NMR were futile because the compounds were obtained in relatively 
low amounts (< 2%) and still required further purification. MS (MALDI) results were 
also inconclusive and after carefully analysis of the result, it was hypothesized that TFA 
was a relatively strong acid catalyst that resulted in the self condensation of the respective 
dicarbinol dipyrromethane and the 1,9-diunsubstituted dipyrromethane 2-6.17b In addition 
to this, the alkylation step to the dicarbinol from the diformyl-dipyrromethane, might not 
have been high yielding because the yields obtained of the desired porphyrin were very 
low. However, none of these postulates were confirmed due to the sensitive nature of the 
bis-carbinol derivative. 
The asymmetric porphyrin 2-4 was finally prepared by an alternative route that 
involved the condensation of the dicarbinol 2-5, synthesized via the NaBH4 reduction of 
diacyl dipyrromethane (2-10) and the 1,9-diunsubstituted dipyrromethane 2-6 (R= 
NHCOCH3) as is shown in Scheme 2-6. The condensation was done at 10 mM in 
acetonitrile using a catalytic amount of BF3.OEt2 and NH4Cl at 0°C.17b The reaction was 
followed using UV-Vis for 1 h and oxidized with DDQ. To ease up on the purification 
process, the porphyrin formed was metallated with a diamagnetic metal Ni (II) and Zn 
(II).32 However, the Zn (II) complex was very acid labile and Cu (II) complex resulted in 
lower yields of porphyrin and could not be easily characterized using 1H NMR.  
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The yields obtained for the Ni (II) complex of the desired asymmetric porphyrin were 
low ~ 10% yield. TLC analysis had a total of 4 spots with the predominant spot being that 
of the desired porphyrin. Purification was done on an alumina thick layer preparative 
chromagraphy eluting with a 1:1 dichloromethane/ petroleum ether solution. This 
procedure gave very low yields of the desired porphyrin. Nickel(II) porphyrin 2-4 was 
characterized by UV-Vis spectra, Soret band at 427 nm and two Q bands at 544 and 571 
nm and by electron spray ionization giving a molecular ion peak at 1184.26. The 1H 
NMR spectrum in deuterated dichloromethane gave four characteristic doublets at 7.81, 
7.76, 7.73 and 6.95, respectively. Figure 2-6 shows the 1H NMR spectrum of Ni(II) 
asymmetric porphyrin. 
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Figure 2-6: 1H NMR spectrum of Ni(II)-Asymmetric Porphyrin 2-4 in CD2Cl2 at 300 
MHz 
 
The other fractions isolated mainly had 1H NMR spectra corresponding to 
symmetric porphyrins due to the presence of symmetric doublet peaks in the aromatic 
region. These compounds were not fully be characterized because they were obtained in 
relatively low yields compared to the predominant asymmetric porphyrins species. 
Oxidation by refluxing in toluene using an eight equivalent excess of DDQ33 afforded the 
corresponding asymmetric TBP. This compound was only characterized by UV-Vis by 
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the presence of a strong Q band peak at 650 nm. This is because the pure starting material 
of porphyrin 2-4 was approximately 10 mg, therefore resulting in isolation of a small 
amount of the desired asymmetric TBP after oxidation that could not be characterized by 
1H NMR. 
The 2 + 2 MacDonald’s route has been studied previously by several research 
groups. Lindsey et al25 has studied the effects of reaction temperature, solvent, acid and 
concentration on condensation of dicarbinol dipyrromethane and 1,9-diunsubstituted 
dipyrromethane. In this dissertation, the conditions used were the ones reported to be able 
to isolate high yields of the desired porphyrin. Some other conditions that were adapted 
in this Chapter are from the studies done by Wallace and Smith et al29b who developed 
methodologies on the acylation of dipyrromethane derivatives using modified Vilsmeier 
Haack reagents. Regardless of using these refined procedures, the yields obtained of the 
dodeca substituted asymmetric porphyrin were very low. This could be explained with 
the fact that the starting material was different from the one studied by these groups. The 
previous group synthesized A3B porphyrins that did not have any β-pyrrolic substituents. 
Studies have reported that steric interactions between substituents on the meso and β-
pyrrolic positions normally cause the porphyrins to be ruffled and it has also been 
reported that the syntheses of dipyrromethanes bearing both β and meso substituents to be 
quite laborious accompanied with the isolation of relatively low yields.17a In addition to 
these, studies done on substituted dipyrromethanes have shown that the substitution 
pattern on the dicarbinol-dipyrromethane derivatives plays a major role in the 2+2 
condensation reactions. The presence of an electron-withdrawing group at the para 
position of the phenyl group at position 5 of the dicarbinol, normally gives high yields in 
  
53 
the condensation reaction.25 However, lower yields were reported for dicarbinols that 
posses electron-withdrawing substituents on all the 1,9 and 5 positions. This observation 
also explains the low yields that were observed, because the dicarbinol-dipyrromethane 
2-5 used had para-bromo aryl groups in all the meso positions. Molecular modeling 
studies done by Boyle et al34 showed that there is a significant twisting of the two pyrrole 
rings on a 5-phenyl dipyrromethane without any β substituents after energy minimization 
and therefore a greater amount of steric strain is involved in the formation of the 
porphyrinogen of the desired dodeca substituted porphyrin compared to the formation of 
uroporphyrin IV methyl ester in the original MacDonalds 2+2 synthesis.8 The 
incorporation of a metal template presumably stabilizes the intermediate cyclic tetrameric 
structure, as used in phthalocyanine synthesis.35 However, in this case, insertion of a 
metal template to facilitate cyclization to form the porphyrinogen was not feasible, 
because the oxidation to from the porphyrinogen to the porphyrin is performed using an 
excess amount of DDQ, and this can therefore increase the chances of the formation of 
the completely aromatized porphyrin complex (TBP),32 which has significant solubility36 
problems and will therefore hamper the purification process. Acidolysis of the 
dipyrromethane derivatives plays a major role in this condensation reaction. The acid-
catalyzed cleavage and reformation of polypyrranes is a well-known problem in 
porphyrin chemistry,37 this explains the isolation of several porphyrin derivatives in the 
2+2 condensations. The mixture of porphyrin products is normally produced in the acid-
catalyzed final step of the reaction as a result of acid redistribution reactions common in 
dipyrromethanes. The postulated mechanism of acidolysis is shown in Scheme 2-7 
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2-4: Tetramerization and Functionalization of the p-Phenyl Substituents 
The functionalization of a symmetric dodeca-substituted porphyrin to the 
asymmetric A3B porphyrin stemmed from previous work done by several research groups 
on the direct peripheral functionalization of porphyrin macroclyles using various 
electrophiles.38 Peripheral functionalization of porphyrins and their derivatives is an 
important reaction because it offers an alternative to producing many new compounds 
that could only be obtained by total synthesis.35 As mentioned earlier, we have seen that 
typical routes to porphyrins that possesess more than one differing β-substituent have 
employed condensations of the appropriate aldehydes with various monopyrroles,39 
substituted dipyrromethane40 or pre-fabricated 1,19-dideoxybiladienes.41 As seen in the 
previous attempted synthesis, due to the inherent unfavourable entropy associated with 
multiple condensation reactions along with acidic and oxidative conditions, the classic 
synthesis of porphyrins typically gives low yields and requires tedious purification 
processes in addition to restrains on preparation of porphyrins with sensitive functional 
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groups.16,42 Theoretical electron density calculations done on porphyrin derivatives have 
shown that, nucleophilic and electrophilic substitutions tend to take place preferentially at 
the meso positions of the macrocyclic ring. In addition to this, steric considerations are 
also important since some bulky substituents can shield some of the sites on the porphyin 
periphery.43 
Electrophilic addition of sulfuric and chlorosulfonic acid to the phenyl groups of 
tetraphenylporphyrin derivatives have been reported and are examples of aryl-group 
modification without the concomitant attack of the electrophile on the macrocycle ring.44 
Subsequent nitrations on the phenyl groups have been performed in our group45 utilizing 
the nitration procedure using sodium nitrite and TFA as the reaction medium on TPP, 
which results in the isolation of mono, di and tri-nitro derivatives depending on the 
reaction times. The desired derivative can then be easily isolated by column 
chromatography. 
Tetraphenyltetracyclohexeno porphyrin 2-12 (R= H), which is the precursor 
porphyrin to the electrophilic aromatic substitution reaction, was synthesized and isolated 
in 85% yield.17 Treatment of 2-12 in TFA with sodium nitrite did not yield the desired 
mono, di and tri-nitro derivatives as is reported for TPP.45 However several other 
derivatives, as described in Scheme 2-7, were obtained. 
When porphyrin 2-12 (R=H) was treated with neat TFA and excess sodium 
nitrite, oxidative macrocyclic ring cleavage occurred and the products isolated were 
biliverdins 2-15 and 2-16.46 When its Ni(II) derivative was dissolved in toluene and 
treated with TFA and sodium nitrite and heated at 80 °C, 2-14 was isolated instead.46  
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All these new compounds were characterized by 1H NMR, electron spray 
ionization (ESI) and X-ray crystallography. An X-ray crystal structure of compound 2-14 
is shown in the Figure 2-7. The mechanism of the synthesis of compound 2-14 is not 
completely understood but could be postulated to occur via a tetraphenyl-cyclohexadiene 
porphyrin intermediate as is shown in Scheme 2-8. 
Heating of Ni(II)-tetracyclohexenoporphyrin, (Ni(II)-TCHP) 2-12 under air, could 
have resulted in the partial oxidation of one of the cyclohexeno rings, ultimately leading 
to the electrophilic nitration of the alkene to give 2-17. TLC analysis showed two spots 
that had very close rf in addition to a main spot of the starting material.  
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The two spots were isolated and characterized by MS (ESI), and they both giving a 
similar molecular ion peak at 929.1 The yields of this reaction were very low, and 
attempts to optimize these yields were not fruitful even after several attempts of varying 
the reaction parameters such as increasing the reaction time and refluxing at higher 
temperatures. Due to the asymmetric nature of the compound, 1H NMR peaks could not 
be easily assigned, because there were several overlapping doublets in the aromatic 
region, however a singlet at ~6.8 ppm corresponding to the vinylic proton of compound 
2-17 was observed.  
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Figure 2-7: X-ray structure of Ni(II)-nitro-cyclohexenotetraphenylporphyrin 2-14 
 
Two sharp singlet peaks corresponding to the proton on the nitro-alkene were also 
observed at 6.87 and 6.83 ppm, respectively for compound 2-14. It is interesting to note 
that 2-17 stirring in dichloromethane at room temperature could easily isomerize to 2-14 
on addition of a few drops of TFA. However, the reverse isomerization was not observed. 
The mechanistic details of the formation of benzoyl-biliverdin derivatives 2-15 and 2-16 
will be discussed in detail in the ensuing Chapters.  Seeing that the proposed route was 
not fruitful, other synthetic strategies to the asymmetric porphyrin were investigated. 
Recently, the development of synthetic methodologies that involve the application 
of transition-metal-mediated cross-coupling reactions have proved advantageous, 
allowing efficient synthesis of a large number of derivatives from a single halogenated 
porphyrin precursor.47 These strategies have been used to build several linkages i. e. C-C 
linkages with Suzuki,48 stille and heck couplings49 and C-N50 bonds, from aryl halides 
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and triflates. Palladium mediated cross-coupling reactions for phosphorus-carbon bond 
formations have also been reported. These reactions have found a niche in the preparation 
of phosphines, phosphine oxides and phosphorus acid derivatives. Pioneering work was 
done by Hirao et. al. who reported on the palladium catalysed cross-coupling of aryl and 
vinyl bromides with phosphonate derivatives, affording the dialkyl phosphonates in  91% 
and 69% overall yields, respectively.51  
Synthesis of the asymmetric porphyrin A3B derivative by employing various 
palladium catalyzed cross-coupling reactions to form the carbon-phosphorus and carbon 
amine bond on tetrabrominated tetracyclohexenoporphyrin was therefore attempted as is 
shown in Scheme 2-10. 5,10,15,20-Tetra-bromophenyl-2:3,7:8,12:13,17:18-tetra-
butanoporphyrin, a precursor to 2-18, was prepared by the condensation of butano pyrrole 
and 4-bromo-benzaldehyde in dichloromethane.16 The reaction was monitored by UV-Vis 
for the appearance of the Soret band at ~ 460 nm that is typical of dication-dodeca-
substituted porphyrins. On completion, the reaction mixture was washed with aqueous 
sodium bicarbonate solution and once with water, dried over sodium sulfate and the 
solvent reduced to dryness. 
The free-base porphyrin was not isolated but was metallated with copper by 
refluxing in toluene in the presence of a ten equivalent excess Cu(II)Cl2 for five 
hours.36b,52 The reaction was monitored by UV-Vis for the appearance of a blue-shifted 
Soret band ~ 425 nm. The metallated porphyrin complex was then filtered through an 
alumina plug, concentrated in vacuo and immediately aromatized to the 
tetrabenzoporphyrin derivative 2-18, by refluxing in toluene with DDQ for fifteen 
minutes.  
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The reaction changed from a deep red to a deep green color while monitoring by 
UV-Vis for the appearance of a strong Q-band at ~ 630 nm which is typical of 
tetrabenzoporphyrins.33 The reaction mixture was filtered through an alumina plug 
eluting with chloroform, concentrated in vacuo and recrystallization out of chloroform 
and methanol afforded beautiful green crystals of 2-18 in an overall 41% yield. This 
compound was characterized by MS (MALDI), showing a molecular ion peak at 1191.5. 
As a result of the paramagnetic nature of the copper complex, the compound was not 
characterized by 1H NMR.  
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In our initial studies, we attempted to do the palladium catalyzed cross-coupling 
reaction on the free-base derivative (M= 2H) of 2-18. 2-18 (M= 2H) was obtained easily 
by demetallation of 2-18 (M = Cu(II)) by dissolving the compound in concentrated 
sulfuric acid and stirring the corresponding solution at room temperature for 5 minutes.52 
The reaction was monitored by UV-Vis by carefully taking a drop of the solution in a 
cuvette and diluting it with concentrated HCl. The appearance of a red shifted Soret band 
at ~ 490 nm and red shifted Q-bands confirmed the completion of the demetallation. 
Pouring carefully into an ice-bath and extracting into chloroform quenched the reaction. 
The dication porphyrin had very low solubility in most organic solvents including 
chloroform, forming a reddish solution with and a greenish precipitate; therefore the 
solubility was enhanced by adding a drop of triethylamine into the chloroform. The 
solvent was rota-evaporated to dryness. A quick alumina plug followed by 
recrystallization out of chloroform and methanol afforded the free-base porphyrin of 2-18 
in 90% yield as green crystals. The free-base could be easily characterized by 1H NMR in 
chloroform, two doublets corresponding to the ortho and meta protons of the phenyl 
groups appeared at 8.51 and 8.13 ppm, respectively with a coupling constant J= 8.23 Hz, 
while the protons corresponding to the benzene rings appeared as a broad single peak at ~ 
7.3 ppm. The cross-coupling palladium catalyzed reaction was performed in a completely 
inert environment patterning a procedure adopted from Lin et al.53 2-18 (M = 2H) was 
dissolved in toluene in a schlenk tube that had been previously evacuated of air and filled 
with argon approximately three times. The solubility of the 2-18 (M = 2H) was not 
instant, therefore the mixture had to be sonicated and heated for several hours for the 
compound to go into solution. Triethylamine, hydrogen diethylphosphite and 10% mol of 
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palladium-tetrakis-triphenylphosphine (Pd(PPh3)4) were  added to the schlenk tube under 
argon. The tube was then sealed with a rubber septum and heated in an oil bath at 100 °C 
for four days. The reaction was monitored using TLC analysis and showed several spots 
that corresponded to the starting material, the mono, di adjacent, di opposite, tri and 
tetraphosphonylated 2-18 (M = 2H). However, after heating the solution for 4 days, there 
was hardly any increase in the yield of the tri-phosphonate derivative 2-19. The addition 
of more hydrogen diethyl phosphite to the reaction mixture did not result to any 
significant increase of the yield of the desired product. The reaction was stopped, diluted 
with chloroform and washed with water so as to get rid of the unreacted diethyl phosphite 
starting material. This compound was then rota-evaporated to dryness and purified on a 
silica gel column with a gradient elution starting from 10% acetone in chloroform and 
gradually increasing the solvent polarity to 30% acetone in chloroform. However, some 
of the fractions collected when evaluated by UV-Vis, had a Q-band typical of a 
metallated TBP derivative. This could have occurred during the oxidative addition 
reaction that goes through the formation of an intermediate Pd2+ species, therefore 
metallating the free-base TBP. The fractions collected were characterized by MS 
(MALDI) showing molecular ion peaks for the tri-and tetraphosphonate peaks at 1304.18 
and 1368.23, respectively. These compounds were obtained in relatively low yields, the 
tri-phosponate compound was obtained in 20% yield while the tetraphosphonate fraction 
obtained in 25% yield. Seeing that this route resulted in the metallation of the 2-18 (M = 
2H), the precursor, 2-18 (M = Cu (II)) was used instead. However, the solubility of the 2-
18 (M = Cu (II)) was worse than its free-base derivative but after several hours of 
sonicating and heating, most of the compound finally went into solution and the reaction 
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was repeated employing the previously mentioned synthetic methodology. However, 
there didn’t seem to be an increase in the yield of the desired compound even after 
changing the reaction conditions i. e. increasing the catalyst load, heating the reaction at 
reflux, using an alternative base with a higher boiling point than triethylamine. The 
compounds isolated in substantial yields were still the mono, di and tetra-substituted 
phosphonates. The tri-phosphonate 2-19 (M= Cu(II)) and tetra-phosphonate derivatives 
were characterized by MS (MALDI) with molecular ion peaks at 1374.33 and 1421.87. 
The tri-phosphonate copper complex was then purified further by preparative silica gel 
TLC eluting with pure dichloromethane and increasing the solvent polarity to 1% 
methanol dichloromethane in order to get rid of excess triphosphine ligand from the 
catalyst. This purification process was very challenging because both the ligand and 2-19 
had very close retention factors. Unfortunately this compound’s purity could not be 
confirmed by 1H NMR due to the paramagnetic copper ion. The Schematic of the 
oxidative elimination palladium catalyzed cross-coupling for the formation of the carbon-
phosphorus bond is illustrated in Scheme 2-11 below. 52 
The next cross-coupling reaction involved formation of a C-N bond. The 
procedure employed was adapted from the palladium catalyzed cross-coupling reaction of 
ammonium surrogates to aryl halides and sulphonates by Hartwig et al.54 Earlier studies 
conducted report on the formation of anilines being accomplished by using allyl and 
diallyamines,55 benzyl and diphenyl amines and a benzophenone imine in the cross-
coupling reactions.56  
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However, some of the drawbacks encountered with these substrates are that they require 
metal-catalyzed cleavage of their protecting groups, which are relatively expensive 
reactions. Hartwig et al reported that the treatment of bis(trimethylsilyl) amides available 
as solutions in hydrocarbon solvents with aryl halides and palladium catalyst at relatively 
low temperatures afforded protected aniline groups that were then deprotected  easily 
using an acidic workup. The procedure could be carried out conveniently without the use 
of a glove box and isolation of relatively good yields of the desired compounds that were 
dependent on the temperature and time. Relatively high temperatures could not be used in 
this procedure due to the highly reactive nature of the lithium hexamethyl-disilyl amide 
base (LHMDS), which could decompose easily. 
2-19 was dissolved in toluene in a schlenk tube, the solution was then degassed 
for approximately 15 minutes and filled with argon before the addition of 10 mol % of 
the palladium catalyst. The reaction was heated to 80 °C for twelve hours and the 
progress of the reaction monitored by TLC using 1% methanol/chloroform solution for 
elution. The desired compound appeared as a streaking less polar spot on the plate. The 
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reaction was stopped, cooled down and the toluene evaporated to dryness. The mixture 
was then demetallated according to the procedure used previously, affording the free-base 
2-20. Purification using preparative TLC and eluting with 1% methanol in chloroform 
afforded 2-20 in an 85% yield. This compound was characterized by 1H NMR and MS 
(MALDI) with a peak at 1387.48 that corresponded to the asymmetric TBP 2-20.  
Due to the solubility set backs that were encountered in the previous cross-
coupling reaction, an alternative synthetic methodology to 2-20 was attempted. The route 
employed was similar to the one on scheme 2-9, the only difference was that the cross-
coupling reaction were performed on the non-aromatized precursor of 2-18 i.e on the 
cyclohexenoporphyrin. The solubility of the non-aromatized precursor porphyrin of 2-18 
was better than its fully aromatized derivative 2-18, because this complex required 
sonicating for a few minutes for the compound to go completely into solution. However, 
the yields obtained of the mono, di, tri and tetra-phosphonate derivatives were no 
different, with mostly the isolation of starting material, mono and di-derivatives. There 
was no difference observed in the yields when the reaction was done in a normal hood 
and in a glove box that normally has strictly inert conditions.  
Since the coupling reaction favored the isolation of the starting material and the 
mono-phosphonated derivatives in higher yields, it was hypothesized that reversing the 
order of the coupling reactions i.e. starting with the formation of the carbon-nitrogen 
bond, then isolating the favored mono-amine derivative and cross-coupling this 
compound to its phosphonate derivative would result to the isolation of better yields of 2-
20. However, these efforts too were not successful, because TLC analysis showed the 
formation of only trace amounts of a new product, compared to the starting material. 
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Figure 2-8: MS (MALDI) Spectrum for TBP 2-20 (M= 2H) 
2-5:  Conclusion and Future Work 
The several routes that were discussed and employed in this Chapter for the 
synthesis of asymmetric tetrabenzoporphyrins, which are precursors to their amphiphilic 
water-soluble derivatives, did bring forth the desired compounds but in very low yields. 
However, a lot of progress was made in that other alternative routes can be tried and also 
several reaction conditions can be played around with to try and optimize the yields. The 
work done in this Chapter also holds a lot of promise because these compounds are novel 
and most of the synthetic methodologies that were used were adopted mainly from 
methodologies used on tetraphenylporphyrin derivatives and other compounds. The 
cross-coupling reactions that were used had a lot of potential but solubility was one of the 
major hindrances to this synthetic route’s success. Alternatively, the 2 + 2 MacDonald’s 
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route was also a facile methodology which had its set backs such as acidolysis and sterics 
resulting to extensive chromatographic procedures. All in all, a novel asymmetric 
tetrabenzoporphyrin 2-20 was synthesized, this compound has application as 
photosensitizer for (PDT) of tumors, as antiviral agent for blood sterilization, and as 
fluorescent maker for the labeling and analysis of nucleic acids and other biomolecules by 
fluorescence detection using confocal microscopy. 
2-6: Experimental Section 
The All experiments were performed under argon atmosphere in oven-dried glassware 
following the standard schlenk techniques. Solvents used as reaction media were distilled 
immediately before use. THF and Toluene were distilled from Na/Benzophenone. 
Methylene chloride was distilled from calcium hydride. 1HNMR spectra were recorded 
on a Bruker AC-250 (250 MHz, 300 MHz, 400 MHz 1H) spectrometer in deuterated 
chloroform (CDCl3: 7.27 ppm). Chemical shifts (δ) are given in parts per million relative 
to tetramethylsilane (TMS, 0 ppm); multiplicities are indicated as br (broad), s (singlet), d 
(doublet), t (triplet), q (quartet) and m (multiplet). 
Analytical TLC was performed on Scientific Adsorbent Company Inc. silica gel plate and 
alumina gel plate. Flash column chromatography was performed using silica gel 
(Scientific Adsorbent Company Inc. 40-63 µM particle size, 60 Å pore size). Electronic 
absorption spectra were measured using a Perkin-Elmer Lambda 35 UV-vis 
spectrophotometer. Mass Spectra were obtained at LSU Mass Spectometry Facility. 
Ethyl 4, 5, 6,7-tetrahydroisoindole carboxylate (2-8) 
To a solution of 1-nitro-1-cyclohexene (2.7 mL, 23.9 mmol) in freshly distilled dry THF 
(30 mL), was added ethyl isocyanoacetate (2.7 mL, 23.9 mmol) and DBU (3.6 mL, 23.7 
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mmol) at 0°C, and the mixture was stirred at room temperature for 15h. The reaction 
mixture was then washed with dilute acid (10% HCl, 100 mL) and extracted into 
ethylacetate (3 × 100 mL), dried over sodium sulfate and solvent evaporated under 
vacuum. The brown oil residue was chromatographed on a silica gel column eluting with 
10% ethyl acetate and Hexane, to give pure yellow crystals of the title pyrrole 4.15 g in a 
90% yield. Mp = 80-82°C: 1H NMR (250MHz) δ (ppm) 8.77 (s, br, NH), 6.64 (d, α-H, J 
= 3 Hz), 4.29 (q, 2H, CO2CH2CH3), 2.82 and 2.54 (t, 2H, each, α CH2), 1.74 (m, 4H, β 
CH2) 1.34 (t, 3H, CO2CH2CH3): MS (MALDI) m/z 193.12 (M+). 
5-(Phenyl)-1,9-ethylesterDipyrromethane (2-9: R = H, Br, NHAc) 
Pyrrole 2-8 (2 g, 10.32 mmol) was dissolved in 80 mL of freshly distilled dichlomethane 
and degassed with argon for approximately five minutes. Montmorillonite K10 clay 
(2.1g) was then added and the round bottom flask sealed. TFA (4.0 mL, 51. 9 mmol) was 
then added followed by benzaldehyde (6.9 mmol). The reaction was allowed to stir under 
argon for 12h before TLC analysis showed completion of the reaction. The reaction 
mixture was then filtered through a 150 mL plug packed with silica gel to remove the 
excess benzaldehyde.  The filtrate was then collected and washed with 100 mL of water 
and 100 mL of aqueous sodium bicarbonate. The organic layer was then collected, dried 
over sodium sulfate and solvent removed via rotary evaporator. Recrystallization from 
dichloromethane and methanol afforded a beige solid in an overall yield of 60-70%. R = 
Br: (1.9 g, 70%) 1H NMR (250 MHz) CDCl3 δ (ppm) 8.4 (s, br, 2H, NH), 7.28 (d, Ar-H, 
J = 8.3 Hz), 6.91 (d, Ar-H, J = 8.3 Hz), 5.41(s, 1H), 4.27 (q, 2H, CO2CH2CH3) 2.79 and 
2.52 (t, 4H each, CH2) 1.73 (m, 8H, CH2), 1.32 (t, 3H, CO2CH2CH3): MS (MALDI) m/z 
553.10 (M+). 
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R = NHAc: (1.64 g, 60%) 1H NMR CDCl3 δ (ppm) 8.27 (s, br, 2H, NH), 7.35 (d, Ar-H, J 
= 8.6 Hz), 7.30 (br, s, 1H, 1NH) 7.15 (d, Ar-H, J = 8.3 Hz), 5.40 (s, 1H), 4.28 (q, 2H, 
CO2CH2CH3) 2.78 and 2.50 (t, 4H each, CH2) 1.73 (m, 8H, CH2), 1.56 (s, 3H, CH3) 1.33 
(t, 3H, CO2CH2CH3): MS (MALDI) m/z 532.80 (M+). 
R = H: (1.71 g, 70%) 1H NMR CDCl3 δ (ppm) 7.8 (s, br, 2H, NH), 7.52-7.17 (m, 5H, Ar-
H), 5.43 (s, 1H), 4.22 (q, 2H, CO2CH2CH3) 2.71 and 2.43 (t, 4H each, CH2) 1.73 (m, 8H, 
CH2), 1.33 (t, 3H, CO2CH2CH3): MS (MALDI) m/z 475.52 (M+). 
5-(Phenyl)-1,9-unsubstituted Dipyrromethane (2-6: R = H, Br, NHAc) 
Dipyrromethane 2-9 (0.393 g, 0.71 mmol) was suspended in ethylene glycol (32 mL) and 
NaOH (0.67 g, 16.75 mmol). The solution was then heated at 100°C for 30 minutes to 
saponify the ethyl ester groups before refluxing at 195°C for 35 minutes to decarboxylate 
the carboxylic groups. An orange precipitate formed on cooling down the hot ethylene 
glycol solution to room temperature. 10-15 mL of water was added to the flask to 
enhance further precipitation and the reaction flask stored in the fridge for another 12 
hours. The reaction mixture was then filtered, and the precipitate washed with water 
before being dried under vacuum. The yield obtained of the title compound (R = Br) was 
(0.181 g, 65% yield). 1H NMR CDCl3 (300 MHz) δ (ppm) 7.43 (s, br, 2H, NH), 7.28 (d, 
Ar-H, J = 8.3 Hz), 6.91 (d, Ar-H, J = 8.3 Hz), 6.41 (s, 2H, αH) 5.41(s, 1H), 2.79 and 2.52 
(t, 4H each, CH2) 1.73 (m, 8H, CH2): MS (MALDI) m/z 394.23 (M+). 
R = NHAc: 1H NMR CDCl3 δ (ppm) 7.45 (s, br, 2H, NH), 6.86 (d, Ar-H, J = 8.6 Hz), 
6.62 (d, Ar-H, J = 8.3 Hz), 6.38 (s, 2H, α-H) 5.40 (s, 1H), 2.78 and 2.50 (t, 4H each, 
CH2) 1.73 (m, 8H, CH2), 1.56 (s, 3H, CH3): MS (MALDI) m/z 375.55 (M+). 
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R = H: 1H NMR CDCl3 δ (ppm) 7.7 (s, br, 2H, NH), 7.42-7.13 (m, 5H, Ar-H), 6.35(s, 
2H, α-H), 5.43 (s, 1H), 2.71 and 2.43 (t, 4H each, CH2) 1.73 (m, 8H, CH2): MS (MALDI) 
m/z 316.89 (M+). 
5-Phenyl-1,9-Diformyldipyrromethane (2-7) 
1,9-unsubstituted dipyrromethane 2-6 (R = H) 0.68g, 1.65 mmol was dissolved in TFA 
15 mL and the flask evacuated of air and filled with argon. The reaction was allowed to 
stir under argon for 10 minutes cooled down to 0°C and trimethyorthoformate (10 mL, 
0.095 mmol) added drop wise to the reaction mixture. The mixture was then allowed to 
stir for an additional 30 minutes before removal of the ice bath and equilibration to room 
temperature. Completion of the reaction was confirmed via TLC analysis and the reaction 
mixture was washed with (2 × 100 mL) of sodium bicarbonate and 100 mL of brine 
solution. The organic fraction was then collected and dried over sodium sulfate and the 
solvent rota-evaporated off. Recrystallization from dichloromethane and methanol gave 
white flaky crystals of the desired product in 0.25 g, 35% yield. R = H: 1H NMR CDCl3 
(300 MHz) δ (ppm) 10.22 (s, 2H, Aldehyde), 9.28 (s, 2H, NH), 7.35(m, 3H, ArH), 7.10 
(m, 2H, ArH) 5.50 (s, 1H), 2.80 (t, 4H each, CH2) 1.75 (m, 8H, CH2): MS (MALDI) m/z 
372.11 (M+). 
4-Bromo-N-Benzoylmorpholine 
To a 200 mL round bottom flask equipped with a dropping funnel and flushed with argon 
was added morpholine (2.4 mL, 27.5 mmol), dry dichloromethane 28 mL and 
triethlyamine (8.56 mL, 61.8 mmol). 4-bromobenzoylchloride (5.6 g, 24.5 mmol) in dry 
dichloromethane 50 mL was added dropwise over a period of 1hour. The colorless 
solution (containing a white precipitate) was stirred at room temperature for 1hour before 
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heating to reflux for 2 hours. The reaction was cooled and washed with 2M HCl (5× 100 
mL), water (2 × 100 mL), once with 100 mL of saturated aqueous sodium bicarbonate 
solution, once with 100 mL of brine, dried over sodium sulfate and evaporated under 
vacuum to yield a yellow oil. Crystallization on standing produced 6 g of a white solid 
(92% yield). 1H NMR 250MHz: (CDCl3) δ 7.57 (d, 2H, ArH, J = 6.6 Hz), 7.30 (d, 2H, 
ArH, J = 6.6 Hz), 3.70 (br, s, 8H, CN4H8O). 
5-(4-Bromophenyl)- 1,9-bis(4-bromophenyl)-diacylateddipyrromethane (2-10) 
To a 100 mL round bottom flask flushed with argon was added 4-bromo-N-
benzyolmorpholine (1.37 g, 5.09 mmol) and freshly distilled POCl3 (1 mL, 10.7 mmol). 
The suspension was warmed to 35°C before being cooled to room temperature and stirred 
for 6h. Dipyrromethane 1-7 (R = Br) 0.52 g, 1.27 mmol dissolved in 20 mL of dry 1,2-
dichloroethane was then added to the Vilsmeier reagent before being allowed to stir at 
room temperature for 14h. Aqueous Sodium Carbonate (40 mL) was then added to the 
red solution and the mixture stirred at room temperature for fifteen minutes and then at 
reflux for 45 minutes. The reaction mixture was then allowed to cool before being 
washed with 100 mL of water and 100 mL of brine and finally dried over sodium sulfate. 
The solvent was then reduced via vacuum and the red oil obtained purified by silica gel 
chromatography eluting with 1% methanol in dichloromethane. The yield obtained of the 
desired product 2-10 was 0.69g in a 70% yield. 1H NMR CDCl3 (300MHz) δ (ppm) 10.02 
(s, br, 2H, NH), 7.48 (d, 4H, Ar-H, J = 8.3 Hz), 7.28-7.34 (2d, 6H, ArH), 6.91 (d, 6H, 
ArH, J = 8.3 Hz), 5.47 (br, s, 1H) 2.35(t, 6H, CH2), 2.25(t, 6H, CH2), 1.70 (m, 10H, 
CH2): MS (MALDI) m/z 775.34 (M+). 
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5-(4-Bromophenyl)-1,9-(4-bromophenyl)-dicarbinoldipyrromethane (2-5) 
NaBH4 (0.66 g, 17.8 mmol, 50 equivalents) was carefully added in small portions (0.2 g 
each) over 20 minutes to a stirred solution of dipyrromethane 2-10 (0.27g, 0.34 mmol) in 
THF-MeOH (2:1, 9 mL). The reduction progress was followed on TLC (alumina; 
ethylacetate-hexanes 1:1). Within 5 minutes a new spot of rf 0.5 was observed 
(monoreduced product), but this compound was fully converted to a second product with 
rf 0.2 (diol) after 2 hours. The reaction mixture was quenched with water and then 
extracted into dichloromethane. The organic phase was dried over sodium sulfate and the 
solvent removed to afford a pale yellow oil.  
5,10,15-Tri(4-bromo-phenyl)-20-(acetamido-phenyl)-2:3,7:8,12:13,17:18-butano-
[Ni(II)]-porphyrin (2-4) 
Due to its limited stability, dicarbinol-dipyrromethane 2-5 (0.34 mmol) was immeadiately 
dissolved in acetonitrile (34 mL) and condensed with 1,9-unsubstituted dipyrromethane 
2-6 (R = NHAc, 0.135 g, 0.34 mmol). The solution was cooled to 0 °C while under argon 
for 10 minutes and then NH4Cl (0.18g, 3.4 mmol) was added followed by BF3.OEt2 (4.2 
µL, 0.034 mmol). The solution instantly darkened, and the progress of the reaction was 
followed by UV-Vis. After 1hour, DDQ (0.37 g, 1.62 mmol) and triethylamine (0.4 mL) 
were added and the mixture stirred at room temperature for 30 minutes followed by 
heating at reflux for 1hour. The entire solution was then washed with 100 mL of NaHCO3 
and extracted into dichloromethane, dried over sodium sulfate and solvent evaporated to 
dryness under vacuum. The residue was re-dissolved in 25 mL of toluene, 10 equivalent 
excess of nickel(II)acetate added and the reaction mixture heated at reflux for 12 hours. 
The metallation was followed by UV-Vis to completion and once complete, the toluene 
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was evaporated off and the residue purified on an alumina gel column eluting with 1:1 
petroleum ether-dichloromethane solution to afford the desired Ni(II)-Asymmetric 
porphyrin in > 10% yield (20 mg) as the second band. Recrystallization from 
dichloromethane afforded pure red crystals of 1-1. 1H NMR (330 MHz) CDCl3 δ: 7.81 (d, 
J = 8.0 Hz), 7.76 (d, J = 8.4 Hz), 7.73 (d, J = 8.3 Hz), 6.95 (d, J = 8.3 Hz), 2.35 (br, s, 
4H), 2.23 (br, s, 12H), 1.4 (br, s, 16H): MS (ESI-MALDI) m/z 1186.89 (M+)  
5,10,15,20-Tetra(4-bromo-phenyl)-2:3,7:8,12:13,17:18-tetrabenzoporphyrin (2-18)  
Freshly distilled dry dichloromethane (214 mL) was added to a round bottom flask fitted 
with a reflux condenser, under argon. 3:4-Butanopyrrole (0.25 g, 2.14 mmol) and 4-
bromo-benzaldehyde (0.39g, 2.14 mmol) were added and the solution was stirred at room 
temperature under a slow steady stream of argon for 15 min. The flask was then shielded 
from ambient light and BF3•OEt2 (0.04 mL, 0.214 mmol) was added. This mixture was 
then stirred for 1 h at room temperature. DDQ (0.7 g, 3.21 mmol) was added to the 
reaction flask and the final solution turned dark pink instantly. This solution was refluxed 
under argon for 1 h to give a dark green solution. The solvent was reduced to dryness 
under vacuum and redissolved in dichloromethane and washed (4 × 100 mL) with 
aqueous sodium bicarbonate solution, (3 × 100 mL) with water and dried over sodium 
sulphate and concentrated under vacuo. The resultant compound was then redissolved in 
toluene, the addition of a 5 mL saturated solution of Cu(II)Cl2 in methanol then ensued 
and the corresponding solution refluxed for 12 h while monitoring by UV-Vis for a blue 
shift in the soret band  to 425 nm. Once the metallation was complete, the reaction 
mixture was filtered through an alumina pad to get rid of the excess Cu(II)Cl2 and 
evaporated to dryness. The metallated porphyrin complex (250 mg, 0.206 mmol) was 
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weighed and dissolved in minimum amount of toluene, (0.37 g, 1.6 mmol) of DDQ added 
to the solution that was then refluxed for fifteen minutes. The reaction was followed by 
UV-Vis for the appearance of a strong q-band at ~ 640 nm and also by TLC. Upon 
completion, the resultant solution was filtered through an alumina plug to get rid of the 
excess unreacted DDQ and recrystallized out of chloroform and methanol giving 0.19 g, 
80% yield of the 2-18, (M= Cu(II)). The corresponding free base derivative 2-18, (M= 
2H) was obtained by redissolving the metallated complex in concentrated sulfuric acid 
and stirring the resultant solution at room temperature for five minutes. UV-Vis was used 
for following the reaction to complete demetallation. Upon completion, the resultant 
mixture was quenched by pouring into an ice-bath and extracted into chloroform, filtered 
through an alumina plug, dried over sodium sulfate and concentrated in vacuo to afford 
the desired 2-18, (M= 2H) 0.18 g, quantitatively. UV-Vis (CH2Cl2): λmax (log ε) 467 
(10.8), 553 (3.75), 593 (4.07), 643 (4.27), 698 (3.85): MS (MALDI) m/z 1121.7 (M+): 1H 
NMR (CDCl3, 300 MHz) 8.51-8.45 (d, 8H, J= 8.23Hz, o-Ar) 8.13-8.11 (d, 8H, J= 8.23 
Hz, m-Ar), 7.52 (s, 16H, Benzylic-H). 
5,10,15-Tri(4-diethylphosphonate-phenyl)-(4-bromophenyl)-2:3,7:8,12:13,17:18-
tetrabenzoporphyrin (2-19) 
80 mg, 0.06 mMol of Tetrabenzoporphyrin 2-18 (M= Cu(II)) and 7 mg, 0.006 mmol of 
Pd(PPh3)4 were placed in an oven dried Schlenk tube. The tube was capped with a rubber 
septum and evacuated and backfilled with argon, this procedure was done three times. 60 
mL of toluene was cannulated to the schlenk tube and the tube purged with argon for five 
minutes. The resultant solution was then sonicated under argon until the compound had 
solubilized. 5 mL of triethyl amine and (0.19 mL, 0. 2 mmol) of diethylphosphite were 
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then added and the resultant solution refluxed at 100 °C for 96 hours following by TLC 
for the consumption of the starting material. After 96 hours, there was no significant 
increase in the yield of the desired product and ther reaction was stopped and quenched 
by the 100 mL of water. The resultant reaction mixture was diluted with chloroform and 
washed (3 × 100 mL) with water so as to get rid of the unreacted diethyl phosphite. The 
solution was then dried over sodium sulfate and concentrated in vacuo. Purification was 
done on a silica gel column with eluting with a gradient solution of 10% acetone in 
chloroform and gradually increasing the polarity to 30% acetone in chloroform. 2-19 was 
obtained as green crystals 16 mg in 20% yield. MS (MALDI) m/z 1374.33 (M+) 
5,10,15-Tri(4-diethylphosphonate-phenyl)-(4-disilyl-hexamethyl-amino-phenyl)-
2:3,7:8,12:13,17:18-tetrabenzoporphyrin (2-20) 
The general procedure mentioned previously was used to couple 2-19 with lithium 
hexamethyl disilyl amide (LiHMDS) using Pd(PPh3)4. 2-19 (16 mg, 0.012 mmol) and 2 
mg, 0.0012 mmol of Pd(PPh3)4 were put in an oven dried schlenk tube. 5 mL of toluene 
was then added to the septum sealed tube via syringe and (0.01 mL, 0.018 mmol) of 
LiHMDS. The tube was then heated at 80 °C for 12 hours under argon. The reaction was 
followed by TLC for the total consumption of 2-19. The reaction was stopped and solvent 
concentrated in vacuo. The resultant residue was purified using preparative TLC using 
silica gel and eluting with 1% methanol and chloroform so as to get rid of the excess 
triphenylphosphine ligand and the slightly unreacted starting material. The desired 
compound collected was the less polar band on the plate. This compound was then 
demetallated following the general demetallation procedure mentioned previously and the 
desired 2-20 isolated was 13 mg, 85% yield. 1H NMR (CDCl3, 300 MHz) 8.51-8.28 (d, 
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10H, Ar-H), 8.04-7.89 (d, 6H, Ar-H), 7.31-7.11(m, 16H, Benzylic-H), 4.34 (m, CH2, 
12H, phosphonate ester), 1.76-1.53 (t, CH3, 18H, phophonate ester), -1.10 (NH, 2H); MS 
(MALDI) m/z 1387.48 (M+) 
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Chapter 3: Novel Synthetic Routes to Biliverdins and their Metallated Derivatives 
 
3-1: Introduction 
Bilverdins are open-chain tetrapyrrole compounds widely distributed in nature 
either free or bound to protein.1 Open-chain tetrapyrroles are found in nature as catabolic 
products (e.g., the neurotoxic bilirubin in the bile fluid), as the chromophores of 
biliproteins performing important photo-biological functions, as pigments in lepidopters 
(e.g., biliverdin IXγ), and as chlorop[hyll degradation products in senescent plants.2 
Biliverdin derivatives have a helical surface,3 and have attracted attention as 
chromophores of remarkably high flexibility, having the potential to adopt a large 
number of configurational, conformational and tautomeric forms.4 They also have 
characteristic spectroscopic properties (UV-Vis, CD, and NMR)5 and display a variety of 
biological and chemical activity, which frequently imply coordination to a metal center.6 
Biliverdins have been shown to display antioxidant and antiviral activities,7 redox 
activity,8 coordinating ability,9 photochemical isomerization and energy transfer.10 Most 
syntheses of open-chain tetrapyrroles have been carried out on simple model compounds 
and have utilized either of two synthetic strategies. The first of these is based on 
biosynthetic theory and involves the oxidative cleavage of porphyrins, chlorins and 
related materials.11 The second involves stepwise syntheses that utilize suitably 
functionalized dipyrromethenone derivatives. In nature, the in vivo cleavage of heme (3-
1), catalyzed by the enzyme heme oxygenase, occurs selectively at the meso-α carbon to 
form verdoheme (3-2) via a meso-hydroxyheme, which reacts with a second molecule of 
oxygen to produce biliverdin IX α (3-3) after loss of the meso-α carbon as CO and 
demetalation (Scheme 3-1).12 Both electronic and steric effects exerted by the protein 
  
82 
control the regioselectivity of heme cleavage by heme oxygenase.13 However, the in vitro 
chemical oxidation of heme (3-1), normally accomplished using O2-ascorbic acid or O2-
hydrazine in aqueous pyridine (the so-called coupled oxidation)14 produces all four 
isomeric biliverdins. This process has been widely used as a model of the heme 
oxygenase catalyzed reactions.15 
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Owing to the low symmetry in biliverdin type compounds, their synthesis requires a 
multi-step route. As mentioned above, some of the early studies done on the synthesis of 
biliverdins utilized the suitably functionalized dipyrromethenone derivatives of types 3-4 
and 3-5 (Scheme 3-2) to synthesise asymmetric biliverdin derivatives.16 Coupling of 
dipyrromethone 3-4 and 3-5 gave moderate yields of linear tetrapyrrole derivatives. This 
approach afforded good control on the stereo and regiochemical feature as well as the 
oxidation states at the crucial ring positions. However, synthesis of the monocyclic 
pyrrolic derivatives, which are the precursor building blocks to the dipyrromethenones, is 
very challenging. 
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A variety of other reaction conditions have also been used for the photo- and 
chemical oxidations of porphyrins as a synthetic route to open chain tetrapyrroles, these 
include H2O2 in pyridine, thallium(III)17 and cerium(IV) salts,18 and O2-NaOMe in 
methanol/THF.19 These reactions typically produce formylbiliverdins (e. g. 3-7, from 
magnesium octaethylporphyrin)20 and biliverdin (e.g. 3-3, via extrusion of CO) from 
meso-unsubstituted porphyrins, and aroyl-substituted bilenes from meso-
tetraarylporphyrins, such as TPP (3-8). The yields obtained in these reactions are usually 
low to moderate, and depend on reaction conditions and the presence and nature of the 
coordinated metal ion. While a myriad of approaches to the oxidation of porphyrins that 
typically produce formyl-biliverdins and biliverdins have been developed, a satisfactory, 
high-yield preparative procedure for such compounds has been lacking. 
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In this Chapter, the facile and high yield preparation of novel benzoylbiliverdins 
from the chemical oxidation of metal-free dodeca-substituted porphyrin 3-8 and some of 
its derivatives and the high yield preparation of corresponding novel metallo-
benzoylbiliverdins will be discussed. 
3-2: Results and Discussion 
The chemical oxidation of the zinc(II) complex of TPP was first reported by 
Smith and coworkers21 using thallium(III) trifluoroacetate and nitrate salts. The purple 
major product obtained (in 17% yield) was assigned structure 3-10. The UV-Vis 
spectrum of this compound in CHCl3 showed two broad bands at 345 and 565 nm.22 The 
photo-oxygenation of the Zn(II), Cd(II), bis-Tl(I) and Mg(II) complexes of TPP also gave 
3-10 as the major product, along with trace amounts of benzoyl-bilverdin 3-11.23  
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The oxygen atoms in 3-10 and 3-11 were shown to come from a single O2 
molecule (thus a one-molecule mechanism), by experiments performed under different 
18O2/16O2 ratios and subsequent MS analyses. Benzoylbiliverdin 3-11 was therefore 
considered an “unstable” intermediate in the formation of 3-10, obtained from 
demetallation and addition of two hydrogens to the metal complex of 3-11 during 
reaction work-up. In parallel with the early studies conducted by Fuhrhop on metallo-
octaethylporphyrin,20a the structure of 3-10 was subsequently proposed as 3-12,19, 24 
bearing an additional oxygen atom at the α-carbon, presumably from ready addition of 
water to 3-11. Several studies were done in different solvents (methanol and ethanol) and 
confirmed there is in fact addition of solvent at the meso-position. The structure 3-12 was 
assigned based on 13C-NMR and MS data, which showed the existence of a quaternary 
meso-carbon at δ 75.0 and a molecular ion consistent with 3-12, although loss of water 
was readily observed by MS, and base peaks consistent with both 3-10 and 3-11, were 
also observed. Under nitrating conditions, using either a mixture of sulfuric and nitric 
acids25 or N2O4 in organic solvents,26 TPP (3-8) and its Mg(II) and Zn(II) complexes also 
produced 3-10 (3-11 or 3-12) as a side product. 
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Our synthetic approach entailed treating a concentrated trifluoroacetic acid (TFA) 
solution of 3-9 with NaNO2 in the presence of ambient oxygen conditions under which 
TPP 3-8 normally undergoes regioselective nitration at the para-positions of the meso-
phenyl rings.27 The product of this reaction for (3-9, R=H) was, however, not the nitro-
derivative but biladienone 3-18; this was obtained in a combined yield of 77% as a 
mixture of two interconvertible stereoisomers, structures of which were fully 
characterized by spectroscopic and crystallographic methods.  However, oxidation of 3-9 
(R= C9H19), affords biladienone 3-18 (R= C9H19) in 10 % yield and bilatrienone 3-19 in a 
70 % yield along with slight traces of starting material. 
The synthesis of meso-tetraaryl tetrabutanoporphyrins (Ar4TCHP) 3-9 is well 
documented.17 Ar4TCHP 3-9 was synthesized by condensation of tetrahydroisoindole (3-
16) with either 4-nonylbenzaldehyde (3-15) or commercially available benzaldehyde as 
shown in Scheme 3-5. 4-Nonylbenzaldehyde 3-15 was synthesized by treating 1-
bromooctane with magnesium turnings in diethyl ether at 0 ºC for 30 minutes affording 
the corresponding octyl-magnesium bromide Grignard that was not isolated but 
immediately treated with 4-bromobenzaldehyde affording the corresponding 1-(4-
bromophenyl)-1-hydroxynonane 3-13 in 97% yield (Scheme 3-6). The reaction was 
quenched by addition of water, and was extracted into dichloromethane, dried over 
sodium sulphate and purified on a silica gel column eluting with 3:1 hexane/ ethyl acetate 
affording pure 3-13 as a pale colored oil. This compound was characterized by 1H NMR 
and had two sets of doublets at 7.5 and 7.3 ppm corresponding to the ortho and meta 
protons.  
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A triplet corresponding to the proton on the carbon with the hydroxyl functional 
group appeared at 4.6 ppm, the hydroxyl group signal appeared at 1.9 ppm while the 
resonances corresponding to the methylene carbons appearing between 2.0 and 1.2 ppm 
and the CH3 protons as a triplet at 0.93 ppm. 3-13 was then treated with 
trimethylsilylchloride and sodium iodide followed by condensation with sodium 
boronhydride in DMSO to give the corresponding 4-bromophenylnonane 3-14 in 79% 
overall yield (Scheme 3-6).  
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The purification of 3-14 was performed by extraction into a solution of hexanes 
from the DMSO layer, drying the corresponding hexane layer over sodium sulphate and 
purifying the oil on a silica gel column eluting with hexane. This compound was 
characterized using 1H NMR and had two doublets at 8.11 and 7.52 ppm, corresponding 
to the ortho and meta protons. The para CH2 protons appeared at 2.92 ppm as a multiplet 
and the methylene protons on the nonanyl chain appeared between 2.3 and 1.2 ppm. A 
triplet peak corresponding to the CH3 group appeared at 0.94 ppm. Formylation of the 4-
bromophenyl-nonane using the Vilsmeier reagent gave the corresponding aldehyde 3-15 
in 65% yield (Scheme 3-6). 3-14 was first dissolved in THF and treated with n-BuLi and 
DMF at -78 ºC. Acidic workup, followed by extraction into hexane afforded a pale 
yellow oil of 3-15 that was purified on a silica gel column eluting 3:1 solution of hexane 
and ethyl acetate. This compound was characterized by 1H NMR giving a similar 
spectrum to the precursor compound 3-14 the only difference being the aldehyde peak 
signal at ~ 9.6 ppm. Figure 3-1 shows a 1H NMR spectrum of aldehyde 3-15.  
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Figure 3-1: 1H NMR of 4-nonanylbenzaldehyde (3-15) in CDCl3 at 300 MHz 
 
The tetrahydroisoindole ester precursor of 3-16 was synthesized via Barton-
Zard28b condensation using commercially available ethyl isocyanoacetate and 1-
nitrocyclohexene affording the corresponding protected 4,5,6,7-tetrahydroisoindole in 
90% yield; this was then deprotected using a one pot basic hydrolysis reaction to give 3-
16 in 85% yield.  
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Figure 3-2: 1H NMR spectrum of ArTCHP (3-9, R= C9H19) at 300 MHz 
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Figure 3-3: 13C NMR Spectrum of ArTCHP 3-9 (R= C9H19) in CDCl3 at 300 MHz 
 
Ar4TCHP 3-9 were synthesized in high yields (65-70%) by condensation of 3-16 
with either benzaldehyde (3-15, R= H) or 3-15 (R= C9H19) with a catalytic amount of 
BF3.OEt2 (Scheme 3-5). Porphyrins 3-9 were purified by using the same procedure of 
first filtering through an alumina plug followed by purification on an alumina gel column 
eluting with 2% methanol in dichloromethane. Porphyrin 3-9 (R= C9H19) was 
characterized by 1H NMR, (see Figure 3-2) the spectrum had two doublets corresponding 
to the ortho and meta protons at 8.11 and 7.52, and a multiplet at ~ 2.97 ppm 
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corresponding to the para methylene group. The 13C NMR of this symmetric porphyrin 
had a total of 16 carbon signals (Figure 3-3) while its MS (MALDI) showed as expected 
the corresponding molecular ion peak at 1335.4. 3-9 (R= H) also gave a similar 1H NMR 
spectrum to 3-9 (C9H19) with slightly shifted resonances and MS (MALDI) with a 
molecular ion peak at 831. 75. 
The chemical oxidation was then effected by adding 6 equivalents of NaNO2 to a 
concentrated solution of 3-9 (R=H, C9H19) (45 mg) in TFA (3 mL) under air and at room 
temperature. When 3-9 (R=H) was oxidized, the major purple product isolated in 77% 
yield, was bilverdins 3-18, along with 6% recovered starting material and trace amounts 
of polynitrated products. Because of the core-deformation from planarity in dodeca-
substituted porphyrins (3-9), as can be seen in the X-ray crystal structure in Figure 3-4, 
these compounds generally have lower oxidation potentials compared with their related 
octa- and tetra-substituted porphyrins.28 The green color of the acidic reaction mixture 
immediately changed to brown. After 10 minutes the reaction was quenched with water 
and neutralized with aqueous sodium bicarbonate solution. When this procedure was 
performed under an inert atmosphere of argon, only starting material porphyrin was 
recovered, indicating that air oxygen is essential, and is probably added to one of the 
porphyrin meso-positions. In addition, when the reaction was performed using 
dichloromethane as a solvent and a catalytic amount of TFA, or in the absence of TFA, 
only starting material (3-9) was recovered. When a radical scavenger (2,6-ditertbutyl-4-
methylphenol) was added to the reaction mixture the ring opening reaction was 
completely inhibited.  
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Figure 3-4: The Side view X-Ray Crystal structure 3-9 (R= H) showing the porphyrins 
core deformity from planarity (with chloroform atom) 
 
 
These results suggest that the porphyrin macrocycle is initially oxidized to the 
corresponding π-cation radical by NO+ and, upon reaction with air/ oxygen, ring-opening 
occurs so as to relieve steric strain. Figure 3-5, shows the postulated ring opening 
mechanism. The reaction of TFA and NaNO2 affords the nitrosonium ion (NO+)27b 
according to equation 3-1, which oxidizes the porphyrin ring to the π-cation radical. 
 
CF3COOH + NaNO2 HNO2 + NaOCOCF3
HNO2 HO-NO
H
+
H2O + NO
+ Eq 3-1 
Nucleophilic addition of the dioxygen molecule at the meso-position of the 
corresponding porphyrin π-cation radical affords 3-20, which is then reduced by the 
nitrosoion to give porphyrin (3-21), that then forms the four membered dioxetane23d ring 
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(3-22) which is sterically hindered and thus readily opens up to the bilverdin derivative. 
Figure 3-5: Postulated Ring-Opening Mechanism of Dodecasubstituted Porphyrin
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Two distinct tetrapyrroles of (3-18) that were purple and pink in color, were 
isolated after work-up and purification by column chromatography. The purple band was 
less polar than the pink band and purification was effected using a gradient of neat 
dichloromethane and gradually increasing the polarity to 2% methanol in 
dichloromethane. Both tetrapyrroles show broad absorption bands in the UV-Vis, which 
indicates significant conformational flexibility, because in solution, bilverdins exist in 
several conformations.28 Mizutani and co-workers also isolated the purple and pink 
  
95 
fractions upon chemical oxidation of iron(III) tetraarylporphyrins and reported that the 
so-called  “pink” biliverdin could be photoisomerized to the “purple” biliverdin while the 
reverse isomerization could not proceed.29 
 The 300 MHz 1H NMR spectra showed the asymmetry of both tetrapyrroles, i.e., 
for the purple, three N-H signals and one O-H signal appearing at 11.5, 11.2, 9.0 and 6.0 
ppm, respectively. These disappeared from the “purple” biliverdin upon performing a 
deuterium oxide shake. The presence of a doublet at around ~ 7.7 ppm due to the ortho 
protons on the benzoyl group is distinguishable from the complex resonances between 
7.8 and 7.3 ppm due to the aromatic protons. The 13C NMR spectrum of the purple 
biliverdin also showed a benzoyl carbonyl peak at 187 ppm, the lactam carbonyl at 174 
ppm, and a quaternary carbon at 75 ppm. A series of peaks between 144-120 ppm 
representing the sp2 carbons and another set between 26 -18 ppm equivalent to the sp3 
carbons were also observed. The tetrapyrrole that was pink in color on the other hand had 
a 1H NMR spectrum with three N-H peaks appearing at 12.5 and 9.46 and one shifted 
upfield at around 3.7 ppm, a singlet corresponding to the hydroxyl group appeared at 4.1 
ppm. Deuterium oxide shake resulted to the disappearance of the three N-H protons and 
the hydroxyl singlet peaks. The 13C NMR spectrum for the “pink” linear tetrapyrrole 
differed only slightly from the “purple” linear tetrapyrrole with almost similar carbonyl 
absorptions appearing at 187.03 and 172.41 ppm and had a quaternary carbon peak at 
77.7 ppm. Characteristic benzoylbiliverdin fragments were observed in high resolution 
ESI for both chromophores; these had M+Na ion peaks at m/z 903.4249 and 903.4224 for 
the pink and purple tetrapyrroles, respectively. Oxidations were also carried out using 
anhydrous methanol, ethanol, and methylamine to quench the reactions, and while 
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methylamine gave no addition product at all, the methanol and ethanol adducts were 
formed in almost negligible amounts as inferred from the appearance of near-baseline m/z 
913 and 927 peaks. Both steric and electronic factors may be invoked to account for the 
above observations. Unfortunately, the amounts of the above products obtained were not 
enough for any further analyses to be performed.  
Chemical oxidation of 3-9 (R=C9H19), resulted in the isolation of mainly 
bilatrienone 3-19 in 70% yield and biladienone 3-18 in 10% yield. The biladienone (3-18) 
isolated was also purple in color and had similar 1H NMR spectrum as the one with R= H 
(Figure 3-6). However, the resonances of 2NH peaks were almost overlapping and 
appeared at 11.6 and 11.4 ppm respectively, while the third NH peak appeared distinctly 
at 8.9 ppm. Two distinct doublets corresponding to the ortho protons on the benzoyl 
group appeared at 7.58 and 7.42 ppm. The 13C NMR spectrum also biladienone 3-18 had 
similar resonances as its counterpart with the quaternary carbon appearing at ~ 74 ppm. 
Bilatrienone 3-19 was also characterized by 1H NMR. However assignment of the peaks 
corresponding to 3-19 on the proton spectrum was more challenging. 4 small broad peaks 
at 12.8, 12.5, 11.9 and 10.8 ppm were tentatively assigned to correspond to the NH peaks. 
This was confirmed by deuterium oxide shake that resulted to the complete disappearance 
of all these peaks. The aromatic region had a series of complex resonances with one 
distinct doublet at 8.22 ppm. From the 1H NMR, it seemed that the bilatrienone existed as 
two conformers and from the integration of the NH peaks, both conformers existed in a 
1:1 ratio. The 13C spectrum of 3-19 also looked almost similar to biladienone 3-18, with 
overlapping four carbonyl resonances, which was a further confirmation of the existence 
of two conformers.  
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Figure 3-6: 1H NMR of Biladienone 3-18 (R= C9H19) in CD2Cl2 at 300 MHz 
 
However, this spectrum evidently lacked the typical quaternary carbon resonance peak 
observed in the other pigments. This compound was also characterized by MS (MALDI), 
giving a molecular ion peak at 1368.21.  
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3-3: Conformation Studies of Biliverdins  
Biliverdins usually have the helical all-syn conformation due to an efficient 
intrachromophoric hydrogen bond system based on the N-H....N-H bonding network. 
Studies carried out on biliverdin derivatives have shown that the ε(vis)/ε(UV) ratio is a 
function of the verdin molecular extension. An increase in ratio indicates a change in the 
porphyrin-like helically coiled form (5Z, 10Z, 15Z) to a more extended form, (e.g., 5Z, 
10E, 15Z or 5E, 10Z, 15Z), where the ratio is similar to that of polyenes.30, 31 The first 
detailed study of the geometry of free bile pigments stemmed from studies done by 
Moscowitz et al. who postulated a cyclohelical porphyrin like structure in solution for 
urobilins.31b  
Free biliverdins adopt the ZZZ helicoidal conformation with an ε(vis)/ε(UV) ratio of 
0.25 in agreement with molecular orbital calculations.32,33,34 Helicoidal (ZZZ)–biliverdins 
could be photoisomerized to their extended EZZ or EZE conformers but the later 
reconverted back to their helical forms.35 In our study, the ε(vis)/ε(UV) of the purple and 
pink biliverdin conformers was 0.47 and 0.64, respectively, indicating a more stretched 
conformation for the pink conformer than the purple one. In addition to this, the 
biliverdin derivatives produced from the chemical oxidation of 3-9 (R=C9H19) were 
bilatrienone 3-19 and biladienone 3-18 with hardly any traces of its pink conformer. This 
could be a result of the bulky alkyl substituent on the phenyl ring which will inhibit the 
EZ isomerization of the C4-C5 bond; similar results were reported by Mizutani et al. for 
etiobiliverdin; These authors ascribed the energy difference between the ZZZ and EZZ 
isomer to the steric repulsion between the β-alkyl groups and the pyrrole ring.18 
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It might be possible that the sole product of the chemical oxidation of porphyrin 
3-9  (R= C9H19) is bilatrienone 3-19 along with some traces of starting material. However 
upon work up and chromatographic purification, biladienone 3-18 is obtained by addition 
of a water molecule across the methine carbon bridge affording 3-18. This could be 
further argued by the fact that upon subjecting 3-18 to higher temperatures, e.g., 40 °C, 
compound 3-19 was isolated. This was confirmed by thin layer chromatography and UV-
vis and 1H NMR spectroscopies. No cotton effect signal was observed when circular 
dichroism (CD) studies were done on 3-19. This compound could be CD inactive as a 
result of the existence of both the M and P helical conformers as a racemic mixture in 
equal ratio in the solution. Circular dichroism studies done on formally achiral bilidiones 
of the biliverdin type derivatives36 indicate that there is a uniform population of two 
enantiomeric conformers 3-23 and 3-24 (Scheme 3-7), which differ in their sign of 
rotation and are in equilibrium with each other. Several authors have reported that the 
equilibrium (helical chirality’s) of biliverdin type derivatives can be shifted by 
dissolution of the compound in chiral solvents,37 or by adsorption to the chiral 
  
100 
biopolymer serum albumin38 and chiral amino acid esters and amines39 so as to observe 
the cotton effects.  
A final confirmation of the molecular structure of the benzoylbiliverdin 3-18 (R= 
H), and bilatrienone 3-19 was provided by X-ray crystallography (Figure 3-7 and 3-8). 
An examination of the ORTEP drawing for the X-ray structure of the title biliverdins 3-
18 (obtained by slow diffusion of hexane into a solution of chloroform) shows the 
compound to be a biladienone, with the third meso-carbon (C15) being quaternary and 
bearing a hydroxyl group. The existence of the –OH group is thus unequivocally 
established and corroborates the structural conclusions reached using 13C NMR data, 
which showed the presence of a quaternary meso- carbon at δ 75 ppm. Within a single 
crystal, two molecules of the biliverdin associate with each other to form 
intermolecularly hydrogen-bonded pairs. Triads of hydrogen bonds exist about an 
inversion center, with the participating groups being the lactam unit on one molecule and 
the benzoyl carbonyl, the pyrrole –NH, and most importantly, the meso-OH on the other. 
The meso-OH•••O (1) bond, though slightly extended, lies at a nearly perfect hydrogen-
bonding angle of ~179.2°, thus allowing for moderately strong hydrogen bonds; the 
remaining hydrogen bonds lie within 20% of the optimum angle of 180°. Stabilization 
offered by the intermolecular association may be the raison d’etre for the hydroxyl group 
and may explain the readiness of the initially formed bilatrienone 3-19 to add a molecule 
of water across its double bonds to give the above biliverdin 3-18. The same, along with 
steric factors, may also explain why oxidations done in methanol, ethanol, or 
methylamine media almost completely failed to give the corresponding addition products 
or gave only in negligible quantities.  
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Figure 3-7:  X-Ray Crystal Structure of Biladienone 3-18 (R=H) 
 
One consequence of the hydrogen bonding is that it predisposes the C (4)=C (5) 
double bond into an E- configuration, making the (EZ)- biladienone conformation the 
most stable one for this biliverdin. This, however, does not discount the possibility of 
various other conformations that may arise out of bond-rotation about the above double 
bond.  
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Figure 3-8: X-Ray Crystal Structure of Bilatrienone 3-19 (R=C9H19) 
 
Theoretical calculations done by Dr. Brahma Ghosh, formerly of Smith research 
group, (B3LYP/6-31G∗) do in fact predict the existence of various stereoisomers of the 
title biliverdin, which differ in energies by 6-10 Kcal/mol at room temperature, and may 
explain why the novel benzoylbiliverdin is obtained as different colored forms, the violet 
and the pink. In fact, similar isomeric biladienones were obtained by Mizutani et al, 
although from β-unsubstituted porphyrin (TPP), and under oxidation different oxidation 
conditions than the one reported in this Chapter. 
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3-4: Syntheses of Metallo-biliverdin Derivatives 
N
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M = Ni(II), Cu(II), Zn(II)
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The metallo-biliverdins 3-25 (Scheme 3-8) were prepared by treating the linear 
tetrapyrroles 3-18 with the appropriate metal salts. Both nickel(II) and copper(II) were 
inserted at reflux in toluene, using the corresponding acetates and in the presence of 
pyridine. On the other hand, zinc(II) was inserted using chloroform as the solvent and a 
saturated solution of the zinc(II) acetate in methanol. During the metallation of 3-18 and 
3-19 with Cu(II) and Ni(II)acetate, a compound that was deep blue in color and had a 
strong absorption at λmax 650 nm was isolated, if Ni(II) is complexed, it is metallated. 
The 1H NMR spectra show one broad singlet N-H peak at 8.95 ppm, a multiplex of peaks 
was also observed at the aromatic region, showing the asymmetry of the molecule.  This 
feature suggested the coordination of the nickel atoms to three nitrogens and one oxygen 
atom. This is in agreement with that of a nickel and copper complex reported by J. Callot 
et al.40  
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Figure 3-9:  X-Ray crystal structure of Ni(II)-Biliverdin 3-25 
 
The results of this compound were also confirmed using low-resolution mass 
spectrometry, which gave a molecular ion peak at 936.3. However crystal growth of this 
compound was also greatly hampered due to the fact that this compound was rapidly 
changing to the metallated benzoylbiliverdin (3-25, M= Ni (II)) over a short period of 
time.   
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The Zn(II) and Ni(II)-biliverdins had similar 1H NMR spectra, showing two 
distinct sets of doublets, downshifted at 8.04 - 7.72 ppm, corresponding to the ortho 
aromatic protons of the benzoyl group. The remaining aromatic protons appeared upfield, 
clustered between 7.64 and 7.21 ppm. A sharp singlet corresponding to two CH2 protons 
of the cyclohexenyl ring adjacent to the benzoyl group, appeared downfield around 2.4 
ppm and the remaining CH2 cyclohexenyl protons appeared as a complex set of peaks 
between 2.2 and 1.1 ppm that were very challenging to assign as a result of the 
asymmetric nature of the compound.  
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Figure 3-11:  X-Ray Crystal Structure of Ni(II)-benzobiliverdin 3-26 
 
The 13C NMR spectra of metallo-biliverdin 3-25 (M= Ni(II) showed, as expected, two 
carbonyl resonances at 189.3 and 181.8 ppm, aromatic carbons between 162.5 and 128.3 
ppm, and the remaining carbons appeared between 31.2 and 22.6 ppm. 3-25 (M= Ni(II)) 
was also characterized using X-ray crystallography as is shown in Figure 3-9. The 
aromatization to Ni(II)-benzoylbiliverdin 3-26 was effected by reflux of Ni(II)-biliverdin 
3-25 in toluene with eight equivalents of DDQ for fifteen minutes (Scheme 3-9).  
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The reaction was followed to completion by TLC and UV-Vis. UV-Vis of the 
reaction mixture showed a broad Q band at ~ 890 nm compared to the starting material 
The reaction mixture was purified by passing through an alumina plug and preparative 
thin layer chromatography eluting with 3:1 dichloromethane/ petroleum ether isolating 
mainly the partially aromatized 3-26 which was characterized by X-ray crystallography 
as shown in Figure 3-11. 3-26 was also characterized by MS (MALDI) giving a 
molecular ion peak at 904.82. MS (MALDI) spectrum of the reaction mixture before 
purification had a peak of lower intensity corresponding to the fully aromatized 
Ni(II)benzobiliverdin 3-27 at 902. 34.   
The 1H NMR spectrum of 3-26 had similar signals at the aromatic region as 3-25, 
the most distinct difference was the several doublet peaks that appeared between 6.5-5.0 
ppm corresponding to the benzylic-protons. Attempts to optimize the yields of the fully 
aromatized derivative 3-27 were hampered because increasing the reaction time resulted 
in a lower yield and increase in decomposition products that were correlated to the base-
line spot on the TLC plate. Several reaction parameters were changed like refluxing the 
precursor Ni(II)-biliverdin 3-25 at higher temperature without the DDQ, this reaction was 
followed by TLC and even after refluxing for 12 hours at 150 °C in toluene, there was no 
evidence of the formation of any new products. It was therefore concluded that during 
oxidation, 3-26 was not as stable to DDQ as anticipated succumbing to decomposition 
therefore lowering the yields of the oxidation material. 3-26 was obtained in very low 
yields of 25%. Oxidation experiments of 3-25 with mild oxidizing agents like p-
chloroanilin, were not investigated. 
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3-5: Conclusion and Future work 
A novel versatile synthetic methodology was developed for the synthesis of stable 
benzoylbiliverdin derivatives in relatively high yields. Previous methodologies reported 
utilize harsh conditions and long routes that require several purification procedures and 
report low to moderate yields of the desired compound. With this route, biliverdins with 
sensitive substituents can be isolated and a variety of diamagnetic metals and lanthanides 
have the potential of being inserted into the biliverdin core resulting in a significant 
change in the photophysical and chemical properties of the biliverdin derivatives. 
Biliverdins have been reported to possess antioxidant and antiviral activity. Therefore 
developing a route to the synthesis of these stable complexes will allow the exploration of 
the potential properties of this unique bile pigments. Electrochemical (redox activity) of 
the metallo-benzoyl biliverdin derivatives were evaluated by Dr. Karl Kadish, in order to 
understand their potential physiological roles.40b 
3-6: Experimental 
All experiments were performed under inert argon atmosphere using a Schlenk line. 
Melting points were measured with an Electrothermal melting point apparatus. The 1H-
NMR spectra were obtained using either a Bruker ARX-300 or a DPX-250 for the 300 
MHz and the 250 MHz, respectively.  Reactions were all monitored using silica gel TLC 
plates from Sorbent Technologies (200 µm). Chemical shifts (δ) are given in parts per 
million relative to tetramethylsilane (TMS, 0 ppm); multiplicities are indicated as br 
(broad), s (singlet), d (doublet), t (triplet), q (quartet) and m (multiplet). Analytical TLC 
was performed on Scientific Adsorbent Company Inc. silica gel plate and alumina gel 
  
109 
plate. Flash column chromatography was performed using silica gel (Scientific Adsorbent 
Company Inc. 40-63 µM particle size, 60 Å pore size). 
Electronic absorption spectra were measured using a Perkin-Elmer Lambda 35 UV-vis 
spectrophotometer. Mass Spectra were obtained at LSU Mass Spectometry Facility. 
All solvents were purchased from Fisher. DCM was dried by distilling over CaH2 and 
THF was dried by distilling first over LiAlH4 then distilling over sodium and 
benzophenone. The low resolution MS experiments reported as FAB (Fast Atom 
Bombardment) were measured with Finnigan MAT 900, and the High Resolution MS 
(HRMS) experiments were measured using an Applied Biosystems Q Star XL 
electrospray (ESI) MS. Elemental analysis experiments were performed by Midwest 
Microlab, LLC. 
Synthesis of 1-(4-Bromophenyl)-1-nonanol (3-13) 
1-Octylbromide (50 mmol, 10.8 g) in diethyl ether (50 mL) under argon was treated with 
magnesium turnings at room temperature and stirred for 30 min to give the corresponding 
octyl-magnesium bromide. This reaction mixture was then cooled down to 0 °C and 
bromobenzaldehyde (40 mmol, 6.75 g) was added to the solution slowly before being 
stirred for 1 h. The reaction mixture was then quenched and washed with water and dried 
over anhydrous Na2SO4; the organic solvents were then reduced under vacuum and the 
yellow oil obtained was taken up in hexane and purified by silica gel chromatography, 
using 3:1 hexane and ethyl acetate solution as the eluant. 1-(4-Bromophenyl)-1-nonanol 
(3-13) was obtained in 97% yield (14.6 g). 1H NMR 300 MHz (CDCl3,), 7.45 (d, 2H, o-
Ar), 7.20 (d, 2H, p-Ar), 4.61 (s, broad, 1H), 1.98 (s, 1H, OH) 1.9-1.2 (m, 14H), 0.85 (t, 
3H): MS (FAB) m/z 299.17(M+) 
  
110 
Synthesis of 4-Bromophenyl nonane (3-14) 
3-13, (50 mmol, 14.9 g) was dissolved in 150 mL acetonitrile, trimethylsilylchloride (300 
mmol, 27 mL) and sodium iodide (300 mmol, 45 g) were added to the corresponding 
solution and stirred under argon for 12 h at room temperature. The reaction mixture was 
then washed with an aqueous solution of Na2S2O3, dried over anhydrous Na2SO4 and 
solvent was reduced under pressure to afford an orange oil. This orange oil was then 
diluted with DMSO (150 mL) and NaBH4 (75 mmol, 2.85 g) was added slowly. The 
resultant solution was stirred under argon for 12 h. The yellow solution was then 
extracted into hexane and purified by silica gel chromatography using hexane as the 
eluent. The first band collected was 4-bromophenylnonane (10.7 g, 76.3%). 1H NMR 300 
MHz (CDCl3,), 7.42 (d, 2H, o-Ar), 7.08 (d, 2H, m-Ar), 2.60 (t, 2H,) 1.58-1.29 (m, 14H), 
0.91 (t, 3H): MS (FAB) m/z 282.16 (M+) 
Synthesis of 4-nonanylbenzaldehyde (3-15) 
3-14, (15 mmol, 4.25 g) was dissolved in freshly distilled THF and the reaction mixture 
was cooled down to –78 °C. n-BuLi (46 mmol, 26.5 mL) was then added drop wise and 
the mixture was stirred at –78 °C for 1 h. DMF (46 mmol, 3.0 mL) was then added to the 
mixture drop wise and stirred under argon for 1 h. The ice bath was removed and the 
reaction mixture was allowed to warm up to room temperature. The reaction mixture was 
then quenched with 1M HCl (100 mL), extracted into hexanes (3 × 100 mL), washed 
with water and finally dried over anhydrous Na2SO4. The solvent was evaporated off to 
afford a yellow oil which was once again purified by silica gel chromatography using a 
3:1 mixture of hexane and ethyl acetate as the eluant to give 4-nonanylbenzaldehyde as 
an oil (2.3 g, 65% yield). 1H NMR 300 MHz (CDCl3,), 10.0 (sharp s, 1H, aldehyde) 7.82 
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(d, 2H, o-Ar), 7.36 (d, 2H, p-Ar), 2.74 (m, 2H) 1.69-1.29 (m, 14H), 0.93 (t, 3H): MS 
(FAB) m/z 233.26 (M+) 
5,10,15,20-Tetraphenyl-2:3,7:8,12:13,17:18-tetra-butanoporphyrin (3-9) R= (H, 
C9H19)   
Freshly distilled dry dichloromethane (214 mL) was added to a round bottom flask fitted 
with a reflux condenser, under argon. 3:4-Butanopyrrole (0.25 g, 2.14 mmol) and 4-
nonanyl-benzaldehyde (0.5 g, 2.14 mmol) were added and the solution was stirred at 
room temperature under a slow steady stream of argon for 15 min. The flask was then 
shielded from ambient light and BF3•OEt2 (0.04 mL, 0.214 mmol) was added. This 
mixture was then stirred for 1 h at room temperature. DDQ (0.7 g, 3.21 mmol) was added 
to the reaction flask and the final solution turned dark pink instantly. This solution was 
refluxed under argon for 1 h to give a dark green solution. The solvent was reduced to 
dryness under vacuum and the resulting residue was dissolved in dichloromethane and 
filtered on an alumina plug so as to get rid of the excess unreacted DDQ and then purified 
by alumina column chromatography using 2% methanol in dichloromethane for elution. 
Recrystallization from hot methanol afforded purple crystals of the title porphyrin (0.5 g, 
70% yield). R= C9H19, 1H NMR 300 MHz (CDCl3), 8.11-8.08, (d, 8H, J= 7.7 Hz, o-Ar) 
7.52-7.49 (d, 8H, J= 7.8 Hz, m-Ar) 2.97-2.92, (t, 8H, each, CH2) 2.33-1.29 (m, 40H, 
CH2), 0.94-0.92 (t, 12H, CH3): UV-Vis (CH2Cl2) λmax 446 nm (ε 66,084), 542 nm (5052), 
615 nm (3720), 679 nm (5698) : MS (MALDI) m/z 1335.30 (M+): Anal. Calcd. for 
C96H126N4: C 84.03, H 9.56, N 4.09. Found: C 84.23, H 9.35, N 4.24: 13C NMR, 300 MHz 
(CDCl3) δ 144. 1, 140.7, 136.2, 129.1, 118.5, 37.4, 33.5, 33.1, 31.29, 31.24, 30.97, 30.64, 
27.3, 25.1, 24.2, 15.7 
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R= H, 1H NMR 300 MHz (CDCl3, drop of d-TFA), 8.42 (s, 8H, o-Ar) 7.91 (s, 12H, p- 
and m-Ar) 2.52, 2.04, 1.79, 1.71 (broad s, 8H each, CH2) -0.51 (s, 4H, NH): UV-Vis 
(CH2Cl2) λmax 441 nm (ε 145,600), 672 (9300): UV-Vis (dication, CH2Cl2) λmax 459 nm 
(214,200), 612 nm (13,000), 670 nm (25,000): MS (MALDI) m/z 831.75 (M+).  
Benzoylbiliverdins (3-18):  
Porphyrin 3-9, R= H (100 mg, 0.12 mmol) was dissolved in TFA (3.0 mL) and NaNO2 
(33 mg, 0.48 mmol) was added to the solution while stirring under air at room temperature 
for 3 min. The reaction mixture was quenched by pouring into water (50 mL), followed 
by extraction with dichloromethane (6 x 25 mL). The organic layers were washed twice 
with saturated aqueous NaHCO3 (2 x 100 mL), once with water (100 mL), and dried over 
anhydrous Na2SO4. The solvent was removed under vacuum and the residue was purified 
by alumina column chromatography using a gradient elution, starting with pure 
dichloromethane. The polynitrated porphyrins and unreacted starting material were eluted 
first. A few drops of triethylamine were added and the polarity of the eluting solvent was 
increased to up 2% methanol in dichloromethane. The major violet band was then eluted 
and obtained in 60% yield (62 mg) after evaporation of the solvent. This compound was 
closely followed by a pink band, giving a 20% yield (20 mg). For the violet band: mp 
194-196 °C. UV-Vis (CH2Cl2) λmax 341 nm (ε 19,200), 574 (41,100): 1H NMR 300 MHz 
(CD2Cl2), 11.62, 11.27 (2 broad s, NH, 2H), 9.00 (singlet, NH, 1H), 7.62-7.57 (d, o-ArH, 
2H), 7.51-7.35 (Ar-H, 18H), 6.01 (s, OH, 1H), 3.7 (m, CH2, 2H) 2.49-1.2 (m, CH2, 30H): 
HRMS for M+Na ion peaks at m/z 903.4224. Anal. calcd for C60H56N4O3: C 74.51, H 6.85, 
N 5.78. Found: C 73.93, H 6.93, N 6.03: 13C NMR (CDCl3) δ 187.1, 174.5, 144.6, 143.3, 
141.8, 139.8, 138.7, 137.7, 135.2, 133.0, 132.7, 132.3, 131.5, 130.4, 130.0, 129.8, 129.7, 
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129.5, 128.9, 122.7, 120.5, 75.8, 55.0, 26.7, 26.2, 25.4, 24.7, 24.4, 24.3, 24.2, 23.6, 22.8, 
22.3. For the pink band: mp 170-173 °C: UV-Vis (CH2Cl2) λmax 341 nm (ε 21,700), 508 
(13,800). 1H NMR 300 MHz (CD2Cl2), 12.57, 9.46 (2 broad s, NH, 2H), 7.56-7.18 (Ar-H, 
20H), 4.13 (s, OH, 1H), 3.7 (broad s, NH, 1H) 2.41-1.32 (m, CH2, 32H): HRMS for M+Na: 
found  m/z 903.4249. Anal. calcd for C60H56N4O3: C 74.51, H 6.85, N 5.78. Found: C 73.71, 
H 6.36, N 6.33: 13C NMR (CDCl3) δ 187.0, 172.4, 145.3, 144.6, 143.9, 141.6, 140.9, 139.2, 
139.0, 137.9, 135.3, 132.9, 132.6, 132.3, 131.4, 130.6, 130.4, 130.1, 130.07, 130.00, 129.8, 
129.5, 129.4, 129.3, 128.7, 128.1, 127.1, 122.7, 117.6, 77.7, 33.1, 32.5, 26.4, 25.4, 25.2, 24.9, 
24.7, 24.6, 24.5, 24.2, 24.0, 23.5, 22.8, 22.2, 15.6 
From porphyrin 3-9, R= C9H19, (100 mg, 0.074 mmol) was dissolved in TFA (2. 0 mL) and 
NaNO2 (30 mg, 0.45 mmol) was added and a similar experimental procedure to that 
reported above was followed. The solvent was removed under vacuum and the resulting 
residue was taken up in chloroform and purified using a gradient elution of chloroform 
and 1% methanol/chloroform, on an alumina column. The first green band eluted with 
pure chloroform (71 mg, 70%) yield was compound 3-19. The violet band 3-18, R= 
C9H19 (11 mg, 10%) was eluted next with 1% methanol/chloroform solution. Trace 
amounts of the starting material were eluted last from the column. For 3-19: Mp 245-247 
°C: UV-Vis (CH2Cl2) λmax 332 nm (ε 30,600), 447 (31,600), 683 (7800): MS (MALDI-
TOF) m/z 1368.3 (M+): 1H NMR 300 MHz (CDCl3) ppm, 12.8, 12.5, 11.9, 10.8 (broad s, 
4NH) 8.22-6.75 (m, Ar-H, 16H), 2,76-1.33 (m, CH2, 64H), 0.94 (m, CH3, 12H): Anal. calcd 
for C96H126N4: C 80.05, H 9.38, N 3.89. Found: C 80.07, H 9.07, N 3.83. For 3-18, R= 
C9H19, Mp 185-190 °C: UV-Vis (CH2Cl2) λmax 345 nm (ε 47,000), 576 (22,700): MS 
(Maldi-TOF) m/z 1386.4 (M+): 1H NMR 300 MHz (CDCl3), 11.61, 11.42 (2 broad s, NH, 
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2H), 8.86 (singlet, NH, 1H), 7.56 (d, o-Ar, J= 8.0 Hz, 2H), 7.40 (d, m-Ar, J= 8.0Hz, 2H), 7.3-
7.1 (m, Ar-H, 14H), 6.10 (s, OH, 1H), 2.7-0.8 (m, CH3, 64H), 0.1 (t, CH3, 12H): Anal. calcd 
for C96H128N4: C 83.19, H 9.31, N 4.04. Found: C 82.98, H 9.24, N 4.12. 13C NMR (CDCl3) 
δ 172.2, 163.5, 146.6, 145.3, 144.3, 143.5, 143.2, 139.6, 138.8, 137.7, 136.6, 135.6, 135.1, 
134.2, 133.5, 131.1, 129.8, 128.9, 128.5, 128.3, 127.2, 125.3, 120.6, 119.4, 74.1, 36.1, 35.8, 
35.7, 32.1, 31.8, 31.6, 29.8, 29.7, 29.6, 29.5, 29.1, 24.9, 24.1, 23.4, 23.0, 22.9  
Synthesis of Ni(II)-biliverdin 3-25 
3-18 (81 mg, 0.09 mmol) was dissolved in toluene (20 mL) and an excess of nickel(II) 
acetate (24 mg, 0.1 mmol) was added to the solution with stirring. The final mixture was 
refluxed for 24 h. The reaction mixture was cooled down to room temperature and the 
solvent was removed under vacuum. Purification was performed on an alumina plug to 
remove excess metal acetate, followed by column chromatography on alumina using 
dichloromethane/petroleum ether 3:1 for elution. The product was collected and re-
crystallized from dichloromethane/methanol to give the Ni(II)-biliverdin in quantitative 
yield (84 mg). Mp 245-247 °C: UV-Vis (CH2Cl2) λmax 318 nm (ε 28,900), 439 (23,500), 
802 (9800): MS (ESI) m/z 918.9 (M+): 13C NMR (CDCl3) 189.3, 181.8, 162.5, 159.1, 
149.8, 149.3, 146.4, 145.1, 142.9, 141.9, 140.3, 140.0, 139.5, 138.3, 134.6, 134.5, 133.2, 
132.5, 132.3, 131.4, 130.2, 130.0, 129.9, 129.8, 129.6, 129.5, 129.2, 128.3, 31.2, 27.5, 
27.3, 27.0, 26.5, 26.1, 25.9, 25.8, 24.8, 24.7, 24.5, 24.3, 24.2, 22.6, 15.6; 1H NMR 
(CDCl3, + 1 drop of d-TFA) 8.04-7.21(m, ArH, 20H), 2.39-1.10 (m, CH2, 32H). HRMS for 
C60H52N4O2Ni+Na: calculated 941.3341, found 941.3353: Anal. Calcd. for C60H52N4O2Ni: C 
72.70, H 6.11, N 5.66. Found: C 73.19, H 6.14, N 5.15.   
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Synthesis of Cu(II)-biliverdin (3-25)  
The metal free benzoylbiliverdin prepared as described above (100 mg, 0.12 mmol) was 
dissolved in 20 mL of toluene and copper(II) acetate (239 mg, 1.2 mMol) was added to 
the solution with stirring. The final mixture was refluxed for 8 h, cooled down to room 
temperature and the solvent was then removed under vacuum. Purification on an alumina 
plug served to remove excess metal acetate, and this was followed by column 
chromatography on alumina using dichloromethane/petroleum ether 3:1 for elution. The 
main band was collected and re-crystallized from dichloromethane/methanol to give the 
title biliverdin (80mg, 75% yield). M.p. 262-265 °C: UV-Vis (CH2Cl2) λmax 326 nm (ε 
28,200), 420 (24,200), 481 (28,400), 806 (10,400): MS (ESI) m/z 924.63 (M+): HRMS for 
C60H52N4O2Cu+Na: calculated 946.3284, found 946.3284: Anal. Calcd. for C60H52N4O2Cu: 
C 73.67, H 5.98, N 5.73. Found: C 73.86, H 5.81, N 5.28 
Zn(II)-benzoylbiliverdin (3-25) 
 The metal free benzoylbiliverdin prepared as described above (100 mg, 0.12 mMol) was 
dissolved in 20 mL of CHCl3 and 5 mL of saturated solution of zinc(II) acetate in 
methanol was added to the solution with stirring. The final mixture was refluxed for 8 h, 
cooled down to room temperature and the solvent was then removed under vacuum. The 
residue was redissolved in dichloromethane (20mL) and this solution was washed once 
with saturated aqueous NaHCO3 (100 mL), once with water (100 mL) and then dried 
over anhydrous NaSO4. Recrystallization from dichloromethane/methanol gave the title 
biliverdin (66mg, 60% yield). Mp 174-177 °C. UV-Vis (CH2Cl2) λmax 329 nm (ε 21,900), 
446 (17,200), 752 (6300): HRMS for C60H52N4O2 Zn: calculated 925.3460, found 
925.3473: 1H NMR (CDCl3) 7.90-7.25 (m, ArH, 20H), 2.40-1.30 (m, CH2, 32H). 
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Chapter 4: Syntheses of Symmetric and Asymmetric Water-Soluble 
Tetrabenzoporphyrin Derivatives 
 
4-1: Introduction 
As porphyrins continue to be one of the most extensively investigated class of 
substances known, research on tetrabenzoporphyrins (TBPs) has progressed relatively 
slowly despite an ongoing interest in the synthesis and properties of these and other 
extended porphyrin macrocycles.1 As pointed out by Bonnett, the chemistry of TBPs has 
been relatively neglected due to their synthesis being difficult.2 TBPs form a class of 
stable compounds with attractive properties as models for naturally occurring tetrapyrrole 
derivatives.  They are macrocyles that contain four fused aromatic subunits at the β-pyrrolic 
positions2c and appear to be very promising because they display notable stability and 
unique chemical, physical and spectroscopic properties. The extension of their π-
conjugated systems results in better-defined spectral features with absorption bands 
significantly shifted to the infrared region compared to the parent porphyrins.3  
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The importance and the development of synthetic methodologies to TBP systems 
(4-1) was inspired from its resemblance to phthalocyanine (4-2) as is shown Figure 4-1. 
Phthalocyanines (4-2) are among the most studied classes of organic pigments having a 
myriad of industrial applications that results in the production of hundreds of successful 
patent applications yearly.4 They find applications as dyes and inks, catalysts, electrical 
conductors and optical materials.5 Alongside the porphyrins, they also have suitable 
properties to act as photosensitizers in photodynamic therapy (PDT) of cancer.6 The 
importance of phthalocyanines has also led to the synthesis of other conjugated 
macrocycles including napthalocyanines,7 hybrid structures such as tetraazaporphyrins8 
and other macrocyles with an intermediary number of bridging nitrogen atoms.9 TBPs 
absorb in the near IR; red shifted porphyrinoid chromophores have been the subject of 
extensive studies over the last few years. This is due in part to their potential utility as 
photosensitizers in PDT where, absorbance in the near IR region is preferred because 
light penetration into tissue is considerably deeper. Tissues have endogenous 
chromophores such as haemoglobin, myoglobin and cytochromes that are present in high 
concentration and absorb light in the wavelength ranges 380-400 nm and 500-560 nm, as 
do several porphyrin derivatives.10, 11Apart from applications in PDT, TBPs also posses 
several other applications as opto-electronic materials, nonlinear optical materials, optical 
limiters, luminescent markers for oxygen, near-IR biomolecule labeling dyes and pH 
sensors in biomedical imaging.12  
4-2:  Background on the Synthesis of Benzoporphyrin Derivatives 
TBPs fall under a classical group of compounds known as benzoporphyrins that 
were first discovered in trace amounts in various oil shales and petroleum. Other 
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porphyrin derivatives that fall in this class are monobenzoporphyrins 4-3, 4-4 and e 
dibenzoporphyrin 4-5 and 4-6, as shown in Figure 4-213 
NH
N
N
HN
Et
MeMe
Et
Me
Me
4-3 4-4
NH
N
N
HN
Et
MeMe
Et
4-5
NH
N
N
HN
Et
Et
Me
4-6
NH
N
N
HN
MeMe
Et
Et
Me
Me
Figure 4-2: Examples of benzoporphyrin derivatives 
 
The syntheses of TBPs were first described by Helberger and coworkers from o-
cyanoacetophenone and various phthalimidines.14 Two main approaches were utilized in 
the development of the synthetic methodology of benzoporphyrin derivatives. The first 
approach was based on the fact that tetrabenzoporphyrins resemble phthalocyanine 
derivatives and therefore mimicked the high temperature condensation using 
phthalimidine derivatives in the presence of a metal template.15 The second approach was 
adapted from the general porphyrin synthesis of condensation of pyrroles with meso-
carbon donors. The pyrroles are replaced by isoindoles16 or its derivatives that are very 
unstable and not easily synthesized.17 Since then, several improvements on the synthesis 
of benzoporphyrin derivatives have been reported. 
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Linstead et al18 was the first group to improve on Helberger’s synthesis of TBPs. 
They investigated these tetrapyrrolic pigments and initially isolated impure TBP 4-11 
from the reaction of o-cyanocinnamic acid 4-8 with zinc salts at high temperatures 
(Scheme 4-1). They subsequently reported a higher yielding route to 4-11 by using a 
zinc(II) acetate template19 of 3-carboxymethylphthalimidine (4-7) at elevated 
temperatures (Scheme 4-1). Vogler and Kunkely20 also isolated 4-11 by the template 
reaction of 2-acetylbenzoic acid (4-9) with zinc(II) acetate in the presence of aqueous 
ammonia and molecular sieves at 400 °C. Condensation of phthalimide (4-10) or its 
potassium salt with sodium acetate or malonic acid in the presence of zinc(II) acetate at 
360 °C also afforded 4-11.21 The intial synthesis of TBPs by heating at 350-400 °C in the 
presence of metal salts such as iron, zinc, magnesium, cadmium, or metallic acetates 
afforded the corresponding metallo-TBPs usually very impure and requiring extensive 
purification process. However, Voglers and Kunkleys synthesis affords the corresponding 
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derivatives in a more pure form and in 17% yield; the free-base was isolated by 
demetalation under acidic conditions. 22  
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Metalated TBP derivatives have been also synthesized by pyrolysis of unstable 
isoindoles in the presence of metals or metal salts, under an inert atmosphere, or by 
refluxing in a high boiling solvent (1,2,4-trichlorobenzene or 1-chloronapthalene) 
affording the symmetrical benzoporphyrins in low yields.23 Remy reported the synthesis 
of 4-11 by a variation of the Rothemund methodology (Scheme 4-2) using isoindole 4-15 
and formaldehyde in the presence of a metal or metal salt.1 High temperature conditions 
are required for this condensation generally affording 4-11 in 53% yield and it was noted 
that the absence of the metal salt, resulted in very low yields of 4-11. The corresponding 
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condensation of 4-15 with benzaldehyde in the presence of a metal salt or 3-
benzylidenephthalimidine in the presence of zinc(II) acetate at high temperature afforded 
a mixture of partially meso-substituted metallo- TBPs; the major product being the metal 
complex of the tetraphenyltetrabenzoporphyrin.24 Vicente et al2b developed milder and 
more modern synthetic methods to prepare 4-11. They prepared pyrrole 4-12 and 4-13 
using Barton Zard conditions25, which upon reduction of the ester with lithium aluminum 
hydride, followed by cyclotetramerization in acetic acid and oxidation with DDQ, gave 
the phenylsulfonyl-substituted porphyrin 4-14 (mixtures of isomers) in 60% yield. Base 
promoted elimination of the phenylsulfinate units, followed by dehydrogenation with 
DDQ in refluxing toluene, gave 4-11 in 53% overall yield (Scheme 4-2). Ono et al26 were 
able to circumvent the instability of the isoindole by using a masked isoindole. 4,7-
dihydro-4,7-ethano-2H-isoindole ester (4-16) was reduced with lithium aluminum 
hydride to the carbinol followed by acid catalysed cyclotetramerization and oxidation 
with DDQ, affording porphyrin 4-17 in 30% yield. Tetrabenzoporphyrin 4-11 was then 
obtained quantitatively in very pure form by heating 4-17 at 200 °C, which resulted in the 
extrusion of 4 equivalents of ethylene, possibly via a retro-Diels-Alder process. Other 
synthetic routes to benzoporphyrins are the condensation of benzodipyrromethene 
hydrobromides,27 and from Diels-Alder type reaction involving β-vinyl porphyrins and 
activated dienophiles.28 Unsubstituted TBP (4-11) is notoriously insoluble as compared with 
porphyrins, in part because of their extended, planar π-conjugated systems and their 
pronounced tendency for π- π stacking. The evaluation of the physicochemical properties 
of these29 compounds over the years has been slow, tardy and hampered as a result of the 
extremely low solubility properties of benzoporphyrins (4-11). Nevertheless, tetraaryl-
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substituted tetrabenzoporphyrins, Ar4TBPs (4-1, R= Ar) show enhanced solubility properties. 
The increased solubility of Ar4TBPs relative to TBPs is probably a result of their 
considerably non planar structure, due to the steric crowding induced by the four meso-aryl 
substituents.30 In this Chapter, the total synthesis of symmetric water-soluble metallo-
tetraaryl tetrabenzoporphyrins (M-Ar4TBP) will be discussed in addition to some 
preliminary photophysical evaluation. 
4-3: Results and Discussion 
The ability to simply change the central metal ion allows for variation in the 
overall optical properties and also provides some fine-tuning capabilities of porphyrin 
derivatives. Generally, metalloporphyrins contain two kinds of metals; the regular or 
irregular metals. Regular metals have only a small effect on the optical absorption and 
emission spectra, while the reverse occurs for the irregular metals.31 In this Chapter, the 
synthesis of several TBP derivatives with different diamagnetic metals in the inner core 
will be discussed. The effects of the central metal ion on the optical absorption and 
emission properties will be discussed in addition to the effect of changing the water-
solubilizing groups at the periphery of the TBPs. 
5,10,15,20-Tetra[(4-methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-
butanoporphyrin, 4-18 (M= 2H) was synthesized by condensation of butano-pyrrole and 
4-methyl formylbenzoate following Lindsey’s reaction conditions.32 The butanopyrrole 
synthesis is described in Chapter 3 (3-16). The synthesis and purification of 4-18 (M= 
2H) is similar to the one utilized in the synthesis of porphyrin 3-9 and is also described in 
detail in Chapter 3.  
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This compound was obtained in 60% yield and characterized by both 1H NMR and MS 
(MALDI). The 1H NMR for 4-18 (M= 2H) has a multiplet peak corresponding to the 
ortho and meta protons between 8.56-8.5 ppm. A singlet peak corresponding to the 
methyl on the ester group appeared at 4.14 ppm, while several multiplet peaks 
corresponding to the methylene protons appeared upfield in the spectrum (Figure 4-3). As 
expected, a molecular ion peak was observed in the MS (MALDI) spectrum at 1064.3.  
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Subsequent aromatization to the corresponding TBP derivative requires the conversion of 
the free-base porphyrin into a metal complex. Literature reports that aromatization of the 
free-base porphyrin to the TBP derivatives results to either no reaction or decomposition 
of the macrocycle.2b This is because on adding DDQ, the free-base dodecasubstituted 
porphyrins that are generally non-planar and thus possess high affinity for protons, form 
dications that are inert to oxidation.33 Another plausible reason is explained in literature 
using the Single Electron Transfer (SET)34 theory that is proposed to be the main 
pathway taken during oxidation. SET normally occurs during oxidation affording the 
corresponding π-cation radical. However, unlike metallo-porphyrins, the π-cation 
radicals of free-base porphyrins are highly transient species. This is because in the latter, 
the electron spin density is concentrated either at the meso-position or in the imine 
nitrogens, but because the meso-position is sterically hindered by the phenyl groups, the 
electron spin density is concentrated at the imine nitrogens resulting in easy protonation 
of these groups.35 
Porphyrin 4-18 (M= Cu(II)) was prepared by treating a solution of 4-18 (M=2H) 
with a ten equivalent excess of Cu(OAc)2.2H2O, a few drops of triethylamine and 
refluxing in toluene. The reaction was monitored by UV-Vis until completion of the 
metal insertion. The choice of metal was dependant upon the ease of demetallation upon 
aromatization to the corresponding TBP 4-19 (M= 2H). Zinc metal can also be used for 
the aromatization, however, the zinc(II) complex is very acid labile and can be 
demetallated very easily in slightly acid media affording a mixture of metal-free and 
metallated complex that require tedious purification measures.24a The copper(II) complex 
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could only be fully characterized by MS (MALDI) due to its paramagnetic nature. 
 
Figure 4-3: 1H NMR of 4-18 (M= 2H) in CDCl3 at 300 MHz 
 
Porphyrin 4-18 (M= Cu(II)) was isolated quantitatively, and its MS (MALDI) 
shows a molecular ion peak at 1123.9. Treatment of 4-18 (M= Cu(II)) with excess DDQ 
under reflux in toluene afforded the corresponding TBP complex 4-19 (M= Cu(II)) in 
80% yield. This complex was demetallated by stirring at room temperature for five 
minutes in concentrated sulfuric acid, and the free-base 4-19 (M= 2H) was isolated in 
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85% yield. The reaction was followed to completion by UV-Vis untill a red-shifted Soret 
band appeared at ~ 500 nm. Despite the harsh conditions required for demetallation, there 
were only slight traces of hydrolysis of the ester side groups. The mixture was poured 
into ice water followed by extraction into chloroform quenched. The chloroform was 
concentrated to dryness under vacuo, and the residue redissolved in chloroform and 
filtered through an alumina plug to get rid of the very polar partially hydrolysed methyl 
ester derivatives. TBP 4-19 (M= 2H) was obtained in 85% yield and was characterized by 
MS (MALDI) giving the corresponding molecular ion peak at 1047.5, while the 1H NMR 
had signals corresponding to the ortho and meta-protons as doublets at 8.65 and 8.5 ppm, 
a broad signal of clustered peaks at 7.3 ppm corresponding to the 16 benzylic protons and 
the methyl ester peak at 4.17 ppm.  
Several diamagnetic metals were then inserted into the inner core of 4-19 (M= 
2H). In the past decade, there has been enormous progress in the synthesis of 
metalloporphyrins resulting to an almost complete “Porphyrin Periodic Table”.36a The 
porphrin complexes reported contain nearly every metal and semimetal in the Periodic 
Table. The series of diamagnetic metals investigated were as follows; Al(III), Ga(III), 
In(III), Mg(II), Zn(II), Pd(II), Ni(II) and Sn(IV). The main reason of studying these metal 
complexes with several oxidation states was to investigate the effect of the nature of the 
metal and associated axial ligand(s) on the optical absorption and emission spectra as 
well as the aggregation (solubility of the TBPs). The procedures that were adopted to 
insert these metal ions were patterned after procedures for metal insertions on several 
phthalocyanine and tetraphenylporphyrin derivatives.36 However, some of these 
procedures were not successful in our study.  
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Insertion of Al(III) into the inner core of 4-19 (M=2H) was attempted by 
refluxing a mixture of Al(III)Cl3 and 4-19 (M=2H) in pyridine, while following the 
reaction by UV-Vis. However, even after refluxing the solution for several hours, the 
UV-Vis spectrum had absorbances of the protonated form of 4-19, despite using pyridine 
as the solvent media. A different route utilizing an aluminum salt that was less Lewis 
acidic and had previously been successful on metallation of phthalocyanine was 
attempted.37 Al(Me)3 in toluene was added to 4-19 (M=2H) dissolved in toluene and 
refluxed under argon and the reaction followed to completion by UV-Vis. However, 
insertion of this metal was not successful even after refluxing the reaction mixture for 
several days. An alternative route that involved the metallation of the precusor non-
aromatized free-base porphyrin (4-18, M= 2H) was not successful either. Insertion of 
Ga(III) into 4-19 (M=2H) was not as successful as anticipated. The salt that was used was 
Ga(III)Cl3, which is a very hygroscopic salt, that fumes on exposure to air and is also 
very Lewis acidic. This procedure was carried out by refluxing a solution of Ga(III)Cl3 
and 4-19 (M=2H) in dimethylformadide38 with a few drops of triethylamine and followed 
by UV-Vis. The reaction was let to go for 12 hours, but never went to completion 
because the UV-Vis spectrum had a sharp Q-band at ~ 660 nm that is typical of TBP 
systems, but there was still some absorbance peaks at 490 nm that corresponded to the 
starting material. Nevertheless, the reaction was stopped and purified on a short alumina 
column. The first band eluted with pure chloroform corresponded to the non-metallated 
species and the polar Ga(III)-TBP complex was eluted by a more polar 2% methanol in 
chloroform solution. However the yield isolated for this compound was only 20%. This 
compound was characterized by 1H NMR in d-chloroform.  
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Figure 4-4: 1H NMR of 4-19 (M= Zn(II)) in DMSO at 300 MHz 
 
The spectrum had two multiplet peaks at 8.62 and 8.42, respectively, corresponding to 
the ortho and meta protons on the phenyl groups, while the benzylic protons also 
appeared as two sets of multiplets at 7.36 and 7.14 ppm and the methyl ester groups 
appeared at 4.2 ppm.  
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Metallation of 4-19 (M= 2H) by reflux with In(III)Cl3 patterning the previous 
procedure were not successful, however 4-18 (M= 2H) was easily metallated 
quantitatively with In(III)Cl3 by refluxing in pyridine for 1 hour. The reaction was 
followed by UV-Vis to completion and was purified by evaporating off the pyridine in 
vacuo, redissolving the porphyrin in chloroform and washing it with water (3 × 100 mL) 
to get rid of the excess salt. The solution was then dried over sodium sulfate, evaporated 
to dryness and filtered through an alumina plug. The compound was characterized by MS 
(MALDI) with a molecular ion peak at 1177.99 and 1H NMR, a multiplet ~ 8.53-8.23 
corresponding to the ortho and meta protons, while the methyl group on the ester 
appeared at 4.15 ppm and the signals corresponding to the methylene protons appearing 
between 2.9 and 1.3 ppm. UV-Vis had a Soret band at ~ 443 nm and a Q band at ~ 574 
nm. The metallated In(III)-TCHP complex was then aromatized to the TBP complex 
using the aromatization procedure as described above. This reaction was followed by 
UV-Vis for the strong q-band at ~ 650 nm that is typical of TBPs and afforded the 
In(III)TBP-complex in 75% yield. The In(III)-TBP complex was also characterized by 1H 
NMR, giving a similar spectrum to its non-aromatized precursor, the only difference was 
that there was a new set of multiplet peaks corresponding to the benzylic protons between 
7.4 and 7.2 ppm, and the complete disappearance of the methylene signals.  
Insertion of the diamagnetic metals Sn(IV), Zn(II), Ni(II), Mg(II) and Pd(II) was 
relatively simple and fast by refluxing the corresponding metal salts with 4-19 (M=2H) in 
DMF.39 However, metallation with Sn(IV) using Sn(II)Cl2 required longer reflux hours, 
but the reaction was complete within 6 h. 
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Figure 4-5: 13C NMR of 4-19 (M= Zn(II)) in CDCl3 at 300 MHz 
 
TBP 4-19 (M=2H) was metallated with magnesium methoxide (Mg(OMe)2) salt, the 
insertion was complete in less than one hour, while acetate salts of Ni(II), Pd(II) and 
Zn(II) were used for their respective metallations. It is important to note that metallation 
of 4-19 (M=2H) using Pd(II)Cl2 was not successful even after refluxing for several hours, 
only trace amount of the desired product were isolated. However, metallation with 
Pd(OAc)2 afforded the Pd(II)-TBP complex in quantitative yield. The complexes were 
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characterized by MS (MALDI), 1H NMR, 13C NMR and UV-Vis giving almost identical 
proton spectra with the signals slightly shifted. Figure 4-4 shows the 1H NMR of Zn(II)-
TBP complex. They were also characterized by UV-Vis affording typical TBP spectra 
with two bands, the Soret band between 440-460 nm and one sharp Q-band between 640-
660 nm.40 The Q-band of the Pd(II)-TBP and Ni(II)-TBP complexes gave the highest 
extinction coefficient.  
Metallation reactions are normally affected by the basicity of the corresponding 
porphyrin.33 Metal affinity increases with decreasing basicity. These studies were 
confirmed by comparing the ease of demetallation of Zn(II)-TBP and Zn(II)-tetraaryl-
tetrabenzoporphyrin.24a It was easier to demetallate the latter with TFA in chloroform, 
compared to Zn(II)-TBP. Non-aromatized precursors that are very basic are harder to 
metallate than their corresponding aromatized derivatives. Nevertheless, metallation is 
also affected by other factors such as the size of the metal ion and the solvent used. It is 
well known that the size of a metal ion is affected by its oxidation state and periodic table 
trend.41 This explains why among the group III metals, it was easier to metallate 4-18 
(M=2H) with indium(III) than aluminum(III) and gallium(III) salts. The UV-Vis of the 
metallo-TBP synthesized complexes is shown in Figure 4-6. The effect of changing the 
diamagnetic metal on the UV-Vis spectrum was not as significant as expected. As a result 
of the square planar coordination adopted by the Ni(II) and Pd(II)-TBP complexes, these 
compounds have very high planar symmetries and are not highly distorted out of 
planarity because of a lack of axial ligands resulting to blue shifts observed in their 
respective spectrum. The rest of the TBP complexes have the ability of coordination to 
one or two axial ligands resulting to some distortion of the TBP-complexes out of the 
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plane, having the metal ion not lieing within the porphyrin core.41c The metallo-TBP 
complexes with hydrolysed methyl ester groups (4-20) were synthesized by adding a 
saturated solution of NaOH in methanol to a solution of the metallo-TBP complexes in 
THF and heating at 40 °C for 6 hours.41b  
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Figure 4-6: Absorbance Spectrum of Metallo-TBP Complexes (4-19) at 50 µM in 
  CHCl3 
 
The reaction mixture was cooled down to room temperature, and the resultant 
carboxylic acid metallo-TBP complexes precipitated out of solution upon dropping the 
pH to ~ 5 by dropwise addition of 1M HCl. The corresponding precipitates of the 
metallo-TBP derivatives 4-20 were isolated quantitatively as dark greenish powders. The 
precipitates were washed several times with water to get rid of the excess NaOH salt and 
with dichloromethane to get rid of unreacted organic impurities. The precipitates were 
dried in vacuo and characterized using MS (MALDI) and 1H NMR. 4-20 (M= 2H, Ni(II), 
Pd(II), Zn(II), Sn(IV), In(III)), gave molecular ion peaks at 991.37, 1047.02, 1095.49, 
1051.77, 1109.97, 1104.71 corresponding to each metallo-TBP carboxylic acid 
derivative. The Mg(II)-TBP complex was hydrolysed using the same procedure, however 
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on dropping down the pH of the reaction solution to 5 using 1M HCl, the magnesium 
metal came out. This complex was very acid labile and using a more dilute solution of 
HCl did not hamper the demetallation process. 
 
Figure 4-4: Emission Spectra of TBP Complexes at 50 µM in DMSO 
 
The water-soluble metallo-TBP optical characteristics were studied in DMSO and 
PBS solution. Figure 4-4 shows the emission spectra of Sn(IV)-, Zn(II)- and In(III)-TBP 
4-20, respectively. The studies were done using 50 µM solutions in DMSO while exciting 
at 645 nm. Sn(IV)-, Zn(II)- and In(III)- TBPs had the highest fluorescent quantum yields 
of 7, 1 and 0.5%, respectively, the rest of the complexes Pd(II), Ni(II) and the free base 
porphyrin fluoresce very weakly giving quantum yields of < 1%. Comparing the 
absorption spectra and the emission spectra of the metallo-TBP derivatives, it is evident 
that there is no significant effect when changing the metal ion in the optical absorption 
spectra but substantial change in optical emission properties. Several other authors have 
also reported these optical properties on different metallo-porphyrin derivatives.42 
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Water-soluble TBP derivatives with a different solubilizing group ie phosphonic 
acid groups, were synthesized according to Scheme 4-4. TBP 4-21 (M= Cu(II)), was 
obtained from the synthesis described in Chapter 2 involving a palladium(0) cross-
coupling reaction of 2-18 (M= Cu(II)) with diethylphosphite and was isolated as one of 
the side products in 25% yield. However, this compound can also be synthesized by 
condensation of diethylphosphite benzaldehyde and butanopyrrole patterning the same 
procedure mentioned earlier used to synthesize 4-18 (M= 2H) in 45% yield. TBP 4-21 
(M=Cu(II)) was characterized by MS (MALDI) giving a molecular ion peak at 1421.87 
and was demetallated using H2SO4 as described above, affording 4-21(M= 2H) with a 
molecular ion peak at 1360. 42. The 1H NMR of 4-21 (M= 2H) had two sets of multiplets 
corresponding to the ortho and meta protons at 8.21-8.07 ppm, and benzylic protons also 
appearing as a multiplet at 6.95-6.83 ppm. The CH2 protons on the phosphonate ester 
group appeared as a quartet at 4.23 ppm while the CH3 protons appeared as a triplet at 
1.48 ppm. TBP 4-21 (M= Sn(IV)) was synthesized in quantitative yield by refluxing 4-21 
(M= 2H) with SnCl2 in DMF for six hours. The metallation reactions were monitored by 
UV-Vis. The reaction was stopped and cooled to room temperature, followed by 
evaporation of the DMF solution. TBP 4-21 (M= Sn(IV)) was then redissolved in 
chloroform and purified on an alumina column eluting with 7:3 chloroform and acetone 
solution due to its polarity. The compound was also characterized by MS (MALDI) 
1479.3 and 1H NMR. The hydrolysis to the phosphonic acid groups (4-22) was done by 
dissolving TBPs 4-21 in minimum amount of dichloromethane and adding an excess of 
trimethylsilylbromide (TMSBr). The resulting reaction mixtures were stirred for 24 hours 
under argon at room temperature. The TMSBr and dichloromethane were then evaporated 
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off, and the compound redissolved in basic aqueous methanol and stirred at room 
temperature for another 6 h. TBP 4-22 was also obtained quantitatively and characterized 
by MS (MALDI) X. The photophysical properties of 4-22 (M= 2H, Sn(IV)) were studied 
by Dr. Irina Nestorov; the UV-Vis obtained were typical of TBP-complexes, no 
fluorescence was observed with TBP 4-22 (M= 2H) however, the Sn(IV) complexes 
flouresced at 717 nm when excited from both the Soret and the Q-bands with a stokes 
shift of 46 nm.  
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The water-soluble nido-carboranyl-TBP 4-25 was synthesized in 43% overall 
yield from condensation of butanopyrrole43 and carboranylbenzaldehyde,44 as shown in 
Scheme 4-5. Porphyrin 4-23 was obtained in 60% yield under Lindsey condensation 
conditions and metallated with Cu(II) quantitatively, using copper(II) chloride in 
refluxing toluene. Cu(II) acetate was not used because lower yields of the 
metalloporphyrin were isolated as a result of partial deboronation of the carborane cages 
to the corresponding nido-carborane derivatives.  
  
139 
H
N
NN
N
H
H
H
H
H
H
H
H
H
Na
Na
Na
Na
H
N
NN
N
H
H
H
H
H
4-23
4-25
C
BH
H
N
NN
N
H
H
H
H
H4-24
1. CuCl2, toluene, reflux
2. DDQ (exc.), toluene, reflux
3. conc.H2SO4, rt
1. Bu4NF, THF, reflux
2. Dowex resin Na
Scheme 4-5  
 
Oxidation of the porphyrin Cu(II) followed by demetallation afforded closo-carboranyl-
TBP 4-24 in 75% overall yield. The water-soluble TBP 4-25 was obtained in 95% yield 
by deboronation of the closo-carborane cages of 4-24, using tert-butylammonium 
fluoride in THF,45 followed by cation exchange on a Dowex 50WX2-100 resin in the 
sodium salt.43 In the presence of pyridine/piperidine43 the deboronation reaction was 
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incomplete, even after 48 h at room temperature. TBP 4-25 was highly soluble in polar 
organic solvents, such as acetone, methanol and DMSO, and sparingly soluble in water.  
Porphyrins 4-23, 4-24 and 4-25 were characterized by MS (MALDI), UV-Vis and 1H 
NMR. An X-ray crystal structure of the Cu(II) complex of 4-24 was obtained by growing 
the crystals by slow diffusion from chloroform into methanol. TBPs 4-24 and 4-25 
display absorption spectra characteristic of TBP’s, with red-shifted bands compared with 
porphyrin 4-23.  
 
Figure 4-7: X-ray Crystal Structure of Cu(II)-carboranyl TBP 
 
The 1H NMR spectra of TBPs 4-24 in acetone show two distinctive doublets for 
the ortho- and meta-phenyl protons around 8 ppm, broad signals for the benzo protons 
around 7 ppm, a singlet for the CH-carborane protons appeared at 4.33 pm, and broad 
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signals for the BH between 2.6 ppm and 1.5 ppm for the BH proton and NH protons 
appearing at -1.04 ppm. The water-soluble TBP 4-25 had a similar 1H NMR spectrum as 
TBP 4-24 with the aromatic and benzylic protons appearing at the same resonances. The 
only difference is that there was an up field shift for the singlet corresponding to the 4 
CH protons which now appeared at 2.69 ppm. In addition, the four protons on the open-
face of the carborane cages of TBP 4-25 appear as a broad singlet at –2 ppm. The MS 
obtained for porphyrins 4-23, 4-24 and 4-25 gave molecular ion peaks with MS (MALDI) 
at 1401.15, 1385.03 and 1433.61, respectively. TBP 4-25 also fluoresced weakly at 630 
nm when excited at 511 nm. 
4-4: Conclusion 
An expeditious route to the synthesis of several water-soluble TBP derivatives was 
developed. Several water-solubilizing groups were attached to the TBPs periphery and 
several diamagnetic metal ions in the TBPs core. So far, the photophysical evaluations do 
not reveal any significant change in the absorption spectrum with the Soret bands and Q- 
bands clustering at around 440-460 nm and 640-660 nm, respectively. However, there 
was a significant change in the emission spectra evident with the high fluorescence 
quantum yields exhibited by Sn(IV)-TBP. The preliminary biological evaluations done of 
the intracellular uptake and phototoxicity show that TBP 4-22 (M= 2H) and TBP 4-20 
(M= 2H) are taken up more compared to the TBP 4-22 (M= Sn(IV)) and TBP 4-20 (M=  
Pd(II)). This is probably because the free-base TBPs aggregate and are taken in more into 
the cells via endocytosis. The phototoxicity evaluations also correlate to the cellular 
uptake results with TBP 4-22 (M= 2H) being most toxic when exposed to dose light (1J/ 
cm2). The corresponding TBP complexes with carboxylic and phosphonic acid groups 
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localized in the vesicles and also exhibited low dark toxicity at concentrations as high as 
100 µM. TBP 4-25 fluoresced weakly, and localized in the cell lysosome and had very 
low dark toxicity with no significant cell death even at concentration as low as 300 µM.46 
Animal toxicity studies reveal that there were no clinical, biochemical, or 
histopathological effects observed which could be attributed to administration of 
compounds 4-25. The maximum tolerated dose was only limited by the solubility of the 
extract, and was thereby determined to be 160 mg/kg at an administered concentration of 
4 mg/ml.47 
4-5: Experimental 
Commercially available starting materials were purchased from Sigma-Aldrich 
and used without further purification. All solvents were purchased from Fisher Scientific 
(HPLC grade) and either directly used or dried and distilled according to literature 
procedures. Silica gel 60 (70-230 mesh, Merck) and alumina grade III (70-230 mesh 
ASTM) were used for column chromatography. Analytical thin-layer chromatography 
(TLC) was performed on Merck 60 F254 silica gel (precoated sheets, 0.2 mm thick). 1H-
NMR spectra were obtained using a Bruker DPX 250 MHz or 300 MHz spectrometer; 
chemical shifts are expressed in ppm relative to TMS (0 ppm). Electronic absorption 
spectra were measured on a Perkin Elmer Lambda 35 UV-Vis spectrophotometer and 
fluorescence spectra on a Perkin Elmer LS55 instrument. Low resolution MS analyses 
were conducted at the LSU Mass Spectrometry Facility on a Bruker Prolix III MALDI-
TOF mass spectrometer, and the HRMS were conducted at the Ohio State University 
Mass Spectrometry and Proteomics Facility. Melting points were measured on an 
Electrothermal MEL-TEMP instrument. 
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5,10,15,20-Tetra[(4-methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-butanoporphyrin 
(4-18 (M= 2H)) 
Freshly distilled dry dichloromethane (300 mL) was added to a round bottom flask fitted 
with a reflux condenser, under argon. 3:4-Butanopyrrole (0.35 g, 3 mmol) and 4-methyl 
formylbenzoate (0.49 g, 3 mmol) were added and the solution was stirred at room 
temperature under a slow steady stream of argon for 15 min. The flask was then shielded 
from ambient light and BF3•(OEt)2 (0.04 mL, 0.214 mmol) was added. This mixture was 
then stirred for 1 h at room temperature. DDQ (1.02 g, 4.5 mMol) was added to the 
reaction flask and the final solution turned dark pink instantly. This solution was refluxed 
under argon for 1 h to give a dark green solution. The solvent was reduced to dryness 
under vacuum and the resulting residue was dissolved in dichloromethane and filtered on 
an alumina plug so as to get rid of the excess DDQ and then purified by alumina column 
chromatography using 2% methanol in dichloromethane for elution. Recrystallization 
from hot methanol afforded purple crystals of the title porphyrin (0.46 g, 60% yield). 1H 
NMR 300 MHz (CDCl3), 8.58-8.5, (m, 16H, o and m-ArH) 4.12 (s, 12H), 2.15-2.0 (m, 
16H, CH2), 1.25-1.15 (m, 16H): UV-Vis (CH2Cl2) λmax nm Log ε 473 (5.4), 618 (4.2), 
676 (4.37): Maldi (MS) 1064. 35 
Synthesis of Cu(II)-5,10,15,20-tetra(methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-
butanoporphyrin (4-18, M= Cu(II)) 
An excess of Cu(OAc)2.2H2O was added to a solution of porphyrin (200 mg, 0.18 mmol) 
dissolved in 20 mL of toluene with a few drops of triethylamine. The mixture was 
refluxed for 6 hours and the conversion monitored by UV-Vis spectroscopy in 
chloroform for the complete upon dissappearance of the Soret band at ~ 440 nm. The 
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mixture was passed through a quick alumina plug and eluting with chloroform to get rid 
of excess salt. The solvent was evaporated to dryness and the residue recrystallized out of 
chloroform and methanol affording 0.18 g of pure reddish crystals of 4-18 (M= Cu(II)) in 
98% yield. Maldi (MS) 1123.91 : UV-Vis (CH2Cl2) λmax nm (Log ε)  429 (5.25), 562 
(4.25), 597 (4.1) 
Cu(II)-5,10,15,20-tetra(methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-
benzoporphyrin (4-19, M= 2H) 
(100 mg, 0.08 mmol) of 4-18 (M= Cu(II)) was dissolved in 50 mL of toluene. An eight-
fold excess of DDQ was added and the mixture was refluxed for 15 minutes. During 
refluxing the color changed from a red-brown color to deep green. The mixture was 
allowed to cool, diluted with chloroform and filtered through an alumina plug eluting 
with chloroform. The solvent was removed in a vacuum and the remaining solid 
recrystallized from chloroform and methanol to affording a blue-greenish crystals 78 mg, 
in 80% yield. Maldi (MS) 1107.32.91 : UV-Vis (CH2Cl2) λmax nm (Log ε) 445 (5.23), 602 
(4.19), 650 (4.86) 
(60 mg, 0.05 mmol) of 4-19 (M= Cu(II)) was dissolved in 10 mL of H2SO4 and the 
mixture stirred at room temperature for 5 minutes. The UV-Vis of the spectrum had the 
Soret band of the dication at ~ 502 nm and demetallation was considered complete upon 
dissappearance of the Soret band of Cu complex. The mixture was poured into ice water 
and extracted into basic chloroform. The solvent was evaporated in vacuo and the 
resultant residue passed through an alumina plug eluting with chloroform and 
recrystallized out of chloroform and methanol affording 48 mg of 4-19 (M= 2H) in 85% 
yield as a green powder. 1H NMR 300 MHz (CDCl3), 8.63, (m, 16H, ArH) 7.2 (br, s, 
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16H) 4.68 (s, 12H), -1.05 (s, 2H, NH): UV-Vis (CDCl3) λmax nm (Log ε) 467 (5.48), 595 
(4.32), 644 (4.65), 701 (4.26): Maldi (MS) 1047.56: 13C NMR (300 MHz): 167.8, 146.6, 
135.3, 131.2, 130.7, 126.8, 126.8, 124.7, 115.5, 53.1 
20 mg, 0.019 mmol of 4-19 (M= 2H) in THF and 2 mL of a saturated NaOH solution in 
methanol were heated at 40 °C for 6 hours. The reaction was let to cool and the pH 
lowered to ~ 5 by adding dropwise 1 M HCl solution. A green precipitate crushed out of 
the solution and was washed  with water (3 × 100 mL) and dichloromethane 100 mL. 18 
mg of the carboxylic acid derivative was obtained in 95% yield. MS (Maldi) 991.37 
Zn(II)-5,10,15,20-tetra(4-carboxylic-acid)phenyl-2:3,7:8,12:13,17:18-
benzoporphyrin (4-20, M= Zn(II)) 
50 mg (0.04 mmol) of 4-19 (M= 2H), 2 mL of a Zn(OAc)2 saturated solution in methanol 
and 10 mL of dimethylformadide were refluxed under argon for 30 minutes. The 
conversion was monitored by UV-Vis to completion. The solution was cooled to room 
temperature and the DMF evaporated off to dyrness and the residue redissolved in 
chloroform and filtered through an alumina plug eluting with chloroform that had a few 
drops of triethylamine. The product was recrystallized out of chloroform and methanol 
affording  40 mg of 4-19 (M= Zn(II)) in a 80% yield. 1H-NMR 300 MHz (CDCl3), 8.56-
8.49, (m, 16H, o and m-ArH) 7.33-7.30 (m, 8H) 7.07-7.04 (m, 8H) 4.68 (s, 12H): UV-Vis 
(DMSO) λmax nm (Log ε) 472 (5.9), 614 (3.99), 658 (4.09): Maldi (MS) 1112. 25 : 13C 
NMR, 300 MHz ; 165.21, 158.78, 158.51, 158.24, 149.12, 144.32, 140.12, 137.51, 
13215, 128.74, 43.31. 
The corresponding methly ester groups were hydrolysed to carboxylic acid groups by 
dissolving 20 mg, 0.02 mmol of 4-19 (M= Zn(II)) in THF and adding 2 mL of a saturated 
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NaOH solution in methanol and heating the corresponding mixture at 40 °C for 6 hours. 
The reaction was let to cool and the pH lowered to 5 by adding dropwise 1 M HCl 
solution. A green precipitate crushed out of the solution and was washed  with water (3 × 
100 mL) and dichloromethane 100 mL. 20 mg of the carboxylic acid derivative was 
obtained in 94% yield. MS (Maldi) 1056.9 
Sn(IV)-5,10,15,20-tetra(4-carboxylic-acid)phenyl-2:3,7:8,12:13,17:18-
benzoporphyrin (4-20, M= Sn(IV)) 
50 mg (0.04 mmol) of 4-19 (M= 2H), 2 mL of a Sn(Cl)2 saturated solution in methanol 
and 10 mL of dimethylformadide were refluxed under argon for 6 h. The conversion was 
monitored by UV-Vis to completion. Similar purification procedure mentioned above 
was followed. However, during filtration through an alumina plug, 2% methanol in 
chloroform was used instead, affording 45 mg of the desired compound in a  85% yield. 
1H-NMR 300 MHz (CDCl3), 8.70-8.52, (m, 16H, o and m-ArH) 7.53-7.15 (m, 16H) 4.21 
(s, 12H): UV-Vis (DMSO) λmax nm (Log ε) 463 nm (4.84), 662 nm (4.2): Maldi (MS)  
1165. 3 : 13C NMR, 300 MHz ; 165.21, 158.78, 158.51, 158.24, 149.12, 144.32, 140.12, 
137.51, 13215, 128.74, 43.31. 
20 mg, 0.017 mmol of 4-19 (M= Sn(IV)) in THF and 2 mL of a saturated NaOH solution 
in methanol were heated at 40 °C for 6 hours. The reaction was let to cool and the pH 
lowered to 5 by adding dropwise 1 M HCl solution. A green precipitate crushed out of 
the solution and was washed  with water (3 × 100 mL) and dichloromethane 100 mL. 17 
mg of the carboxylic acid derivative was obtained in 90% yield. MS (Maldi) 1109.9 
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Ni(II)-5,10,15,20-tetra(4-carboxylic-acid)phenyl-2:3,7:8,12:13,17:18-benzoporphyrin 
(4-20, M= Ni(II)) 
A 2 mL saturated solution of Ni(OAc)2 and another of Pd(OAc)2 in methanol were added 
to two flasks respectively each containing 50 mg (0.04 mmol) of 4-19 (M= 2H)  
dissolved in 10 mL of dimethylformadide ; the following solutions were refluxed under 
argon for 1 h. The procedure mentioned previously was patterned. The desired Ni(II)-
TBP complex and Pd(II)-TBP complex were isolated in 85% and 80% yield respectively 
affording 37 mg and 36 mg of the respective complexes. 
Ni(II)-TBP 
1H-NMR 300 MHz (CDCl3), 8.40-8.08, (m, 16H, o and m-ArH) 7.07-6.91 (m, 16H) 4.05 
(s, 12H): UV-Vis (DMSO) λmax nm (Log ε) 450 nm (4.84), 648 nm (4.42): Maldi (MS)  
1103. 92: 13C NMR, 300 MHz (CDCl3) 167.6, 145.7, 138.5, 158.24, 137.0, 134. 2, 131.1, 
130.8, 125.7, 123.7,  115.3, 52.9. 
Pd(II)-TBP 
1H-NMR 300 MHz (CDCl3), 8.56-8.37, (m, 16H, o and m-ArH) 7.21-7.08 (m, 16H) 4.16 
(s, 12H): UV-Vis (DMSO) λmax Log ε 445 nm (4.32), 610 nm (4.06): Maldi (MS) 1152. 
87: 13C NMR, 300 MHz  CDCl3; 167.2, 146.1, 138.1, 137.6, 134.1, 130.8, 130.4, 125.7, 
123.8,  117.3, 53.6. 
20 mg, 0.018 mmol of 4-19 (M= Ni(II)) and 20 mg, 0.017 mmol of (M= Pd(II)) in two 
round bottomed flasks each in THF and with 2 mL of a saturated NaOH solution in 
methanol were heated at 40 °C for 6 hours. The reaction was let to cool and the pH 
lowered to 5 by adding dropwise 1 M HCl solution. A green precipitate crushed out of 
each solution and was washed  with water (3 × 100 mL) and dichloromethane 100 mL. 18 
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mg of Ni(II)-derivative and 17 mg of Pd(II)-derivative of the carboxylic acid derivative 
were obtained in 95% and 91%yield respectively. MS (Maldi) 1047.02 for the Ni(II)-
derivative and 1095.49 for the Pd(II) derivative. 
5,10,15,20-Tetra[(4-methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-butanoporphyrin 
4-18 (M= In(III)) 
 80 mg, 0.075 mmol of 4-18 (M= 2H) was dissolved in 10 mL of pyridine, and a 3 mL 
solution of saturated InCl3 in methanol added to the mixture. The mixture was refluxed 
under argon for 1 hr while monitoring by UV-Vis to the complete metal insertion. The 
reaction was then allowed to cool and pyridine evaporated off to dryness under vacuo. 
The residue had a purple-greenish color was redissolved in chloroform and washed with 
water (3 × 100 mL) so as to get rid of the excess salt. The solvent was dried over sodium 
sulfate, redissolved in chloroform and filtered through an alumina plug isolating pure 
In(III)-porphyrin complex in 90% yield, 79 mg. 1H NMR 300 MHz (CDCl3), 8.53-8.23, 
(m, 16H, o and m-ArH) 4.15 (s, 12H) 2.93 (br s, 16H), 1.16-1.30 (m, 16H): UV-Vis 
(CH2Cl2) λmax nm (Log ε) 443 (5.05), 574 (4.02): Maldi (MS) 1177.07: 13C NMR, (250 
MHz) CDCl3 168.9, 148.2, 148.0, 143.7, 136.1, 131.7, 130.6, 130.3, 119.7, 54.0, 33.1, 
28.6, 24.9, 24.2 
60mg, 0.05 mmol of 4-18 (M= In(III)) was dissolved in 5 mL of toluene and 92mg, 3.2 
mmol of DDQ added to the resultant mixture. The same aromatization procedure 
followed by work up was patterned affording 4-19 (M= In(III)) in 43 mg in a 75% yield 
as deep green crystals. 1H NMR 300 MHz (CDCl3), 8.40-8.08, (m, 16H, o and m-ArH) 
7.07-6.91 (m, 16H) 4.05 (s, 12H): UV-Vis (DMSO) λmax nm (Log ε) 462 (4.87), 642 
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(4.07): Maldi (MS) 1162. 81: 13C NMR, 250 MHz (CDCl3) 167.5, 147.3, 145.2, 143.6, 
138.5, 134. 8, 131.5, 130.8, 129.4, 128.6, 127.3, 125.7, 125.3,117.0, 53.0 
5,10,15,20-Tetra[4-(diethylphosphonate)phenyl-tetrabenzoporphyrin(4-21) 
80 mg, 0.06 mmol of Tetrabenzoporphyrin 2-18 (M= Cu(II)) and 7 mg, 0.006 mmol  of 
Pd(PPh3)4 were placed in an oven dried Schlenk tube.  The tube was capped with a rubber 
septum and evacuated and backfilled with argon, this procedure was done three times. 60 
mL of toluene was cannulated to the schlenk tube and the tube purged with argon for five 
minutes. The resultant solution was then sonicated under argon until the compound had 
solubilized. 5 mL of triethylamine and (0.19 mL, 0.2 mmol) of diethylphosphite were 
then added and the resultant solution refluxed at 100 °C for 96 hours following by TLC 
for the consumption of the starting material. After 96 hours, there was no significant 
increase in the yield of the desired product and the reaction was stopped and quenched by 
adding 100 mL of water to the reaction mixture. The resultant reaction mixture was 
diluted with chloroform and washed (3 × 100 mL) with water so as to get rid of the 
unreacted diethyl phosphite. The solution was then dried over sodium sulfate and 
concentrated in vacuo. Purification was done on a silica gel column with eluting with a 
gradient solution of 10% acetone in chloroform and gradually increasing the polarity to 
30% acetone in chloroform. 4-21(M= Cu(II)) was obtained as green crystals 22 mg in 
25% yield. MS (MALDI) m/z 1421.87 (M+): 1H NMR 300 MHz (CD3OH), 8.21-8.07, 
(m, 16H, o and m-ArH) 6.95-6.83 (m, 16H) 4.30-4.22 (q, 16H), 1.48-1.35(t, 24H) 
22 mg, (0.015 mMol) of 4-21 (M= Cu(II)) was dissolved in concentrated sulfuric acid 
and stirred at room temperature for five minutes. The reaction was quenched following 
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the demetallation procedure previously mentioned affording 20 mg of pure 4-21 (M= 2H) 
quantitatively. MS (MALDI) m/z 1360.42 (M+) 
4-21 (M= Sn(IV) was synthesized by refluxing 20 mg (0.014 mmol) of 4-21 (M= 2H) in 
DMF and excess SnCl2 for six hours. The reaction was stopped and the reaction mixture 
cooled down to room temperature before evaporating off the DMF. The reaction mixture 
was then redissolved in chloroform and washed with 100 mL of water. The solvent was 
then dried over sodium sulfate, evaporated and purified on an alumina column eluting 
with 7:3 chloroform and acetone affording 18 mg of 4-21 (M= Sn(IV) in 86% yield. MS 
(MALDI) m/z 1479.3 (M+): 1H NMR 300 MHz (CD3OH), 8.66-8.62, (m, 8H, o and m-
ArH) 8.34-8.27 (m, 8H), 7.47-7.28 (m, 16H) 4.41-4.28 (q, 16H), 1.49-1.44 (t, 24H) 
5,10,15,20-Tetra[4-(phosphonic acid)phenyl-tetrabenzoporphyrin (4-22) (M= 2H) 
A solution of 4-21 (M= 2H) in dichloromethane (15 mg, 0.01 mmol) and TMSBr (0.5 
mL, 3.7 mmol) was stirred at room temperature. After 24 hours, the solvent was removed 
under reduced pressure and the residue dissolved in 5 mL of methanol and 1 mL of 0.1 M 
NaOH solution and stirred at room temperature for half an hour. The pH of the solution 
was dropped to ~ 5 by the dropwise addition of 1M HCl and a green precipitate crushed 
out of solution. The precipitate was washed with water (3 × 100 mL) and 100 mL of 
dichloromethane and dried under vacuum to afford 15 mg of desired compound in 
quantitative yield. 
5,10,15,20-Tetra[4-(o-carboranyl)phenyl]-2:3,7:8,12:13,17:18-butanoporphyrin (4-
23)  
 
3:4-Butanopyrrole  (0.13 g, 1.06 mmol) and of 4-(o-carboranyl)benzaldehyde (0.26 g, 1.06 
mmol) were dissolved in dried, freshly distilled dichloromethane and the solution was stirred 
at room temperature under argon for 15 minutes. The reaction flask was shielded from 
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ambient light and BF3•OEt2 (0.02 mL, 0.106 mmol) was added. This solution was stirred for 
1 h at room temperature before DDQ (0.36 g, 1.59 mmol) was added and the final mixture 
refluxed under argon for 1 h to give a dark green solution. After cooling down to room 
temperature, the solvent was evaporated under vacuum and the resulting residue was purified 
by alumina grade III column chromatography using dichloromethane for elution. 
Recrystallization from methanol gave purple crystals of the title porphyrin (0.22 g, 60% 
yield). m. p. > 300 °C; 1H NMR (CDCl3, drop of d-TFA, 300 MHz): δ 8.36 (d, 8H, J = 8.27 
Hz, o-PhH), 8.03 (d, 8H, J = 8.27 Hz, m-PhH), 4.33 (s, 4H, carborane-CH), 3.5-1.3 (br, 40H, 
BH), 2.36 - 1.15 (m, 32H, CH2), -0.47 (s, 4H, NH). UV-Vis (CH2Cl2): λmax nm (log ε) 466 
(4.52), 617 (3.36), 674 (3.60) nm. HRMS (MALDI) m/z 1401.1681, calculated for 
C68H94N4B40 1401.1582.  
5,10,15,20-Tetra[4-(o-carboranyl)phenyl-tetrabenzoporphyrin (4-24) 
To a solution of 4-23 (150 mg, 0.11 mmol) in toluene (20 mL) was added an excess of 
copper(II) chloride (143 mg, 1.06 mmol). The mixture was refluxed until the reaction was 
complete, for about 2 h, as evidenced by TLC and UV-Vis spectrophotometry. The solvent 
was evaporated under vacuum, the residue dissolved in dichloromethane (150 mL) and 
washed once with aqueous saturated NaHCO3 and once with water before being dried over 
anhydrous Na2SO4. After removal of the solvent under vacuum the remaining residue was 
purified by alumina grade III column chromatography using dichloromethane for elution. 
The Cu(II)-porphyrin was recovered in quantitative yield upon precipitation using 
dichloromethane/ethanol. To a solution of this Cu(II)-porphyrin (150 mg, 0.102 mmol) in 
toluene (20 mL) was added excess DDQ (185 mg, 0.82 mmol) and the final mixture was 
refluxed for 15 minutes. During reflux the color of the solution changed from red to deep 
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green. The mixture was then allowed to cool down to room temperature, diluted with 
chloroform (150 mL) and washed once with aqueous saturated NaHCO3 and once with 
water. The solvent was removed under vacuum, and the remaining residue was purified 
by alumina grade III column chromatography using chloroform for elution. 
Recrystallization from methanol afforded Cu(II)-tetrabenzoporphyrin (110 mg) as dark 
green crystals in 75% yield. Cu(II)-Tetrabenzoporphyrin (110 mg, 0.076 mmol) was 
dissolved in concentrated sulfuric acid and stirred at room temperature for five minutes. 
The solution was poured into a water/ice bath and extracted with chloroform (4 x 150 
mL).  The organic layers were collected, dried over anhydrous Na2SO4 and the solvent 
evaporated under vacuum. The resulting residue was recrystallized from methanol to give 
green crystals of the title compound (105 mg) in quantitative yield from Cu(II)-
tetrabenzoporphyrin. M. p. > 300 °C; 1H NMR (acetone-d6, 250 MHz): δ 8.34 (d, J = 8.35 
Hz, 8H, o-PhH), 8.17 (d, J = 8.35 Hz , 8H, m-PhH), 7.49-6.93 (br m, 16H, benzoH), 5.55 (s, 
4H, carborane-CH), 3.5-1.4 (br, 40H, BH), -1.04 (br s, 2H, NH). UV-Vis (CH2Cl2): λmax nm 
(log ε) 467 (10.10), 553 (3.80), 593 (4.00), 643 (4.37), 698 (3.90) nm. HRMS (MALDI) 
m/z 1385.0347, calculated for C68H78N4B40 1385.0326.  
5,10,15,20-Tetra[4-(nido-carboranyl)phenyl-tetrabenzoporphyrin (4-25) 
Tetrabenzoporphyrin 4-24 (25 mg, 0.018 mmol) was added to a 1 M solution of 
Bu4NF•3H2O in THF (0.32 ml, 1.08 mmol) and the solution was refluxed for 6 h. After 
cooling down to room temperature, the solvent was removed under vacuum, the residue 
dissolved in dichloromethane and washed once with water before being dried over 
anhydrous Na2SO4. The solvent was evaporated under vacuum, the residue redissolved in 
methanol and purified on a Sephadex LH-20 column, using methanol for elution. The 
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resulting residue was dissolved in 40% aqueous acetone and passed slowly through a 
Dowex 50WX2-100 resin in the sodium form. The porphyrin fraction was collected, 
dried under vacuum, redissolved in 60% aqueous acetone and passed twice through the 
ion-exchange resin. Removal of the solvent under vacuum gave the title 
tetrabenzoporphyrin (24 mg) in quantitative yield as a green powder. M. p. > 300 °C; 1H 
NMR (acetone-d6, 250 MHz): δ 8.04 (d, J = 8.22 Hz, 8H, o-PhH), 7.82 (d, J = 8.22 Hz, 
8H, m-PhH), 7.48-7.28 (br m, 16H, benzoH), 2.69 (s, 4H, carborane-CH), 2.9-1.3 (br, 
36H, BH), -1.13 (s, 2H, NH), -2.25 (br s, 4H, BH). UV-Vis (CH2Cl2): λmax (log ε) 464 
(5.2), 542 (3.73), 585 (3.97), 637 (4.27), 694 (3.60) nm. LRMS (MALDI-TOF) m/z 
1433.619.  
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Chapter 5: Synthesis of 5,10,15-Triaryl-2:3,7:8,12:13,17:18-Butanocorroles and 
5,10,15-Triaryl-2:3,7:8,12:13,17:18-Benzocorroles 
 
5-1: Introduction 
N N
N HN
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N
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Figure 5-1: Porphyrin, Corrole and Corrin Structure
N HN
NH HN
5-1 5-35-2
 
 
Corroles (5-2) are porphyrinoid compounds in which one of the meso atoms is 
replaced with a direct pyrrole-pyrrole bond.1 They were first synthesized more than 30 
years ago, and were an outcome of Johnson’s and Kay’s research, as they were trying to 
use corroles as a precursor to the synthesis of the corrin ring while trying to develop a 
synthetic methodology to vitamin B12.2 Corroles (5-2) are considered to be intermediates 
between porphyrins (5-1) and corrins (5-3) because of their structure (Figure 5-1).3 The 
structure of corroles was first confirmed by an X-ray crystal structure by Harrison et al in 
1971.4 These authors reported that the structure was not strictly planar because of the 
short C-N bonds induced by the direct C1-C19 carbon link. Unlike D4h symmetry 
possessed by unsubsituted porphyrins (5-1), unsubstitued corroles (5-2) posses a C2v 
symmetry which is as a result of steric strain in the macrocylic ring which normally 
forces the molecule slightly out of the plane of the four nitrogens.5 
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Corroles are aromatic in nature retaining an 18-π electron system that is in close 
resemblance to porphyrins. The inner core hydrogens atoms are subject to shifts giving 
rapidly interconverting structures. Dyke et al.6 and Ghosh et al.7 did extensive theoretical 
calculations that suggested a fast NH tautomerisation in free-base corroles with no 
significant energy difference between the possible tautomers (Scheme 5-1). As a result of 
high stability and intense color, corroles qualify as porphyrin-like macrocyles having 
spectroscopic and chemical properties that reveal a close relationship to porphyrins. 
Corrroles have UV-Vis spectra that show intense absorptions around 400 nm and weaker 
bands at ~ 500-600 nm that can be related to the Soret and Q bands of porphyrin systems, 
indicating the presence of an aromatic system. Corroles also have luminescent properties 
with emission bands at ~ 600 nm and very short Stokes-shifts.8 The 1H NMR spectra of 
corroles reveal a diamagnetic current effect with all resonances showing significant shifts 
similar to those observed in the porphyrin analogues.9 A unique property of corroles is 
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that they have three inner core protons and are therefore trianionic ligands with a smaller 
cavity compared to porphyrins, corroles also tend to stabilize metals of higher oxidation 
states.10 The free-bases of corroles are usually more acidic than porphyrins, easily 
forming monoanionic species in slightly basic media while retaining their aromaticity 
(have a Soret Band).8a They also generate monoprotonated derivatives with dilute acids, 
the addition of the proton occurring at the inner core nitrogen atom while still retaining 
their Soret band in the absorption spectrum. However, stronger acids tend to cause 
significant changes in the absorption spectra resulting to the disappearance of the Soret 
band because of meso-protonation either at positon 5 or 15, which results in a interruption 
of the π-conjugation system.11 
Corroles find applications as catalysts because of their ability to stabilize metals 
of high oxidation states, such as Ni(III), Cu(III), Fe(IV) and Co(IV), among others. They 
have been shown to be good catalysts for epoxidations, cyclopropanations, 
hydroxylations12 and aziridination,13 in addition to finding applications as molecular 
magnets and sensors. Aviezer et al also demonstrated certain corroles to have potential as 
anti-tumor candidates.14 
5-2: Historical Background on the Syntheses of Corroles 
Corroles have been the focus of significant synthetic efforts in recent years, which 
have led to the discovery of facile synthetic methods to make corroles and their metal 
complexes.15 The synthetic pathways leading to corroles, however are still rather small in 
number, albeit, a large body of work has been conducted in recent years towards general 
approaches to differently substituted corroles, mainly by the group of Paolesse16 and 
Gross.17 Most corroles synthesis known till 1999 involved biladiene cyclization,18 meso-
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carbon or sulfur extrusion of meso-thia-porphyrin,19 or synthesis from mono-pyrrole 
precursors.20 
5-2-1: Biladiene Cyclization 
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N N
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5-7
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The most general method used to synthesize corroles was the cyclization of a,c-biladiene. 
The synthesis of an a,c-biladiene is described in detail in Chapter 1, Scheme 1-5; it 
involves the condensation of a dipyrromethane dicarboxylic acid (1-19, R= H) with two 
equivalents of a formylpyrrole (1-20) in the presence of HBr.8a The cyclization of the a,c-
biladiene unit to the corrole was first carried out photochemically using a basic 
methanolic solution, by addition of excess ammonia or sodium acetate, affording the 
desired compounds in 20-60% yields.8a Later synthesis reported on cyclizations without 
irradiation using various oxidizing agents under basic conditions.21 It was hypothesized 
that the reaction went through the formation of a bilatriene followed by rapid cyclization, 
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following a free radical pathway. However, this hypothesis was refuted because 
cyclization reactions were not affected in any way by free radical scavengers.22 Another 
postulated mechanism involving the two-electron oxidation of the bilatriene and a 
subsequent conrotarory cyclization to give the corrole, was permitted using Woodward-
Hofmann rules.23 meso-Substituted corroles were synthesized by treating 5-
phenyldipyrromethane-1,9-dicarboxylic (5-4) acid with 2 equivalents of 2-formylpyrrole 
(5-5) in the presence of hydrogen bromide, affording the crystalline a,c-biladiene 
dihydrobromide (5-6) that was then cyclized to afford 10-substituted corrole  (5-7) in 
good yield (Scheme 5-2).24 Metal-free corroles were synthesized by cyclization of 1,19-
dibromo-a,c-biladiene dihydrobromides25 by refluxing in DMF. The precursor a,c-
biladiene was synthesized by condensation of two dipyrromethenes using Friedel-Crafts 
alkylation developed by Johnson and co-workers. 
5-2-2: Synthesis from Monopyrroles 
Cobalta-corroles (5-10) have also been synthesized by the treatment of 5-
hydroxymethylpyrrole carboxylic acid (5-8) with acidic ethanol, in the presence of 
cobalt(II) acetate and triphenylphospine, in 25% yield. This reaction is postulated to 
occur via formation of dipyrromethene (5-9) intermediate which then self condenses to 
afford the desired corrole; this reaction conditions are reported to favor the porphyrin, 
however no porphyrin was isolated.25 The use of 2-formylpyrrole under the same acidic 
conditions and using same cobalt(II) ions afforded a porphyrin and three corroles instead. 
It was postulated that the corrole mixture was because of the intermediacy of the 
dipyrromethenes.26 It is interesting to note that the use of other metals i.e nickel(II) and 
copper(II) in the above reaction afforded only porphyrin. 
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meso-Substituted corrole (5-12) has also been reported to be synthesized by the reaction 
of pyrrole (5-11) and benzaldehyde in a 1:3 ratio in refluxing acetic acid for four hours in 
6% yield (Scheme 5-4).27 Corroles have also been reported as side products during 
porphyrin synthesis using aldehydes and pyrroles.28 
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5-2-3: Synthesis from Bipyrroles 
Johnson et al29 showed that corrole (5-14) could be synthesized by a Mac-Donald-
type (2 + 2) cyclization via the treatment of 2,2’-bipyrrole-5,5’-dicarboxylic acid (5-12) 
with the 1,9-diformyldipyrromethane (5-13) in the presence of acid. These authors 
showed that the presence of a metal salt (Co(II)acetate) and triphenylphosphine was 
imperative, because the reaction failed without the metal salt due to the possible 
formation of a macrocyclic octapyrrole.30 This reaction was also reported to work if the 
fomyl groups were put on either dipyrromethane derivative (Scheme 5-5). 
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5-2-4: Synthesis from Macrocycle Ring Contraction 
 
This synthesis involves the macrocyclic ring contraction of non-aromatic meso-
thiaphlorin (5-17) by the loss of the sulfur atom through an electrocyclic reaction. 5-17 
was synthesized from the (2+2) acidic condensation of dipyrrylsulfide dialdehyde (5-15) 
with dipyrromethane (5-16).31 The corresponding corrole (5-18) was isolated in 60% 
yield by heating 5-17 in o-dichlorobenzene in the presence of PPh3 (Scheme 5-6).32  
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Lower yields of 5-18 were reported in the absence of the triphenylphosphine and when 
there were only alkyl substituents32 present probably because of the instability of the 
corresponding meso-thiaphlorin intermediate. A radical process as the reaction pathway 
was ruled out because the presence of radical scavengers such as hydroquinones or tert-
butyl catechol did not affect the yields of the reaction; this ruled out a radical mechanism 
and indicating a concerted reaction. Further developments on this synthesis have not been 
reported because of the difficulty in the synthesis of the sulfur containing starting 
material and because this approach does not offer significant advantages as to other 
synthetic approaches.1 
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5-2-5: Functionalization of Corroles 
Unlike porphyrins,33 the modification of peripheral positions of corroles has not 
been studied and explored in detail. The major set back demonstrated is the easy 
decomposition of the corrole ring.34 The only reactions reported in literature concern the 
alkylation’s and subsequent rearrangements of the free-base and metallo-corroles35 and 
Vilsmeier reaction24b of free-base corrole. The synthesis of metallo-corroles was reported 
immediately after the discovery of free-base corroles.36 Several metals have been 
successfully incorporated utilizing either the cyclization of 1,19-dideoxybiladienes–a,c 
under the templating effect of a metal or the introduction of a metal into the free-base.37  
The developments of synthetic methodology to metallo-corroles have been mostly 
derived from the extensive knowledge available in porphyrin chemistry.38 In the 
following Chapter, the syntheses of novel Cu(III)-5,10,15-triphenyl-butano corrole and 
its corresponding benzo derivative will be discussed. 
5-3: Results and Discussion 
The synthetic methodology to Cu(III)-5,10,15-triphenylbutano corrole (5-20) was 
adopted from the recent synthesis reported by Paolesse et al.39 These authors reported the 
synthesis of 5,10,15-triphenyl-corrole without the concomitant formation of porphyrin by 
solventless condensation of a 10:1 molar ratio of pyrrole and aldehyde in the presence of 
a catalytic amount of TFA. However, the methodology presented here was tailored to the 
nature of the starting material. Pyrrole 5-19 is a solid at room temperature, and therefore 
had to be dissolved in minimum dichloromethane and condensed with aldehyde 
(benzaldehyde or 4-methylformylbenzoate) in a 5:1 ratio and stirred at room temperature 
for 10 minutes under argon followed by the addition of BF3.OEt2 (Scheme 5-7).  
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The resultant mixture was stirred for two hours and an absorbance was observed by UV-
Vis at ~ 488 nm, DDQ was added and stirred for another 6 hours at room temperature to 
ensure that the oxidation was complete. The corresponding free-base corroles were not 
isolated but the reaction mixture was washed with basic water several times to get rid of 
the excess DDQ, dried over sodium sulfate and the solvent evaporated in vacuo. The 
resultant residue was then redissolved in dichloromethane and stirred at room 
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temperature with an excess of CuCl2 for 24. The reaction was monitored by UV-Vis to 
completion for a Soret band at ~ 400 nm that is typical of metallated Cu(III)-corroles. 
Once complete, when R= H (Scheme 5-7), the resultant mixture was filtered through a 
silica plug to get rid of the base line oligopyrrolic material and eluted with chloroform, 
the desired metallo-corrole was eluted first as a red fraction. The red fraction was then 
purified further on preparative silica gel chromatography, eluting with 55:45 chloroform 
and hexane affording the desired corrole 5-20, (R= H) in 8% yield. During purification, 
the first band to be eluted was olive green in color which has also been observed by 
several authors and reported in literature, followed by a bright red band with an 
absorbance band at 427 nm which was the Cu(II)-porphyrin and the desired corrole was 
eluted third with a Soret band at 409 nm.  
Corrole 5-20, (R= CO2Me) was isolated in 10% yield and there was no formation of the 
porphyrin. The Soret band for this compound was observed at 413 nm. Purification was 
carried out relatively easily on a silica gel column eluting with chloroform. TLC showed 
only one spot and there was no need to purify further by preperative TLC.  
Several experiments were carried out by changing the molar ratios of the reactants 
to try and optimize the yields. A 10:1, 5:1 and 4:1 molar ratio of butanopyrrole and 
benzaldehyde were evaluated, but there was no significant increase in the yield of the 
reaction and the formation of porphyrin was not evaded. An increase in the pyrrole ratio 
resulted in the isolation of lots of unreacted starting material and in addition to this, the 
reaction also had to be done in relatively small scale of (2-3 mMol). An increase in 
corrole yield was observed with less formation of porphyrin when 4-methylformyl 
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benzoate was used probably as a result of the increased electrophilicity on the aldehyde. 
 
Figure 5-1: 1H NMR of Cu(III)-5,10,15-triphenylbutanocorrole (5-20, R= H) in CD2Cl2 
at 300 MHz 
 
The synthesis of corrole using 4-nonylbenzaldehyde was not successful, and only 
afforded trace amounts of Cu(III)-corrole that was not isolated. This reinforces the 
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presumption of isolation of low yields of corrole based on the electrophilic nature of the 
aldehyde used.  
 
Figure 5-1: 1H NMR of Cu(III)-5,10,15-Tri(4-methylcarboxylate-phenyl)-butanocorrole 
(5-20, R= CO2Me) in CD2Cl2 at 300 MHz 
 
Corroles 5-20 (R= H, CO2Me) were characterized by 1H NMR, MS (MALDI) and 
X-ray crystallography. For 5-20 (R= H), the 1H NMR showed a multiplet of peaks 
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between 7.38- 7.23 ppm corresponding to the ortho, meta and para protons on the phenyl 
rings. 
 
Figure 5-3: X-ray Crystal Structure of Cu(III)-5,10,15-Triphenylbutanocorrole (5-20, R= 
H) 
 
 A peak at 2.95 ppm corresponded to the 4 methylene protons on the cyclohexene rings 
adjacent to the directly linked pyrrolic units. The rest of the methylene protons appeared 
between 1.64 and 0.79 ppm as clustered peaks. MS (MALDI) had a molecular ion peak at 
803.94. Corrole 5-20 (R= CO2Me) was also characterized by 1H NMR giving almost 
similar resonances as for R= H, with the ortho and meta protons in the aromatic region 
appearing as sets of multiplets at 8.04- 7.94 ppm and 7.45-7.41 ppm, respectively. The 
methyl groups on the esters did not appear as a single peak but as a singlets at 3.95 and 
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3.87 ppm, while the methylene protons on the cyclohexene rings adjacent to the direct 
pyrrolic link appeared at 2.95 ppm.  
 
Figure 5-3: An x-ray crystal of Cu(III)-5,10,15-triphenylbenzocorrole (5-21, R= H) 
 
The rest of the methylene peaks also appeared clustered between 1.6 and 1.82 ppm. MS 
(MALDI) had a molecular ion peak at 955.07. The subsequent formation of the 
aromatized derivative 5-21(R= H) was carried out patterning the procedure followed in 
the previous chapters. However, 5-21 was isolated in very low yield probably due to the 
unstable nature of the corrole towards peripheral reactions.40 Prolonged oxidation times 
resulted in a significant decrease of the yield of 5-21 (R= H). 5-21 (R= H) was purified 
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on an alumina gel plug eluting with chloroform and because of the low solubility of this 
compound, the plug had to be washed with lots of chloroform, because it was evident that 
the compound was precipitating out of solution. This compound was characterized by MS 
(MALDI) with a molecular ion peak at 793.73 and by X-ray crystallography. The crystals 
were grown by the slow diffusion of methanol into dichloromethane. 1H NMR spectrum 
obtained did not have distinct peaks in chloroform, as a result of solubility problems, and 
the peaks could not be assigned easily. 
5-4: Conclusion 
Two new novel compounds, Cu(III)-5,10,15-butanocorrole and its benzo derivatives were 
synthesized from synthetic methodology adopted from Paolesse et al. These compounds 
were obtained in very low yields as has also been reported by several authors. The first 
X-ray crystal structures of these compounds are presented. These compounds can 
stabilize metal ions of higher oxidation states and can therefore have applications as 
catalysts, molecular magnets and also do have potential as PDT agents as a result of the 
red shifted absorbance observed in Cu(III)-5,10,15-benzocorrole (5-21).  
5-5: Experimental 
Commercially available starting materials were purchased from Sigma-Aldrich 
and used without further purification. All solvents were purchased from Fisher Scientific 
(HPLC grade) and either directly used or dried and distilled according to literature 
procedures. Silica gel 60 (70-230 mesh, Merck) and alumina grade III (70-230 mesh 
ASTM) were used for column chromatography. Analytical thin-layer chromatography 
(TLC) was performed on Merck 60 F254 silica gel (precoated sheets, 0.2 mm thick). 1H-
NMR spectra were obtained using a Bruker DPX 250 MHz or 300 MHz spectrometer; 
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chemical shifts are expressed in ppm relative to TMS (0 ppm). Electronic absorption 
spectra were measured on a Perkin Elmer Lambda 35 UV-Vis spectrophotometer and 
fluorescence spectra on a Perkin Elmer LS55 instrument. Low resolution MS analyses 
were conducted at the LSU Mass Spectrometry Facility on a Bruker Prolix III MALDI-
TOF mass spectrometer, and the HRMS were conducted at the Ohio State University 
Mass Spectrometry and Proteomics Facility. Melting points were measured on an 
Electrothermal MEL-TEMP instrument. 
Cu(III)-5,10,15-tri(4-methylcarboxylate-phenyl)-butanocorrole (5-20, R= CO2Me) 
Butanopyrrole (5-19) (0.25g, 2.1 mmol) was dissolved in 6 mL of dichloromethane and 
allowed to stir to a homogenous solution under argon. 4-Formylmethylbenzoate (68 mg, 
0.42 mmol) was then added to this solution and the solution stirred for another ten 
minutes. BF3. OEt2 was then added and reaction was stirred in the dark for two hours at 
room temperature while monitoring the reaction using UV-Vis for a broad porphyrinogen 
peak at ~ 510 nm. Upon completion, 0.05 g, 0.21 mmol of DDQ was added to the 
reaction mixture and allowed to stir for 12 h. UV-Vis had a band at ~ 460 nm. The 
reaction mixture was then diluted with chloroform, and washed 2 × 100 mL of aqueous 
sodium bicarbonate solution to get rid of the unreacted DDQ, washed with water and 
dried over sodium sulfate. To ease up on purification, the free-base corrole was not 
isolated, but immediately metallated with copper, by stirring in dichloromethane with an 
excess of CuCl2 at room temperature for 24 hours. The mixture was purified on a quick 
silica gel column eluting with chloroform and the first red fraction was collected with a 
Soret band at 413 nm was obtained in 38 mg, 10% yield. MS (MALDI) 955.07: 1H NMR 
(CDCl3, 300 MHz): δ 8.04-7.94 (m, 6H, o-PhH), 7.45-7.28 (m, 6H, m-PhH), 3.95-3.87 (s, 
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9H, CH3), 2.96 (s, 4H, 2CH2), 2.26-0.86 (m, 28H, CH2): UV-Vis (CH2Cl2): λmax nm (log ε) 
413 (5.06), 536 (3.95) 
Cu(III)-5,10,15-triphenyl-butanocorrole (5-20, R= H) 
Butanopyrrole (0.25g, 2.1 mmol) 5-19 was dissolved in 5 mL of dichloromethane and let 
to stir for ten minutes. Benzaldehyde (0.04 mL, 0.41 mmol) and 5 µL (0.03 mmol) of 
BF3.OEt2 were then added to the reaction and let to stir for another 2 hours. The same 
procedure mentioned previously was patterned uptil the metallation. The metallation was 
considered complete when a Soret band at 408 was evident. The reaction mixture was 
then purified through a silica gel plug, eluting with chloroform and the first red band 
eluted was collected. The red fraction was redissolved in dichloromethane, and purified 
on an alumina gel preparative TLC eluting with 55:45 chloroform/hexane. The first band 
was the Cu(II)-butanoporphyrin and the second reddish brownish band was the desired 5-
21(R= H) and was obtained in  31 mg, 8%  yield. MS (MALDI) 803.94: 1H NMR 
(CDCl3, 300 MHz): δ 7.38-7.23 (m, 15H, o, m, p-PhH), 2.96 (s, 4H, 2CH2), 1.64-1,12 (m, 
28H, CH2): UV-Vis (CH2Cl2): λmax nm (log ε) 409 (4.39), 552 (3.56) 
Synthesis of Cu(III)-5,10,15-triphenyl-benzocorrole (5-21) 
20 mg, 0.02 mMol of 5-20 (R= H) was dissolved in toluene and DDQ (45 mg, 0.19 
mMol) was added to the mixture before heating at reflux for 5 minutes. The reaction was 
followed by TLC (alumina) for the appearance of a green streak at the baseline. Once the 
reaction was complete, the mixture was allowed to cool and filtered through an very short 
alumina plug and eluted with around 100 mL of chloroform. UV-Vis, had an absorbance 
band similar to that of Cu(II)-TBP complexes with a split Soret band. MS (MALDI) 
793.73: UV-Vis (CH2Cl2): λmax nm (log ε) 447 (4.57), 459 (4.5), 598 (3.78), 647 (4.1) 
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